Raman spectroscopy and diffuse reflectance spectroscopy for diagnosis of human cancer and acanthosis nigricans by Devpura, Suneetha
Wayne State University
Wayne State University Dissertations
1-1-2012
Raman spectroscopy and diffuse reflectance
spectroscopy for diagnosis of human cancer and
acanthosis nigricans
Suneetha Devpura
Wayne State University,
Follow this and additional works at: http://digitalcommons.wayne.edu/oa_dissertations
Part of the Biomedical Engineering and Bioengineering Commons, and the Condensed Matter
Physics Commons
This Open Access Dissertation is brought to you for free and open access by DigitalCommons@WayneState. It has been accepted for inclusion in
Wayne State University Dissertations by an authorized administrator of DigitalCommons@WayneState.
Recommended Citation
Devpura, Suneetha, "Raman spectroscopy and diffuse reflectance spectroscopy for diagnosis of human cancer and acanthosis
nigricans" (2012). Wayne State University Dissertations. Paper 504.
  
RAMAN SPECTROSCOPY AND DIFFUSE REFLECTANCE SPECTROSCOPY FOR 
DIAGNOSIS OF HUMAN CANCER AND ACANTHOSIS NIGRICANS 
by 
SUNEETHA DEVPURA 
DISSERTATION 
Submitted to the Graduate School 
of Wayne State University, 
Detroit, Michigan 
in partial fulfillment of the requirements  
for the degree of 
DOCTOR OF PHILOSOPHY 
2012 
       MAJOR: PHYSICS 
            Approved by: 
_______________________________________ 
                                     (Advisor)                            Date 
_______________________________________ 
                                     (Co-Advisor)                  Date 
_______________________________________ 
                                             
_______________________________________ 
                                      
           _______________________________________ 
i 
 
 
                                      
 
 
DEDICATION 
 
 
 
 
 
 
“To my loving husband, my parents, and my sisters” 
 
 
 
 
 
 
 
 
ii 
 
ACKNOWLEDGEMENTS 
 I would like to thank advisor Dr. Ratna Naik and my co-advisor Dr. Steven J. Rehse 
for their advice and immense support throughout these years.  Their guidance and 
unconditional support strengthened my abilities to move forward as a graduate student, 
and to achieve my research goals.  
 A researcher cannot be successful unless he or she has a good team to work with; I 
was lucky from the beginning of my work to get involved with kind, supportive,  and friendly 
faculty members of the Wayne State University, and also physicians at Henry Ford Health 
System, Karmanos Cancer Institute, and Children’s Hospital of Michigan.  I would like to 
especially thank Dr. Jagdish S. Thakur.  I consistently received help from Dr. Thakur from 
day one and the extremely helpful discussions I had with him regarding my work were really 
helpful.  I also thank Dr. Vaman M. Naik for his generous advices and support all these 
years and also teaching me everything about the Raman instrument we use, and the 
physics behind it.  I thank Dr. Peter Hoffmann for teaching me the basics of biological 
physics and helpful discussions. 
 I would like to thank all the collaborators who I’ve worked with; Dr. Houbei Dai who 
trained me to use the Raman instrument at the Children’s Hospital of Michigan and helped 
me learn how to take Raman measurements from human tissues.  I’m grateful to Dr. Wael 
Sakr, Dr. Fazlul Sarkar and Dr. Seema Sethi at Karmanos Cancer Center for educating me 
on the biomedical side of the research and providing insight into each cancer type.  I thank 
Dr. Iltefat Hamzavi, Dr. Henry Lim and the team for giving me an opportunity to carry out in 
vivo research at Henry Ford Hospital using diffuse reflectance and colorimetric instruments.  
I thank Dr. Michel D. Klein for allowing me to use his Raman facility at Children’s Hospital of 
Michigan.  I also thank Dr. Janet M. Poulik (Children’s Hospital of Michigan) and Dr. Rajah 
Rabah (University of Michigan-Ann Arbor) for educating me about the morphology of 
iii 
 
pediatric tumors and giving useful tips to train my eyes to identify these tumor or normal 
cells under a microscope.  I also thank Dr. Olena Palyvoda for her kind support. 
I would also like to thank all the professors who strengthened my Physics knowledge, 
Dr. Gavin Lawes, Dr. Paul Keyes, Dr. Sergei Voloshin, Dr. Jhy-Jiun Chang, Dr. Paul Karchin, 
Dr. William Rolnick, Dr. Robert Harr, Dr. Zhixian Zhou and all the other faculty members, 
especially Dr. Jogindra Wadehra for advising me and directing me to complete all the 
necessary documents to complete my thesis work.  Also I thank Dr. Chandran Sudakar and 
Dr. Ambesh Dixit for helping me with the Raman instrument at Physics and for the useful 
discussions. 
There are not enough words to express my gratitude towards my parents, so I’m 
going to simply say “thank you” to my loving parents, Dharmasena Devpura and Lakshmi 
Wijeweera.  I also thank all my sisters for helping me in their own ways, especially my 
third sister, Neluka Devpura for her kind guidance, support, and encouragements to be the 
person I am today. 
There’s a saying that behind every successful man there is a woman, in my case it’s 
quite the opposite.  My loving husband, Akila Kumarasiri, was with me every step of the 
way.  Thank you very much for everything.    
 
 
 
 
 
iv 
 
TABLE OF CONTENTS 
Dedication------------------------------------------------------------------------------------------ii 
Acknowledgments---------------------------------------------------------------------------------iii 
List of Tables-------------------------------------------------------------------------------------vii 
List of Figures------------------------------------------------------------------------------------viii 
Chapter 1 Introduction and Background---------------------------------------------------------1 
1.1 Cancer/Acanthosis Nigricans -----------------------------------------------------1 
1.1.1 Head and Neck Squamous Cell Carcinoma-----------------------2 
1.1.2 Prostate Cancer----------------------------------------------------5 
1.1.3 Pediatric Tumors---------------------------------------------------8 
1.1.4 Acanthosis Nigricans---------------------------------------------12 
1.2  Optical Techniques Used in Diagnosis------------------------------------------14  
1.2.1 Raman Spectroscopy---------------------------------------------15  
1.2.2 Diffuse Reflectance Spectroscopy -------------------------------18 
1.2.3 Fluorescence Spectroscopy--------------------------------------20 
Chapter 2: Raman Spectroscopy and Diffuse Reflectance Spectroscopy ---------------------22 
2.1 Raman Spectroscopy----------------------------------------------23  
2.2 Diffuse Reflectance Spectroscopy---------------------------------29 
Chapter 3: Instrumentation and Data Collection-----------------------------------------------33 
3.1 Instrumentation----------------------------------------------------33 
3.1.1 Raman Spectroscopy------------------------------------33 
3.1.2 Diffuse Reflectance Spectroscopy and Colorimetry----37 
3.2 Tissue Processing--------------------------------------------------40 
3.3 Data Collection and Processing------------------------------------44 
Chapter 4: Statistical Analysis/Chemometric Methods-----------------------------------------49 
   4.1 Principal Component Analysis---------------------------------------49 
v 
 
vi 
 
   4.2 Discriminant Function Analysis--------------------------------------52 
   4.3 Other Statistical Methods--------------------------------------------57 
Chapter 5: Results and Discussion: Raman Spectroscopic Study of HNSCC------------------63  
Chapter 6: Results and Discussion: Raman Spectroscopic Study of Prostatic Intraepithelial 
Neoplasia --------------------------------------------------------------------------77 
Chapter 7: Results and Discussion: Raman Spectroscopic Study of Pediatric Tumors-------93  
Chapter 8: Results and Discussion: Diffuse Reflectance Spectroscopic/Colorimetric Study      
of Acanthosis Nigricans ----------------------------------------------------------110 
Chapter 9: Conclusions and Future Work-----------------------------------------------------136 
Appendix A Supplementary Tables------------------------------------------------------------142 
Appendix B Step by Step Instructions for Data Processing----------------------------------145 
References--------------------------------------------------------------------------------------149 
Abstract-----------------------------------------------------------------------------------------164 
Autobiographical Statement--------------------------------------------------------------------166 
 
LIST OF TABLES 
Table 1.1: A description of TNM clinical staging-------------------------------------------------4 
Table 1.2: International Shimada classification-------------------------------------------------9 
Table 1.3: Peak assignments of Raman spectra-----------------------------------------------16 
Table 5.1: Raman peaks assignment for the observed bands. The Raman shifts written       
in bold face show a significant variation in intensity depending on the   
pathological state of the tissue------------------------------------------------------72 
Table 6.1: Raman peak assignment------------------------------------------------------------83 
Table 6.2: Classification results of BE, PIN, and cancer---------------------------------------86 
Table 6.3: Classification results of stroma in BE, PIN, and cancer----------------------------89 
Table 7.1: The pathologies and the number of Raman spectra obtained from FFPP tissues    
of nine patients-----------------------------------------------------------------------96 
Table 8.1: Percent deviations for prosthesis and patients------------------------------------118 
Table 8.2: Difference in patient average and control subject average for each of the six 
measured parameters expressed in units of sigma (the standard deviation of     
the patient measurements)--------------------------------------------------------125 
Table 8.3: Truth tables for leave-one-out classification results of (a) DRS and (b) 
colorimetry--------------------------------------------------------------------------130 
Table 8.4: Truth tables for patient exclusion classification results of (a) DRS and (b) 
colorimetry--------------------------------------------------------------------------131 
 
Table A1: Pearson correlation with 2-tailed significance for selected 12 Raman bands in 
      head and neck squamous cell carcinoma (see Chapter 5)------------------------142  
Table A2: Correlations between the L*, a*, and b* color parameters (colorimetry) vs 
melanin, oxyhemoglobin (HbO2), and deoxyhemoglobin (Hb) (DRS) measured   
on acanthosis nigricans neck lesions (see Chapter 8)----------------------------143 
Table A3: Percent difference in measured parameters between lesion skin and normal       
skin in the AN study (see Chapter 8)----------------------------------------------144 
 
               
 
vii 
 
LIST OF FIGURES 
Figure 1.1: Tumor sites for head and neck cancers---------------------------------------------3 
Figure 1.2: Tongue squamous cell carcinoma: Invasion of epithelial cells into the stroma---4 
Figure 1.3: Prostate gland------------------------------------------------------------------------5 
Figure 1.4: (a) Low-grade PIN which has a star shaped glandular form with a prominent 
basal layer (b) High-grade PIN shows increased number of atypical cells in    
the lining of the duct----------------------------------------------------------------6 
Figure 1.5: Gleason system of cancer cell architecture-----------------------------------------7 
Figure 1.6: Neuroblastoma with stroma poor in the background -----------------------------10 
Figure 1.7: Ganglioneuroma---------------------------------------------------------------------11 
Figure 1.8: Acanthosis nigricans skin condition in the neck area -----------------------------12 
Figure 1.9: Skin structures----------------------------------------------------------------------13 
Figure 1.10: Typical Raman spectra of cells & biopolymers-----------------------------------15 
Figure 1.11: (A) and (C) are unstained and stained tissue sections respectively which    
have both non-tumor and tumor areas, (B) represents matching colors and  
(D) average spectra: red-muscle tissue, purple-tumor, green- collagen fiber 
and blue and yellow-transition between the two types--------------------------17 
Figure 2.1: Jablonski energy diagram----------------------------------------------------------22 
Figure 2.2: A schematic illustration of scattering and absorption processes -----------------24 
Figure 2.3: Graphical representation of Raman active and inactive modes ------------------25 
Figure 2.4: Specular reflection and diffuse reflection------------------------------------------30 
Figure 3.1: Schematic diagram of Raman Instrument-----------------------------------------33 
Figure 3.2: A schematic of the Renishaw RM1000 Raman spectrometer---------------------35 
Figure 3.3: A Physical set-up of the triax550 Raman spectrometer---------------------------36 
Figure 3.4: A schematic of the interior of the USB 2000 spectrometer. The key optical 
components are representing through 1-8: the entrance fiber, the entrance    
slit, an optical filter, the collimating mirror, the grating, the camera mirror,    
and the detector array -------------------------------------------------------------38 
Figure 3.5: A schematic of the integrating sphere system with SCI and SCE options-------39 
viii 
 
Figure 3.6: Left: DRS setup with spectrometer, light source, calibration plate, bifurcated 
fiber optic cable, and laptop; a close-up of DRS probe showing 2.5 mm fiber   
core. Right: Colorimeter and a close-up of colorimeter 8 mm aperture---------40 
Figure 3.7: Pathological images of H&E stained tissue section and unstained tissue            
section ------------------------------------------------------------------------------42 
Figure 3.8: Raw spectrum, where black line shows the adaptive minmax fit                      
(b) De-noised, fluorescence subtracted and normalized spectrum--------------46 
Figure 3.9: Left: DRS probe applied to patient’s posterior neck; Right: Colorimeter 
measuring patient’s posterior neck------------------------------------------------47 
Figure 4.1: Separation of data using SVM------------------------------------------------------60 
Figure 4.2: Structure of neural network--------------------------------------------------------61 
Figure 5.1: Mean Raman spectra of (a) normal, (b) carcinoma in situ, and (c) invasive   
SCC.  The three images on the right represent corresponding pathology    
images. Circle marks represent the approximate locations where the spectra 
were taken (images are taken from 20x)-----------------------------------------66 
Figure 5.2: PCA plots for full spectrum analysis (a) PC 2 vs. PC 1, (b) PC 3 vs. PC 1-------67 
Figure 5.3: DF plot for the analysis using full spectrum, and the corresponding    
classification results. Ellipse (blue), star (green), and cross (red) symbols 
represent normal, carcinoma in situ, and invasive SCC, respectively-----------69 
Figure 5.4: DF plot for the analysis using 12 selected Raman bands (shown on the      
Raman spectra), and the corresponding classification results.   Ellipse (blue),    
star (green), and cross (red) symbols represent normal, carcinoma in situ,     
and invasive SCC, respectively----------------------------------------------------70 
Figure 5.5: Upper panel: The mean Raman spectra for normal (solid blue line), carcinoma  
in situ (dotted green line), and invasive SCC (dashed red line), lower panel: 
Raman spectra of keratin and L-tryptophan--------------------------------------71 
Figure 5.6: ROC curves calculated from the analysis (from left to right) of; full spectra 
analysis and 12 Raman bands-----------------------------------------------------75 
Figure 6.1: Pathology pictures of (a) BE, (b) PIN, and (c) Cancer (images are taken        
with 40x magnification).  Elliptical symbols represent locations of the Raman 
measurements----------------------------------------------------------------------81 
Figure 6.2: Average Raman spectra of BE (Blue dash line), PIN (green), and cancer        
(red dotted line).  The lower panel shows the Raman spectral range of          
600-1145 cm-1----------------------------------------------------------------------82 
Figure 6.3: PCA results of BE, PIN, and cancer. PC2 vs PC1 is on the left panel and the    
PC3 vs. PC1 is on to the right------------------------------------------------------84 
Figure 6.4: DF plot of BE, PIN, and cancer-----------------------------------------------------85 
ix 
 
Figure 6.5: Average Raman spectra of stroma in BE, stroma in PIN, and stroma in        
cancer together with the epithelial cells of BE, PIN, and cancer, respectively 
which represent in black dotted format-------------------------------------------87 
Figure 6.6: DF plot of stroma surrounding BE, PIN, and cancer.  The average Raman  
spectra of stromal data for each category are shown to the right of the       
figure--------------------------------------------------------------------------------88 
Figure 6.7: DF plot of all the categories: BE, PIN, Cancer, and stroma surrounding BE,    
PIN, and cancer---------------------------------------------------------------------90 
Figure 6.8: ROC curves for PIN vs cancer (left) and stromal PIN vs stromal cancer (right)-91 
Figure 7.1: The mean Raman spectra of normal adrenal gland: from top to bottom,      
frozen (black), deparaffinized (red), difference (blue), beta-carotene      
(orange), lipid( dark yellow), and cholesterol (brown).  Pathology image            
of the normal adrenal gland is taken with 40 magnification--------------------99 
Figure 7.2: The mean Raman spectra of neuroblastoma: frozen (black), deparaffinized 
(red), and difference (blue)------------------------------------------------------101 
Figure 7.3: The mean Raman spectra of ganglioneuroma: frozen (black), deparaffinized 
(red), and difference (blue)------------------------------------------------------103 
Figure 7.4: DF plots of the frozen tissue data (left) and the deparaffinized tissue data 
(right): normal adrenal gland (green circles), neuroblastoma (red triangles),  
and ganglioneuroma (blue squares)---------------------------------------------105 
Figure 7.5: (a) The mean Raman spectra of the archived FFPP tissues: normal adrenal  
gland (green), neuroblastoma (red), and ganglioneuroma (blue) and (b) DF  
plots of the archived FFPP tissue data-------------------------------------------106 
Figure 7.6 DF plots of the archived FFPP training set with three test patients:              
normal adrenal gland (green circles), neuroblastoma (red triangles), 
ganglioneuroma (blue squares).  From left to right: Patient 1 (black         
crosses), patient 2 (purple crosses), and patient 3 (orange crosses) ----------107 
Figure 8.1: L*a*b* color space----------------------------------------------------------------112 
Figure 8.2: Steps to obtain L*, a*, and b* parameters--------------------------------------113 
Figure 8.3: Patient 1; comparison between normal neck-normal forearm and AN lesion  
skin-normal forearm--------------------------------------------------------------120 
Figure 8.4: Patient 1; comparison between AN lesion skin-normal neck--------------------121 
Figure 8.5: Dermatological images of the 8 visits of a patient-------------------------------123 
Figure 8.6: Comparison of colorimetry and DRS measurements made on control       
subjects and diagnosed AN patients.  (left) Difference of the colorimetry      
data (L*, a*, b*) obtained from the posterior neck and normal neck 
measurements for both control subjects and patients.  (right) Difference of      
the DRS-calculated concentrations (melanin, oxyhemoglobin, and 
x 
 
deoxyhemoglobin) obtained from the posterior neck and normal neck 
measurements for both control subjects and patients.  The data points with    
error bars represent the control subjects and the blue shaded areas      
represent the patients’ standard deviation around the mean ------------------124 
Figure 8.7: Mean absorbance spectra of forearm control, neck control, and lesion.       
Lesion tissue obviously demonstrates significantly greater absorption   
/scattering-------------------------------------------------------------------------128 
Figure 8.8: Discriminant function plots for (a) DRS and (b) colorimetry data obtained     
from all patients over the course of this study----------------------------------129 
Figure 8.9: DF plots showing (a) DRS and (b) colorimetry data with patient 8’s lesion     
data input as unclassified data into the analysis.  This patient’s lesion data, 
which clustered well with itself, was significantly different from the mean          
of the other patients’ lesion data.  Nonetheless, it was easily and reliably 
classified as “lesion” in both analyses--------------------------------------------132 
Figure 8.10: ROC curves of a test to differentiate neck control measurements from lesion 
measurements as shown in Figure 8.8 on the basis of the DF1 score alone for     
(a) DRS and (b) colorimetry data.  The area under the curves for (a) was     
0.985 and for (b) was 0.995-----------------------------------------------------133 
 
xi 
 
1 
 
CHAPTER 1 
INTRODUCTION AND BACKGROUND 
1.1 Cancer/Acanthosis Nigricans  
Cancer and diabetes are common chronic diseases in the world causing numerous 
deaths in adults as well as children.  Cancer can occur in various organs of adults and 
children.  Some of the common types of cancers in adults are prostate, breast, colon, head 
and neck squamous cell carcinoma, while among children; neuroblastoma and 
ganglioneuroma are quite common.  In 2008, 903,500 (14%) new prostate cases were 
recorded and about 258,400 (6%) men died.  The highest incidence rates are observed in 
the developed countries such as Oceania, Europe, and North America.1  There are 25.8 
million (8.3% of US population) children and adults in America who suffer from diabetes and 
nearly 7 million people are not aware of their diabetic condition.2  If untreated, many long 
term health problems such as kidney failures, blindness, neuropathies, risk of heart 
diseases, stroke and complications in pregnancy can happen.  
What is common to both these illnesses is the necessity to detect these conditions in 
their early stages so that appropriate medical treatments can be provided to avoid 
complications in their later stages and possibly prevent deaths.  Most common early cancer 
detection techniques include screening tests such as mammography, cytology, prostate 
specific antigen (PSA), trans-rectal ultrasound tests, Pap exams, biopsies, and blood tests.  
In addition, imaging tests such as CT, MRIs, and nuclear medical scans are also used 
widely. 
Most of the above diagnostic procedures are lengthy and expensive.  With the 
advancement in optical technologies, it is becoming desirable to have non-invasive and 
reliable optical detection methods whose results are interpreted objectively.  Raman 
spectroscopy and diffuse reflectance spectroscopy are two of the widely used analytical 
optical spectroscopic methods where the spectral output contains information about the 
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molecular composition of the target tissue.  For example, Raman spectroscopy can measure 
changes in the bio-molecular composition of a tissue.  At the onset of the disease in an 
organ, the biochemical composition begins to change from its normal values.  
Diffuse reflectance spectroscopy provides direct measurement of light absorption and 
scattering from a medium.  For example, diffuse reflectance spectrum can provide 
information about the main chromophores (light absorbing chemical groups) present in skin 
(hemoglobin and melanin) and other optical properties such as scattering coefficients and 
scatterer size.3  
The main goal of our research work is to investigate the applications of (1) Raman 
spectroscopy to diagnose head and neck squamous cell carcinoma, prostate cancer, and 
pediatric tumors, and (2) diffuse reflectance spectroscopy to detect acanthosis nigiricans 
skin disorder.  The optical spectroscopic methods can possibly detect the onset of a disease 
which otherwise can be elusive to conventional methods of detection or to the person 
suffering from it. 
 
1.1.1 Head and Neck Squamous Cell Carcinoma 
The most common malignancy in the head and neck region is the head and neck 
squamous cell carcinoma.  Worldwide, 644,000 new cases are diagnosed every year, of 
which about 49,260 cases are reported in the United States, resulting in 16,320 deaths 
every year.4  The main tumor sites are oral cavity (tongue, lip or floor of mouth), nasal 
cavity, paranasal sinuses, salivary glands, pharynx (nasopharynx, oropharynx, and 
hypopharynx), larynx, trachea, and esophagus (see Fig. 1.1).  The use of tobacco including 
smokeless tobacco products is the major cause for all of the head and neck cancers.  The 
risk of developing squamous cell carcinoma in oral cavity is higher for the people who are 
habitual smokers, alcohol consumers, and betel quid chewers.5  
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Figure 1.1 Tumor sites for head and neck cancers6 
 
Carcinoma in situ is the precursor lesion of the head and neck squamous cell 
carcinoma.  Squamous dysplasia, an abnormality of the squamous epithelium is also 
considered as the precursor to invasive squamous cell carcinoma.  However, it is difficult to 
separate squamous dysplasia from carcinoma in situ as the morphological changes show a 
continuum.  The key pathological findings to distinguish between normal and carcinoma in 
situ are architectural disorder, nuclear size variability, nuclear irregularity, and the nuclear 
chromatin changes.7  During the progression of carcinoma, downward growth, complex and 
irregular branching, paradoxical keratinization, excessive volume of atypical epithelial 
proliferation in the stroma, and inflammatory stromal response to the invading tumor can 
happen.  An example of epithelial cells invading the stroma can be seen from Fig. 1.2. 
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Squamous 
cells 
Stroma 
Figure 1.2 Tongue squamous cell carcinoma: Invasion of epithelial cells into the stroma 
 
Currently, the tumor-node-metastasis (TNM) staging is one of the most important 
factors clinically used for estimation of survival.  The clinical stages are listed in the Table 
1.1.  Reliable estimates of survival are important not only for patient counseling but it may 
also impact the physicians’ choice of therapy.  Physicians take into consideration the TNM 
stage when recommending treatment options.  Early stage patients are offered single 
modality treatment such as radiation or surgery, while multimodality treatment is offered 
for advanced stage cancer.  Head and neck squamous cell carcinoma is a heterogeneous 
disease and TNM staging provides only a rough estimation.8  Not all patients in the same 
tumor stage respond in a uniform manner to the available treatment options.  With the 
availability of novel technologies, there is an urgent need to improve diagnostic accuracy, 
prognosis, and treatment of head and neck squamous cell carcinoma patients.  
 
Clinical stage Description 
0 Tis, N0, M0 
I T1, N0, M0 
II T2, N0, M0 
III T3, N0, M0/ T1-3, N1,M0 
IV T4, N0-1-M0/Any T, N2-3, M0/Any T, and N, M1 
Table 1.1 A description of TNM clinical staging8 
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The nomenclatures of the Table 1.1 are; Tis: carcinoma in situ, T1: Tumor less than 
2 cm in dimension, T2: Tumor size is between 2 cm and 4 cm, T4: Tumor invades adjacent 
structures, N0: No regional lymph node metastases (M), N1: M to a single ipsilateral lymph 
node (≤3 cm), N2: N1 but less than or equal 6 cm, M0: No evidence of distance M, and M1: 
Distance M can be seen.  
 
1.1.2. Prostate Cancer 
Prostate cancer is one of the most common type of cancers among North American 
men.  The mortality rate for this disease can be dramatically reduced if it can be diagnosed 
in its early stages with some reliable technique.  Cancer occurs in the prostate gland which 
is a part of the male reproductive system as shown in Fig. 1.3.  It produces and stores an 
alkaline fluid which provides an extra medium for mobility and life of sperm.  The prostate 
consists of three zones: peripheral zone, transition zone and central zone. 
 
 
Figure 1.3 Prostate Gland9 
 
The peripheral zone is nearly 70% of the glandular mass of the prostate.  Most of the 
prostate cancers originate predominantly in this zone.  The central zone is nearly 25% of 
the prostate and rarely contributes to prostatic carcinoma.  If the cancer develops from the 
epithelial cells, it is referred to as “carcinoma”.  However, it contributes to the spread of the 
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Figure 1.4 (a) Low-grade PIN which has a star shaped glandular form with a prominent 
cancer since it is surrounded and accompanied by the ejaculatory ducts from the seminal 
vessel.10  The transition zone which is 5% of prostate volume is the origin of basal cell 
hyperplasia, clear cell cribriform hyperplasia and clear cell carcinoma. 
 
a) Prostatic Intraepithelial Neoplasia 
Prostatic Intraepithelial Neoplasia (PIN) is a precursor lesion in prostate cancer which 
can be of high grade or low grade category.  Usually, PIN is classified as high grade capable 
of developing into cancer within the next 10 years or so.11  One study has suggested that 
anti-tumor activity of certain dietary flavonoids prevents the progression of high grade PIN 
to cancer.12  However, this hypothesis could not be established in a randomized double-
blind study performed with 303 men in twelve Canadian centers.  These men were given 
soy, vitamin E, and selenium on daily basis for three years.  The results were not 
statistically significant to show their effects on decreasing the progression of cancer or 
eliminating it.13  When the cancer progresses, the epithelium thickens due to the 
development of atypical cells.  In addition, intra-luminal papillae are formed as seen in Fig. 
1.4 (b) and ultimately the glandular lumen will be linked creating a papillary arrangement. 
 
 
(a)  (b) 
basal layer (b) High-grade PIN shows increased number of atypical cells in the lining of the 
duct 
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PIN is mainly seen in needle biopsies of benign prostatic hyperplasia (an 
enlargement of prostate in men over 50) and in cancer patients as well.  The patients who 
have high grade PIN histology have high probability of developing prostate cancer.  
 
b) Categorization of Cancer: The Gleason Grading System 
Prostate cancer is categorized using the Gleason system which is used to evaluate 
the prognosis of men with prostate cancer.   In this system, a tissue is assigned five grades 
ranging from 1 to 5 to indicate the degree to which the cancerous tissue differs, 
histologically, compared to normal prostate tissue.  Grade 1 is more towards the normal 
prostate morphology which contains proliferated microacinar structures contoured by 
prostatic luminal cells without a basal cell layer.14  Grade 5 contains irregular, poorly 
differentiated infiltrating individual cells, and grade 2, 3, and 4 fall in between as shown in 
Fig. 1.5.  
 
 
Figure 1.5 Gleason system of cancer cell architecture15 
 
Since the different parts of cancer may have different grades, pathologists grade two 
areas and add the two grades.  An example of grading is as follows: consider Gleason grade 
7, this can be described as a combination of 3 and 4 as 3+4=7.  Here, the first score 
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represents the most prevailing grade of the tissue and the second score represents the next 
most prevailing grade.  Therefore, the Gleason grade varies between 2 to 10.  A Gleason 
grade of 6 is the most commonly seen Gleason grade.  It has been reported that the DNA 
content of PIN is in between the DNA content of benign glands and cancer.10  In addition, as 
the number of aneuploid nuclei or abnormal number of chromosomes increases, so does the 
level of PIN.  However, the proliferation activity and ploidy values (the amount of DNA 
content in a cell) of PIN and carcinoma are similar to each other.  The progression of PIN 
stage to carcinoma stage is evident in the basal layer with an increase of mean nuclear 
volume in PIN, which was discovered by Teba et al.16  However, the nuclear features of the 
luminal layer in PIN remain the same as in carcinoma.  
 
1.1.3 Pediatric Tumors 
Neuroblastoma and ganglioneuroma are peripheral neuroblastic tumors.  These are 
derived from immature sympathetic nervous system and adrenal gland.  Neuroblastoma, 
the third most common type of cancer, occurs in embryonic neuroblasts of the sympathetic 
peripheral nervous system which can spontaneously be matured into ganglioneuroma.17  It 
is a solid malignant tumor which can be observed in abdomen, around the spinal cord near 
the chest region, or pelvis.  Neuroblastoma has been called the “great masquerader” since 
its symptoms mimic many other diseases.18  
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Table 1.2 International Shimada classification19, 20 
 
According to International Neuroblastoma Pathology Classification, there are four 
basic morphological categories: neuroblastoma (Schwannian stroma-poor), 
ganglioneuroblastoma-intermixed (Schwannian stroma-rich), ganglioneuroma (Schwannian 
stroma-dominant), ganglioneuroblastoma-nodular (Composite, Schwannian stroma-
rich/Schwannian stroma-dominant and Schwannian stroma-poor) as described in Table 1.2. 
 
1.1.3.1. Neuroblastoma (Schwannian Stroma-poor) 
Neuroblastoma frequently occurs in infants and children.  This is subdivided into 3 
groups: differentiating, undifferentiated, and poorly differentiated.  The poorly differentiated 
and differentiating neuroblastoma are further categorized as favorable and unfavorable 
cases.  For favorable case, there is a probability of appropriate age maturation, and while 
for biologically unfavorable peripheral neuroblastic tumors, there is no such a probability. 
The survival rate of favorable neuroblastoma is much higher than the unfavorable 
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histopathology.  Figure 1.6 shows a pathology image of favorable neuroblastoma with poor 
surrounding stroma.  
 
 
Neuroblasts 
Figure 1.6 Neuroblastoma with stroma poor in the background 
 
1. Undifferentiated Neuroblastoma: When a tumor tissue is composed of 
undifferentiated neuroblastic cells without identifiable neuropil (region between 
neuronal cell bodies in the gray matter of the brain and spinal cord), it falls under 
this subcategory.  These neuroblasts have indistinct nuclei cytoplasm borders where 
size can vary from small to medium. 
2. Poorly Differentiated Neuroblastoma: In this category most of the tumor cells 
are undifferentiated but still there is a presence of varying amount of neuropil 
corresponding to Schwannian differentiation.  Ganglion cells appear up to 5% of the 
tumor cells but still can be distinguished from neuroblasts. 
3. Differentiating Neuroblastoma: More than 5% of the tumor cells are 
differentiating neuroblasts and ganglion cells.  These neuroblasts have distinct 
borders of cytoplasm and they also show synchronous enlargement of nuclei and 
cytoplasm. 
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1.1.3.2. Ganglioneuroma (Schwannian Stroma-dominant) 
Ganglioneuroma contains distributed maturing or mature ganglion cells with 
predominantly dominant Schwannian stroma in the background.  This type of tumor can be 
commonly seen in locations such as posterior mediastinum and retroperitoneum.  However, 
it is rarely seen in adrenal gland.  Ganglioneuroma can be subdivided as maturing and 
mature.  Mature ganglioneuroma contains fully matured ganglion cells and Schwannian 
stroma (see Fig. 1.7) while maturing ganglioneuroma has maturing ganglion cells and less 
contents of differentiating neuroblasts.  
 
 
Ganglions 
Schwann cells 
Figure 1.7 Ganglioneuroma 
 
1.1.3.3 Wilms’ Tumors 
 Wilms’ tumor is the most common childhood kidney cancer.  Due to therapeutic 
advancement, the survival rate in the United States has increased to 90% in 1996. 
However, the survivors are at a greater risk of dying after several years.21  Nephrogenic 
rest (persistent embryonal remnants in the kidney) is considered as the precursors of 
Wilms’ tumor.  When multiple or diffuse nephrogenic rests are observed, they are called 
“nephroblastomatosis”.  The common characteristics of nephrogenic rest are dormancy, 
maturation, involution, hyperplastic overgrowth, and neoplastic induction.22   
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1.1.4. Acanthosis Nigricans 
Obesity is one of the major health problems in the USA.  According to one 
overweight and obesity prevalence estimation, over two thirds of American adults are 
overweight and over one third of adults are obese.23  Among insulin-resistant diabetic 
patients who also suffer from obesity, acanthosis nigricans is a very common dermatologic 
condition causing skin darkening and roughening mostly occurring in the posterior (see Fig. 
1.8) and lateral folds of the neck, the axilla, inframammary, groin, and other areas.  
 
 
Figure 1.8 Acanthosis nigicrican skin condition in the neck area 
 
Classically, it was described as a herald for internal malignancy, but in 1976, 
acanthosis nigricans was shown to have a direct association with hyperinsulinemia.24, 25, 26  
It is considered a cutaneous marker for insulin resistant states including type 2 diabetes 
mellitus and polycystic ovarian syndrome.27, 28, 29, 30   
In the year 2000, the American Diabetes Association established acanthosis nigricans 
as a criterion for identifying children at risk for developing diabetes mellitus.31, 32  It has 
been demonstrated that hyperinsulinemia or insulin resistant states can lead to acanthosis 
nigricans.  At higher concentrations, insulin interacts with insulin-like growth factor-1 
receptors particularly on keratinocytes and fibroblasts in skin; this results in acanthosis 
nigricans, a state of hyperproliferation.33  As hyperinsulinemia is treated, acanthosis 
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nigricans should improve and may entirely resolve.  However, the exact relationship 
between insulin, obesity, and insulin resistance of diabetic patients is not yet fully 
understood.34  Acanthosis nigricans can occur due to several other conditions such as a 
result of glandular disorder, Addison disease (deficiency of hormones from the adrenal 
gland), disorder from the pituitary gland, low level of thyroid hormones, and oral 
contraceptives.  However, obesity remains the major cause.35   
Skin has a complex structure as shown in Fig. 1.9.  The human skin has many 
layers.  The three main layers are called the epidermis, dermis, and hypodermis (subcutis).  
 
 
Figure 1.9 Skin Structures36, 37 
 
The epidermis, stratified epithelium that forms the outer layer of the skin can further 
be subdivided into 5 layers, namely, stratum basale, stratum spinosum, stratum corneum, 
stratum lucidum, and stratum granulosum.  The bottom layer of epidermis is the stratum 
basale where cell division occurs, followed by keratinization in the layer of stratum 
spinosum.38  The keratinization is the skin renewal process where daughter cells are 
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transformed into pickle cells and then they die eventually.  These dead cells are pushed to 
the top layer of stratum corneum.  The next adjacent layer, stratum lucidum helps to 
reduce friction and shear forces between stratum corneum and stratum granulosum which 
can be seen in thick skin.  It also protects the skin from ultra-violet rays.  The dermis 
consists of two layers; papillary layer which contains thin collagen fibers that provides 
strength to the skin and reticular layer which contains thick collagen fibers that will add 
support to the surrounding cells.  
The flexibility of skin is due to elastic fibers which are in the reticular layer.  Hair 
follicles, lymph vessels, smooth muscles nerve cells, and sweat glands also grow in this 
layer.  The blood flows to the epidermis through the capillaries in the dermis.  The 
hypodermis contains loosely connective tissues and bases of hair follicles and sweat glands. 
 
1.2. Optical Techniques Used in Diagnosis  
Detection and confirmation of any disease/cancer is very crucial for its successful 
treatment in order to improve survival rate.  Sometimes, the standard screening programs 
can provide misleading results leading to wrong or over-treatments, and occasionally, to 
fatal consequences.  The interpretations of histological examination of biopsies, considered 
as the “gold standard” for diagnosis, are often subjective and can vary significantly from 
one pathologist to another.39  Hence, it is imperative to detect the state of the disease with 
a method which is objective and capable of providing results within a very short period of 
time.  Optical spectroscopy techniques, namely Raman spectroscopy, diffuse reflectance 
spectroscopy, etc. are very well suited for these types of goals as they are also capable of 
probing diseases at cellular level. 
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1.2.1 Raman Spectroscopy 
Raman spectroscopy can provide information about the changes in the 
concentrations of the constituent biomolecules of tissues and detect the progression or state 
of the disease.  In Raman spectroscopy measurements, a monochromatic laser light incident 
on a sample and the scattered light is collected and analyzed to derive the information 
about the contents of the sample.  A majority of the light scatters elastically; however, a 
very small fraction of it scatters inelastically carrying information about the molecular 
nature of the sample, their mutual interaction, and their relative concentrations in the 
sample.40  The chemical nature of molecules can be uniquely determined from their 
vibrational energy levels and Raman spectroscopy has the capability to measure these 
vibrational energy levels.41, 42   
Typical Raman spectra from some biopolymers and cells obtained by Notingher et 
al43 are shown in Fig. 1.10.  This study demonstrates that Raman spectroscopy can become 
a powerful investigation method to determine the biochemical composition of a biological 
material.  
 
 
Figure 1.10 A typical Raman spectra of cells and biopolymers43 
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The peaks observed in a Raman spectrum of a tissue sample are often assigned to 
the vibrational energy states of the chemical groups and the backbones structures of the 
molecules.  Table 1.3 lists the assignments found in the literature for the Raman bands (in 
the 600 - 1800 cm-1 region) observed in tissue samples.  
 
 
Table 1.3 Peak assignments of Raman spectra43 
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A Raman mapping study was done by Jong et al using tumor and healthy bladder 
tissues.44  Figure 1.11 shows the mean spectra corresponding to those areas. 
 
 
Figure 1.11 (A) and (C) are unstained and stained tissue sections which have non-tumor 
and tumor areas, (B) represents matching colors and (D) average spectra: red-muscle 
tissue, purple-tumor, green-collagen fiber and blue and yellow transition between the two 
types44 
 
Using near-infrared Raman spectroscopy, a significant spectral differences between 
normal and dysplastic gastric mucosa tissues were found, particularly in the spectral ranges 
of 850–1150, 1200–1500, and 1600–1750 cm-1, and were able to differentiate dysplasia 
from normal gastric mucosa.45  Haka et al studied freshly excised surgical breast cancer 
tissues and successfully developed an algorithm to diagnose their pathological states.46 
Crowe et al reported a study of both the adenocarcinoma biopsies47 and cell lines48 of 
prostate cancer and successfully classified the benign and cancerous cells/tissues.  
The studies on nasopharyngeal biopsy tissues showed that the spectral features of 
three Raman bands varied significantly when tissue changed from normal to malignant 
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state49, and in another study on frozen tissues from larynx showed that the characteristic 
Raman spectral features for normal, carcinoma, and papilloma tissues are different.50  
Rabah et al reported Raman investigation of neuroblastoma and ganglioneuroma in fresh 
tissue specimens51 and found distinct spectral differences between tumor and normal 
adrenal gland.  Subsequently, an investigation was done to distinguish neuroblastoma and 
related tissues from healthy tissues in fresh vs. frozen specimens.52  A high correlation 
between fresh and frozen tissues was found and a faster method of identifying pathological 
conditions was developed.  In addition, normal kidney specimens were distinguished from 
Wilms’ tumor.53  In this study, both fresh and frozen tissue specimens from Wilms’ tumor 
treated or untreated, normal kidney, and other related renal tumors which show various 
similar morphologies were used, but still Raman technique could distinguish between them 
successfully.  
 
1.2.2. Diffuse Reflectance Spectroscopy 
Diffuse reflectance spectroscopy provides information about the relevant 
physiological parameters and the biochemical composition.  When light is incident on a 
sample, reflection, scattering, absorption and transmission through the sample can occur. 
The reflection of light obeys the law of reflection and the transmission of light obeys Snell’s 
law.  The Fresnel’s equations describe reflection and transmission of light through multiple 
media having different indices.54  Further, the reflection can be either specular or diffuse. 
Specular reflection is the reflection off of a smooth or a glossy surface in which an incoming 
ray is reflected into a single outgoing direction obeying the law of reflection.  Conversely, 
when parallel rays of light are incident on a rough surface, the direction of the reflected light 
rays may differ due to different orientations of the surface normals for various incident rays. 
This type of reflection is called “diffuse reflection”.  
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Many theoretical models have been developed to describe the diffuse reflectance 
phenomenon.  The model proposed by Farrell et al in 199255 is quite successful in extracting 
tissue optical properties.  This model allows determination of optical properties of tissues 
from diffuse reflectance spectra, using only the shape of the reflectance curve.  This model 
was improved by Zonios et al in 199956 and was applied to biological tissues, human colon 
specimens of normal colonic mucosa, and adenomatous colon polyps (precursor lesion) by 
introducing four main parameters: hemoglobin concentration, hemoglobin saturation, 
effective scatterer density, and effective scatterer size of the tissue.   
Hemoglobin and melanin are the main chromophore absorbers in the skin.  
Absorption (scattering) can be explained using the characteristic parameter called 
absorption (scattering) coefficient μa (μs-cm-1) which is defined as the probability of photon 
absorption (scattering) per unit path length in a medium.  This coefficient depends on the 
cross section and the number density of the absorbers (scatterers).3  Since hemoglobin can 
be either in the form of oxyhemoglobin or deoxyhemoglobin, their concentrations can be 
estimated using the known absorption coefficients of biological tissues at different 
wavelengths.  Subsequently, quantitative assessment of human skin melanin, hemoglobin, 
and light scattering properties were determined using diffuse reflectance spectroscopy in the 
visible and near-infrared regions based on the same analytical model.57  Since all these 
experiments were done using fiber optic probes, attempts to design a ball lens coupled fiber 
optic probe for depth resolved spectroscopy of epithelial tissues were also reported.58, 59 
Katika et al investigated optical properties of human skin using steady state directional 
diffuse reflectance through numerical simulations using a seven-layer skin model.60  Nuclei 
size and density distribution of the mucosal tissues were also extracted through the 
backscattered light by analyzing the frequency and the amplitude of the fine structure.61  
Benign and malignant breast tissues were also investigated through diffuse 
reflectance spectroscopy.  Brestlin et al found adipose tissues do not contain -carotene, 
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and thus, an indicator to differentiate malignant from benign.62  In another in vivo breast 
cancer study, hemoglobin saturation and total hemoglobin content was determined from the 
diffuse spectra and found that the hemoglobin saturation is significantly lower in benign 
tissues and also negatively correlated with the tumor size.63 
 
1.2.3. Fluorescence Spectroscopy  
Fluorescence spectroscopy has been widely tested to characterize skin.  The principal 
fluorophores of the skin are tryptophan, pepsin digestible collagen cross-links, collagenase 
digestible collagen cross-links, elastin cross-links, and NADH.  When characterizing the skin 
fluorophores, the penetration depth of light plays an important role.  Usually, skin 
penetration is about 1 mm at about 700 nm and this depth decreases as the wavelength 
decreases.  Fluorescence excitation spectra showed three excitation bands, 295, 335, and 
370 nm in a mouse skin investigation64.  Hamzavi et al observed that blue vitiligo 
characterization can be done much better using the autofluorescence spectroscopy 
compared to the reflectance spectroscopy.65  A high correlation between fluorescence and 
skin pigmentation and redness was also seen.  Thus, once the influence of skin 
pigmentation and redness was corrected a trend between the 375 nm fluorescence and the 
age can be observed.66  
 
Research Goals 
The goal of our research work is to investigate the applications of (1) Raman 
spectroscopy to diagnose head and neck squamous cell carcinoma, prostate cancer, and 
pediatric tumors, and (2) diffuse reflectance spectroscopy to detect acanthosis nigricans 
skin disorder.  In Chapter 2, the theoretical background is presented and Chapter 3 
summarizes the instrumentation of both Raman spectroscopy and diffuse reflectance 
spectroscopy followed by the tissue processing and data collection.  All the research data 
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are analyzed using chemometric methods such as principal component analysis and 
discriminant function analysis which is explained in detail in Chapter 4.  Chapters 5, 6, and 
7 summarizes the results of Raman spectroscopic investigations of ex vivo tissue 
characterization in head and neck squamous cell carcinoma, prostate cancer, and pediatric 
tumors, respectively whereas Chapter 8 presents the diffuse reflectance and colorimetric 
investigation of acanthosis nigricans in vivo.  Chapter 9 presents the conclusions and future 
work.    
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Figure 2.1 Jablonski energy diagram3 
 
When a light wave of sufficient energy is incident on a molecule or an atom, it can 
cause a transition of an electron from the ground state to an excited state.  This excitation 
CHAPTER 2 
RAMAN SPECTROSCOPY AND DIFFUSE REFLECTANCE SPECTROSCOPY 
The theory of Raman scattering is well worked out and the principles of Raman 
spectroscopy applied to polyatomic molecules, and solids are well explained in number of 
books.3, 67, 68  Similarly, the principles of diffuse reflectance spectroscopy and its biological 
applications have been described in numerous articles and book.3, 55-61, 69  Here, a brief 
description of the principles of these techniques will be given. 
 
Light is an electromagnetic wave.  When light is incident on a surface of a bulk 
material, various processes can happen to a varying degree depending on the nature of the 
surface and the wavelength of the light used.  In this research work, the interest lies on 
absorption and scattering processes.   
 
Excited State 
Vibrational energy levels 
Absorption 
Nonradiative 
relaxation Fluorescence 
Virtual state 
Raman 
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process is commonly referred as an electronic transition.  In a molecule, the atoms can 
rotate and vibrate with respect to each other.  Thus, for a given electronic state, there are 
associated discrete vibrational and rotational energy levels, which can be thought of as 
being packed on top of each electronic level.  The excited electrons can relax in radiative or 
non-radiative processes.  If the excited electrons relax without producing photons, then the 
relaxation process is called non-radiative relaxation.3 
However, if the excited electron relaxes to the ground state spontaneously by 
producing another photon, it is called fluorescence.  Figure 2.1 schematically describes 
these relaxation processes.  Usually, fluorescence light is shifted to longer wavelengths 
relative to the excitation light which is commonly referred to as red shift.  This is due to the 
fact that a part of the energy is lost in the excited state due to molecular vibrations.  
However, if the electrons in the excited state or ground state are in a higher vibrational 
state due to thermal energy at high temperatures, this may not be the case.  Then, the 
emitted light will have a shorter wavelength than the incident light.  
  
2.1 Raman Spectroscopy 
The phenomenon of Raman scattering was discovered by Sir Chandrasekhara 
Venkata Raman in 1928.40  When a photon is incident on a polarizable molecule it can excite 
(de-excite) vibrational modes of the molecules, resulting in scattered photons with 
decreased (increased) energy by the amount of the vibrational transition energies.  Raman 
scattering is an inelastic scattering process as there is an energy exchange between the 
molecule and the photon.  If the scattered photon has the same energy as the incident 
photon, the scattering is called Rayleigh scattering which is an elastic scattering process.3   
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Figure 2.2 A schematic illustration of scattering and absorption processes 
 
This inelastic scattering is further distinguished as Stokes scattering or anti-Stokes 
scattering depending on the loss or gain in energy of the scattered photon.  In Stokes 
scattering, the electron is excited to a virtual state.  Since, this virtual state is unstable the 
electron may quickly decay into a higher vibrational instead of the initial state as shown in 
green arrow in Fig. 2.2.  Here, the energy is absorbed by the molecule.  Thus, the emitted 
photon has a longer wavelength or in other words the scattered photon is red shifted.  It is 
common to use the term “red shifted” or “blue shifted” if the energy of the scattered light is 
lower (longer wavelength) or higher (shorter wavelength).  If the  scattering results in an 
excitation from an initial excited vibrational state to a virtual state and subsequent de-
excitation to a ground state or a lower excited state than the initial state, then the emitted 
photon has more energy than the absorbed photon (blue-shifted), and this is called anti-
Stokes scattering.  However, the number of electrons in the excited vibrational state 
depends on the Boltzmann distribution.67 
It is important to distinguish scattering and absorption processes (Fig. 2.2).  Infrared 
absorption involves molecules making direct transitions from one vibrational state to a 
higher vibrational state by absorbing a photon of exact energy equal to the difference 
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between the vibrational states (~ 12–400 meV).  In other words, the incident photon 
energy exactly coincides with the energy difference between vibrational states.  This is 
shown schematically in Fig. 2.2 along with the difference between Stokes and anti-Stokes 
Raman scattering and Rayleigh scattering. 
 
Figure 2.3 Graphical representations of Raman active and inactive modes.67 
 
he basic necessary condition for observing the Raman scattering is that the 
polariz
T
ability ( ) must change during vibrations of the molecules.  The bigger the change, 
the greater the effect is.  However, for infrared absorption, a change in dipole moment (μ) 
causes the absorption68 and it is a necessary condition.  Usually, for Raman scattering, 
symmetric stretching causes the most intense scattering whereas for infrared absorption 
asymmetric stretching causes the greatest.  In centro-symmetric molecule, both Raman 
scattering and infrared scattering cannot occur at the same time.  Thus, both these 
techniques can be used to get complimentary information about a particular form of 
vibration in a molecule.70, 71  
If a given non-linear molecule contains N atoms in this molecule, then there are 3N-
6 possible vibrations (degrees of freedom) except for a linear molecule where there are 3N-
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5 poss
etic wave interacts with a molecule, the electron cloud around molecule 
distort
ible vibrations.  Molecular vibrations are periodic motions of the atoms in a 
molecule.68 
The classical explanation of the Raman scattering is as follows. When an 
electromagn
s, thus, an induced dipole moment can occur.  This induced dipole moment is a 
function of the polarizability and the incident electric field, E.71  
EP  ------------------------------------------------------------------------------(2.1.1) 
The electric field of the incident electromagnetic wave can be written as, 
 0EE )2cos( 0t ------------------------------------------------------------------(2.1.2) 
o is the frequency of the electromagnetic wave and E  is its amplitude.0   Thus, the 
induced dipole moment can be expressed as 
)2cos( tE 00P  -----------------------------------------------------------------(2.1.3) 
The perturbation of the electron cloud depends on relative location of the atoms of 
the molecule.71  Hence, 
positio
the polarizability of the molecule depends on the instantaneous 
n of the atoms in it.  Thus, by using the Taylor expansion, the polarizability can be 
approximated as 
dQ
Q
  ---------------------------------------------------------------------(2.1.4) 0
 where, is the displacement of the atoms about their equilibrium position.  For a 
given vibrational mode,  can be written as 
dQ
 dQ
)2( tQdQ cos0 vib ----------------------------------------------------------------(2.1.5) 
 where vib is the vibrational frequency of the molecule and  is the maximum 
displacement about the equi
oQ
librium.  By substituting, the polarizability is written as, 
)2cos(00 tQQ vib
 
 --------------------------------------------------------(2.1.6) 
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Hence, induced dipole moment can be expressed as 
 ])(2cos[]))(2cos[
2
)2cos(
)2cos()2cos()2cos(
00
00
000
000000
ttEQ
Q
tE
ttEQ
Q vib
tEP
vibvib 




---------(2.1.7) 
This equation illustrates that there are three frequencies which con
induced dipole moment.  They are 

tribute to the 
o , )( vibo   , and )( vibo   .  These three frequencies, 
respect
d the anti-Stokes scattering f
al, this is also 
known 
ively, are the scattered frequency, which coincides with the incident light frequency 
(Rayleigh scattering), the Stokes an requency.67 
The energy difference between the incident photon and the Raman scattered photon 
is defined as the Raman shift.  Since energy and frequency are proportion
as the vibrational frequency of the scattered molecule (cm-1).  Raman shift is given 
by 
scatteredincident 
 11  -------------------------------------------------------(2.1.8) 
where   is called the wave num
transitions appear in the 104 to 102 cm-1 region.  
Q
In a molecule, the chemical bond between 
the ato
ber in units of cm-1.  For Raman spectra, vibrational 
uantum mechanically, vibrational energy levels of a molecule can be determined by 
solving the Schrödinger equation for a molecule.  
ms can be considered as a spring (with spring constant K) and the motion of the 
atoms then can be described by Hooke’s law.  In treating diatomic molecule as a single 
particle with reduced mass μ, the Schrödinger equation for such a quantum mechanical 
system (a simple harmonic oscillator) can be written as,  
0
2
18
2
2
2
2




hdq
d 2   KqE ----------------------------------------------------(2.1.9) 
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The Eq. 2.1.9 can be solved for the energy eigenvalues or frequencies of the system, 
which are given by  2
  1nhEn   and  K
1 .  Here n is called the vibrational 
quantum number.  For a quantum mechanical simple harmonic oscillator, the allowed 
transitions are , whereas for anharmonic systems 
2
1n ,...3,2 n  can be observed 
g 
Fourier transform Raman scattering is regular Raman scattering with a different 
cattered light.  Fourier transform Raman 
metho
Confocal Raman micro-spectroscopy allows one to obtain inference-free Raman 
 small specimens which are embedded in a 
strong
which are commonly known as overtones.67  
 
2.2.1 Fourier Transform Raman Scatterin
mechanism for collecting and analyzing the s
ds utilize Michelson interferometers and Fourier transform processors.  Once the 
scattered light from the target is collected and the elastically scattered light is removed, it 
goes through a Michelson interferometer.  In Michelson interferometer, the incident laser 
beam is split into two beams where one incident on a fixed mirror and the other on a 
varying mirror.  The reflected beam from these two mirrors, combine at the beam-splitter 
producing a sinusoidal interference pattern.  Then, this signal is detected through an 
infrared detector and Fourier transformed to get a Raman spectrum.72  
 
2.2.2 Confocal Raman Micro-spectroscopy 
spectra in two or three dimensional images of
 scattering media.  The confocal microscopy configuration consists of two pinhole 
apertures to remove the residual scattered light generated from out of focus points in the 
sample.  When this is utilized in conjunction with a spectrometer to analyze the Raman 
scattered signal, the improvement in spatial resolution and depth discrimination can be 
achieved.  These are the major advantages for using this technique.72  
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ational spectroscopic 
structures.68  The main drawback of using IR 
spectro
nce Spectroscopy 
When a laser beam hits a sample, reflection, scattering, absorption, and transmission 
ction of light obeys the law of reflection, i.e. the 
angle o
2.2.3 Infrared Absorption Spectroscopy 
Infrared (IR) absorption spectroscopy is another valuable vibr
method which is used to identify molecular 
scopy in biological tissues is the high absorption of water and CO2 in the 
fundamental frequency range.  The water absorption bands lie in the 400-1800 cm-1 
wavenumber region, and thus interfere with bands due to biomolecules of interest.  In fact, 
IR spectra need to be corrected for absorption due to water molecules and CO2 in air.  This 
makes it difficult to use IR spectroscopy in ex vivo or in vivo fresh biological tissue 
characterization for cancer diagnostic purposes.  Further, as the Fourier transform IR 
spectrometers are based on the use of Michelson interferometer, it is difficult miniaturize 
them to make them hand-held and portable.  Nevertheless, both Raman and IR 
spectroscopy are needed to determine the complete set of vibrational modes of molecules 
with center of symmetry, as the Raman and IR activity of modes in such molecules is 
mutually exclusive.70 
 
2.3 Diffuse Reflecta
through the sample can occur.  The refle
f incidence is same as the angle of reflection.  The transmission of light obeys Snell’s 
law, 2211 sinsin  nn   where θ1 and θ2, are angles of incidence and refraction respectively, 
and n1 and n2 are refractive indices of the two media.  When the light travels in multiple 
media having different indices, its reflection and transmission behavior is described by 
Fresnel equations.73  If the light is incident close to the normal incidence, then the reflection 
(R) and transmission (T) coefficients can be described by the following equations; 
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ar reflection or diffuse reflection.  Specular reflection is 
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Reflection can be either specul
 as reflection off of smooth surfaces such as a glossy surface in which an incoming 
ray is reflected into a single outgoing direction obeying the law of reflection as shown in Fig. 
2.4. 
Specular Reflection 
(Smooth surfaces) 
Diffuse Reflection 
(Rough surfaces) 
Figure 2.4 Specular r d diffuse reflection
W
nt although each ray follows the law of reflection.  This is due to different orientations 
of the surface, and thus, the normals for the incident ray are different.  This reflection is 
called diffuse reflection.  The diffuse reflectance is defined as the probability of photon 
reemission per unit surface area from a scattering medium.74  This is also known as the 
relative diffuse reflectance and we will use these measurements to find the optical 
properties of biological tissues. 
The absorbers or the chr
ngths (λ).  The main chromophores of skin are melanin, DNA, amino acids, 
hemoglobin, etc.75  In a tissue, the absorption at certain wavelengths will be higher than 
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the other wavelengths depending on the chromophores present.  To arrive at the absorption 
spectrum, we first consider the analytical form of a diffuse reflectance spectrum. 
The diffuse reflectance spectrum of skin at a given site, R(λ), can be calculated from 
the equation below,76    
        darkref dark
S S
R
S S
   
  ---------------------------------------------------------(2.3.3) 
where, S(λ) is the measured spectral signal of the reflected light at each wavelength, Sdark 
(λ) is the dark correction obtained from a spectrum of a dark (0% reflectance) standard, 
and Sref(λ) is the reference reflectance standard obtained from a white (100% reflectance) 
standard.76 
The absorption spectrum A(λ) of the tissue can then be calculated as the negative of 
the logarithm base 10 of R(λ).76                               
             10logA R   ---------------------------------------------------------------(2.3.4) 
Melanin concentration is calculated from the slope of this absorption spectrum in the 
620-720 nm range.77  The absorption spectrum in this spectral range includes both melanin 
and other scattering components.   
Scattering is a change in the direction of incident light caused by variations in the 
refractive index between layers, cellular components, and the extracellular matrix such as 
collagen, elastin fibers, erythrocytes, and melanosomes.  Scattering component can be 
explained using the scattering coefficient μs (cm-1), defined as the probability of photon 
scattering in a medium per unit path length.74  The inverse of the scattering coefficient is 
known as the mean scattering length.   
 μs = a x λ-b -------------------------------------------------------------------------(2.3.5) 
Here, a and b represent constants which are characteristics of the tissue.  The value 
of a can be on the order of 104–105 and whereas b may vary between 1.2 and 1.5.78  This 
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scattering coefficient also depends on the scattering cross section and the scatterer number 
density.3   
Hemoglobin can exist as oxyhemoglobin or deoxyhemoglobin depending on whether 
it has a bound oxygen.  The apparent concentrations of oxyhemoglobin and 
deoxyhemoglobin can be calculated from the melanin-corrected absorption curve using the 
known extinction coefficients for these molecules and the intensity of the absorption curve 
at the maxima of absorption for these two molecules: 560 and 580 nm.77  The hemoglobin 
concentrations can be estimated using absorption coefficients of biological tissues at 
different wavelengths as follows.3 
  dedeoxoxa CC )()10ln()()10ln( 111   ---------------------------------------(2.3.6) 
  dedeoxoxa CC )()10ln()()10ln( 222   --------------------------------------(2.3.7) 
Here εox (cm-1M-1) and εde are molar extinction coefficients (probability of photon 
interaction with a medium per unit path length) which can be obtained from experimental 
curve of molar extinction coefficient vs. wavelength for each type of oxy and 
deoxyhemoglobin, and Cox and Cde are their molar concentrations.  Here, μa (cm-1), 
absorption coefficient is defined as the probability of photon absorption per unit path length 
in a medium.  The inverse of the absorption coefficient is commonly known as the mean 
absorption length.  This coefficient depends on the absorption cross section and the number 
density of the absorbers.  Note that extinction coefficients include both absorption and 
scattering.  Once the concentration of oxy and deoxyhemoglobin are determined, the 
oxygen saturation (SO2) and the total concentration (CHb) can be calculated as follows.3 
deOX
OX
CC
CSO 2 -------------------------------------------------------------------(2.3.8) 
deOXHb CCC  ---------------------------------------------------------------------(2.3.9) 
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CHAPTER 3   
INSTRUMENTATION AND DATA COLLECTION 
In this chapter, the Raman spectroscopy instrumentation and the diffuse reflectance 
spectroscopy/colorimetry apparatus used in this work as well as data collection and 
analyses are described.  In addition, the tissue preparation for the Raman spectroscopic 
measurements and collection of data from acanthosis nigricans patients are also described. 
 
3.1 Instrumentation 
3.1.1 Raman Spectroscopy 
The basic elements a of a Raman spectrometer include a source of excitation 
wavelength (a laser source), a band-pass or a line filter to filter out the unwanted laser 
lines, a grating to disperse the collected scattered light, a notch filter to eliminate the 
intense elastically scattered (Raleigh) light,  and a detector to record the spectrum.  Often a 
position sensitive charge coupled detector (CCD) is used to record the entire dispersed light 
(spectrum) simultaneously.  There are other detectors in use, such as a photomultiplier 
tube, but the recording the spectrum with it, is a time consuming process as the only one 
point of the spectrum is measured at a given time.  The CCD increases the speed of data 
acquisition.  The spectrometer control and data acquisition is accomplished by a computer 
equipped with appropriate software.  A schematic of a Raman spectrometer is shown in Fig. 
3.1. 
 
 
Figure 3.1 Schematic diagram of a Raman instrument79 
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The performance of a CCD detector depends on quantum efficiency (QE) and its 
operating temperature.  The dark current (noise) of a detector depends on its operating 
temperature, and thus, liquid nitrogen cooled detectors have a superior performance 
characteristics compared to their air cooled counterparts.  The dark current originates from 
thermal agitation.80  Hence, in liquid N2 cooled CCD detectors, the dark current is very low, 
less than 1 electron/pixel/hour.  There is a type of noise associated with dark current, which 
is called dark noise.  This dark noise occurs due to statistical variations in dark current.80  
Thus, dark noise can be minimized by cooling.  The QE is ratio of number of photoelectrons 
generated to the number of photons strikes on a photoactive surface of the detector.  As 
CCD chip is made of silicon, the QE is very high, about 45-50% at 750 nm and depends on 
several factors such as energy band gap of the semiconductor sensing light. 
For the work reported in this thesis, we have used two different Raman 
spectrometers to record the spectra from frozen and archived human tissues.  One is a 
Renishaw RM1000 Raman microscope-spectrometer equipped with a 785 nm near-infrared 
laser excitation source and this instrument is housed in the Children’s Hospital of Michigan, 
Detroit, MI (see Fig. 3.2).  The other is a Jobin-Yvon Horiba Triax550 Raman spectrometer 
system equipped with a 514.5 nm argon-ion laser excitation source, and it is housed in the 
Department of Physics and Astronomy, Wayne State University (see Fig. 3.3).  Both these 
instruments are capable of working with 514.5 nm and 785 nm excitations laser 
wavelengths. 
 
Renishaw RM1000 InVia Raman Microscope 
 The Renishaw Raman system is a commercial system and consists of a Leica 
microscope, air cooled 578x385 pixel Charge-Coupled Device (CCD), ProScan II motorized 
xy stage and a computer equipped with Wire2 software to control the spectrometer and 
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acquire the Raman spectra.  The microscope is furnished with three objectives 5x, 20x, and 
50x.   
 
 
Figure 3.2 A schematic of the Renishaw RM1000 Raman spectrometer81 
 
We used the 50x objective with a 0.5 numerical aperture (NA) for all the Raman 
measurements taken with this instrument.  NA is defined as the product of the refractive 
index, n (n of the medium between the lens and the specimen) and sin (α), where α is half 
of the cone of the collected light.82  It is an important parameter in deciding the type of 
objective one wants to use for their Raman measurements.  A high NA objective collects 
much more scattered light compared to a low NA objective,83 thus, reducing the sample 
exposure time.  
A schematic of the Renishaw Raman spectrometer is shown in Fig. 3.1.  We used the 
1200 lines/mm grating to disperse the scattered light.  The maximum power of the GaAs 
laser source is about 500 mW with stability less than 1 cm-1.  The power at the sample is 
about 30 mW and the resolution of the Raman signal is about 3.5 cm-1.  With a 50x 
objective the instrument focuses the laser onto an area of 2 x 20 µm2 at the sample.  As the 
focal length of the 50x objective is 1 mm, it was chosen to avoid accidental contacts with 
the samples.  
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Jobin-Yvon Horiba Triax550 Raman Spectrometer System 
The Jobin-Yvon Horiba Triax550 Raman spectrometer is a triple grating spectrometer 
equipped with 2400, 1200, and 150 grooves/mm gratings which can be selected by the 
software.  The spectrometer is coupled to an Olympus BX41 optical microscope and the 
laser source with optical fibers.  The CCD detector (2000x800 pixels) is cooled with liquid 
nitrogen and the detector operating temperature is ~136 K.  The spectrometer is controlled 
with a computer equipped with Labspec software for control and acquisition of Raman 
spectra.  We used a 100x long working distance (3.4 mm) objective with 0.8 numerical 
aperture for recording the Raman spectra.  Again, the choice of long working distance 
objective was to avoid any contact between the objective lens and the tissue specimen.  
 
 
Figure 3.3 A physical set-up of the Triax550 Raman spectrometer 
 
Triax550 can disperse the signal 1.55 nm/mm at 514.5 nm with a 1200 g/mm.  The 
resolution is of 0.03 nm.84  The focal length of this spectrometer is 550 mm and the input 
aperture of the monochromator (F number or the focal length divided by the effective 
aperture diameter) is F/6.4.  If the focal length is longer, then the resolution becomes 
better.  It is note that the light collecting power increases with the inverse square of the F 
number.     
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The spectrometer can record a spectral range of ~1400 cm-1 without moving the 
grating (static scan).   The microscope focuses the laser beam to a circular spot of ~1 µm in 
diameter on the sample.  The Raman intensity is directly proportional to the forth power of 
the scattered wavelength.67  Thus, the Raman intensity increases as the wavelength 
decreases.  This is one of the advantages of using a shorter wavelength excitation source.  
However, the fluorescence background effect is larger for 514.5 nm compared to 785 nm 
excitation wavelength.  This can be minimized by acquiring data from a smaller sample 
volume or by quenching, i.e. delivering laser light onto the specimen for a certain time 
period before collecting data85 (Note that quenching can be done only for the samples which 
are not prone to damage due to long laser exposure time).   
Both these Raman instruments are calibrated using the known silicon peak (520.5 
cm-1) prior to each measurement.  This Si calibration procedure is described in more detail 
in section 3.3.1.   
 
3.1.2 Diffuse Reflectance Spectroscopy and Colorimetry 
The diffuse reflectance spectroscopy apparatus consists of a HL-2000 Ocean Optics 
deuterium tungsten halogen lamp for skin illumination, a broadband spectrophotometer 
(USB 2000 light detector; BWTEK, Inc., USA) capable of detecting absorbance in the 
wavelength range 350-850 nm (visible to near infrared region), a bifurcated fiber optic 
probe for light delivery and scattered light collection, and a computer.  The output end of 
the bifurcated fiber bundle which is placed in contact with the skin was 2.5 mm in diameter.  
The absorbance spectra are calculated from the measured scattered light spectrum by a 
custom Labview 8.0 (Labview Inc.) program (Johnson and Johnson, NJ, USA).  A schematic 
of the USB 2000 spectrometer is shown in Fig. 3.4. 
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Figure 3.4 A schematic of the interior of the USB 2000 spectrometer. The key optical 
components are representing through 1-8: the entrance fiber, the entrance slit, an optical 
filter, the collimating mirror, the grating, the camera mirror, and the detector array86  
  
The USB2000 spectrometer consists of a holographic 1200 diffraction grating and a 
one dimensional CCD detector array with 2048 pixels.  The spectral resolution is about 0.5 
nm.  The F number of the optical fiber is F/2.3 and matches with F number of the 
collimating mirror.86  Prior to data acquisition, the spectrophotometer is also calibrated 
using pure black and pure white tile standards to obtain a dark spectrum and a high-
reflectance spectrum, respectively.  
 
Colorimetry 
The colorimeter apparatus consists of a CM-2600d spectrophotometer (Konica 
Minolta CM-2600d, Osaka, Japan) which utilizes a Xenon arc lamp as a source of light for 
illuminating the skin and a computer.  Scattered light is collected by the CM-2600d through 
an integrating sphere whose internal surface is coated with a barium sulfate coating to 
make the light diffuse uniformly.87   
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Figure 3.5 A schematic of the integrating sphere system with SCI and SCE options87 
 
Figure 3.5 shows the optical geometries, where the reflected light (in all directions) 
is collected (SCI-specular component included) or excluding the specular reflection (SCE-
specular component excluded).  This instrument uses the standard tristimulus color analysis 
method utilizing the L*a*b* color system.  The primary colors are blue (450 nm), green 
(525 nm), and red (610 nm).  The numerical parameters L*, a*, and b* represent, 
respectively, a color’s darkness to lightness, its green to red color component, and its blue 
to yellow color component.87  A circular patch of skin 8 mm in diameter is illuminated by the 
CM-2600d instrument.  This instrument can record both SCI and SCE measurements 
simultaneously (see Fig. 3.5).  Similar to diffuse reflectance spectroscopy, the colorimeter is 
also corrected for detector dark current and calibrated with a standard white target prior to 
measurements on every patient.   
The apparatus of both these instruments are shown in Fig. 3.6 together with the size 
of the each probe. 
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Figure 3.6 Left: DRS setup with spectrometer, light source, calibration plate, bifurcated fiber 
optic cable, and laptop; a close-up of DRS probe showing 2.5 mm fiber core. Right: 
Colorimeter and a close-up of colorimeter 8 mm aperture88   
 
3.2 Tissue Processing 
 Raman investigations on head and neck squamous cell carcinoma (HNSCC), prostate 
cancer, and pediatric tumors were carried out using human tissue specimens.  All these 
human tissue investigations are conducted under the established rules of Wayne State 
University Human Investigation committee (HIC), Institutional Review Board (IRB), and 
HIPAA (Health Insurance Portability and Accountability Act) regulations (IRB protocol 
numbers are 0705004871 and 0810006496).  In pediatric tumor investigation, we have 
studied frozen and formalin fixed paraffin processed (FFPP or deparaffinized) tissues from 
the same patients.  For the Raman spectroscopic evaluations of HNSCC and prostate cancer 
specimens, only the FFPP tissues were examined as there were no frozen tissues available.  
As acanthosis nigricans research was done in vivo, tissue processing was not necessary.  
For the investigation of HNSCC and prostate cancer, the samples were obtained from 
Karmanos Cancer Center and Harper University Hospital in Detroit, MI and for pediatric 
tumors, the tissue specimens were obtained from the Children’s Hospital of Michigan. 
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3.2.1. Pediatric Tumors 
The goal of this work was to explore the feasibility of applying the Raman 
spectroscopy for diagnosis using the deparaffinized tissues.  It is known that archiving the 
tissues using formalin fixing and paraffin processing leads to alteration of the biochemical 
content of the tissues.  Thus, a comparison of the Raman spectra of FFPP or deparaffinized 
archived tissues with the corresponding fresh tissues would give information about the 
nature of the alterations.  We have studied the frozen tissues of normal adrenal gland, 
neuroblastoma, and ganglioneuroma from three different patients, and subsequently 
preserved the same tissues using formalin fixing and paraffin embedding, and again 
investigated them after deparaffinizing/FFPP.  The details of the procedure used are 
explained below.   
 
Frozen Tissue Specimens 
The specimens were thawed for about 20 minutes and then the desired frozen 
sections were cut with a microtome using optimal cutting temperature (OCT) solution.   In 
each tissue specimen from a given patient, a 5 μm thick section was cut and stained with 
Haematoxylin and Eosin (H&E) for pathological examination and additionally three adjacent 
10 μm thick parallel sections were cut for Raman measurements.  Then, the remaining 
tissue specimen, keeping the same orientation, was put in formalin for about 24 hours and 
subsequently preserved in paraffin wax at Karmanos Cancer Center, Detroit, MI.  
 
Deparaffinized/FFPP Tissues 
Once the tissues are embedded in paraffin wax these tissue blocks were processed 
again to remove paraffin wax from the tissue using several ethanol methanol baths.  It is 
important to remove all the wax from the specimens because paraffin gives a strong Raman 
bands and any residual paraffin left in the specimens interferes with the Raman bands of 
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Figure 3.7 Pathological images of H&E stained tissue section and unstained tissue section89 
 
the specimens’ leading to misinterpretation.  Similar to frozen tissue sectioning, four parallel 
tissue layers, one for H&E staining and the rest for the Raman spectroscopic investigation 
were cut from each specimen.  It is important to note that these four tissue sections are 
adjacent to the four sections that were cut in the frozen state prior to preserving the tissue 
in paraffin. 
 
3.2.2 Head and Neck Squamous Cell Carcinoma and Prostate Cancer   
For head and neck squamous cell carcinoma and prostate cancer investigation, only 
formalin-fixed paraffin-embedded tissue blocks were used. The archived specimens 
embedded in paraffin were processed before recording their Raman spectra.  Similar to the 
frozen vs deparaffinized study, for each specimen two adjacent parallel tissue sections were 
cut and deparaffinized, where one of the sections was stained using H&E for histological 
examination and the other unstained section was put on a stainless steel substrate for 
Raman spectroscopic studies.  We used stainless steel substrates because it gives less 
background signal and no characteristic peaks of its own compared to glass, quartz, or 
sapphire. 
 
H&E stained section     Unstained section     
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When collecting data, pathologically identified regions of the H&E stained tissue were 
used as a guide to identify the corresponding regions in the unstained tissue section as 
shown in Fig 3.7.  For the pediatric tumor project Drs. R. Rabah (University of Michigan- 
Ann Arbor) and J. M. Poulik (Children’s Hospital of Michigan) made the ink markings 
identifying appropriate pathology regions on the H&E slides.  Dr. C-H. Chang (Children’s 
Hospital of Michigan) also served as an external reviewer of the pathology diagnosis.  For 
the prostate cancer project, Drs. W. Sakr and S. Sethi (Karmanos Cancer Center) marked 
the desired regions and Dr. D. Shi (Karmanos Cancer Center) also reviewed the H&E slides.   
Staining is an important and necessary process in histopathology examination.   
Hematoxylin and Eosin are commonly used dyes for tissue staining.  Haematoxylin gives a 
blue color to the nucleus whereas eosin dye makes the rest of the content (cytoplasm, 
collagen, etc.) pinkish in color, thus, providing contrasts to identify the morphology and 
diagnose a state of the disease.  Pathologists rely on being able to see the morphology for 
disease diagnosis.  However, stained tissues produce strong fluorescence from eosin dye 
and not suitable for Raman spectroscopic studies.90  Often, the fluorescence is so strong 
that the Raman signal cannot be discerned or the detector gets saturated even for brief 
exposure.  Thus, we only make Raman measurements on unstained frozen or deparaffinized 
tissues. 
 
3.2.3 Acanthosis Nigricans 
 Spectroscopic investigation of acanthosis nigricans skin disease is done in 
collaboration with Department of Dermatology, Henry Ford Hospital, Detroit, MI under the 
leadership of Drs. I. Hamzavi and H. Lim.  In this research work, we test patients’ skin sites 
in vivo using a diffuse reflectance spectrometer and a colorimeter.  Consequently, tissue 
processing is not required as in the Raman investigations.  However, it is a necessary 
requirement that all the patients be in an insulin resistant condition, meaning elevated 
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fasting insulin levels with normal fasting glucose levels.  The patients with type 1 diabetes, 
women who were lactating, pregnant, or planning to become pregnant, and those who were 
hypersensitive to oral metformin medication were excluded from this study. 
In this AN study, eight female patients, ages 12 years and older with AN as 
diagnosed by a dermatologist were enrolled.  During the course of this research, all patients 
were consulted by an endocrinologist for treatment of their hyperinsulinemia with diet 
control, weight reduction and/or oral metformin.  Patients’ consents were obtained through 
an informed consent form and all study-related procedures were explained before enrolling 
them in the study.   
 
3.3 Data Collection and Processing 
In this section, the collection, processing and analyses of data using statistical 
analysis are explained. The methods used in both Raman investigations and the diffuse 
reflectance studies are described. 
 
3.3.1 Raman Data Collection 
The Raman spectrometers were calibrated prior to each recording session, using well 
known silicon peak at 520.5 cm-1.  For this purpose a small piece of the silicon wafer was 
used, and any correction needed was applied using the spectrometer control software.  The 
Renishaw Raman system has an automated “health check” routine that performs an 
calibration and alignment check and makes necessary adjustment/alignment so that silicon 
peak appears at the expected position with optimum intensity.  
When targeting a particular region of the tissue, all three objectives of the 
microscope (5x, 20x, and 50x) are used.  First the desired region of the unstained tissue 
section is located using the H&E slide with 5x objective.  After final focusing and 
adjustments, a Raman spectrum is taken using the 50x objective.  In order to achieve a 
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better signal to noise ratio, three accumulations of 20 s each averaged to obtain a 
spectrum.  The range Raman shift range of 400-1800 cm-1 is usually considered as the 
“biological window” because it contains most of the useful fundamental Raman active modes 
of biological molecules.  However, we collected the data in the range of 500-1900 cm-1 for 
fluorescence background subtraction and for the statistical analysis.  While only the 600-
1800 cm-1 region was used for spectral identification, the extra coverage was to minimize 
artifacts at the boundaries of the spectral region which can arise from the computerized 
background subtraction of the spectra.   
For the Raman spectral data obtained from the Jobin-Yvon Horiba Triax550 Raman 
spectrometer system, a 40 second integration time was used and spectra were averaged 
over five accumulations which gave the optimal signal to noise ratio of a Raman spectrum.  
Care was taken to ensure that each spectrum was collected from a new location on the 
tissue.  The spectra were recorded in the 428–1812 cm–1 region that involved no motion of 
the grating (static scan), thus, avoiding any spurious Raman shifts because of backlash 
errors associated with grating motions.  The spectrometer does not have an automated 
“health check” routine and thus the alignment and calibration using silicon were done 
manually. 
 
3.3.2 Raman Data Processing 
 The raw Raman spectra (shown in Fig. 3.8 (a)) often contain a large fluorescence 
background and occasionally some unexpected peaks (noise) may appear due to stray light 
or cosmic.  Therefore, before analyzing the data, each spectrum is examined manually and 
the unusable spectra are removed from the data set.  This is followed by the removal of 
obvious noise peaks and the background fluorescence of the selected Raman spectra. 
De-noising and background subtraction is done using a MatLab algorithm91 which 
removes fluorescence on a spectrum-by-spectrum basis.  This procedure utilizes the 
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following approach.  First, the noise of the raw spectrum is removed and smoothened using 
a medium filter followed by a wavelet function.  Then, the background fluorescence is 
removed using two steps of the adaptive minmax method.   
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Figure 3.8 (a) Raw spectrum, where black line shows the adaptive minmax fit (b) De-
noised, fluorescence subtracted and normalized spectrum 
 
The first step is to perform constrained and unconstrained polynomial fits using two 
different orders.  The different orders are determined using F/S ratio, the ratio of maximum 
fluorescence to maximum subtracted Raman signal selecting the minimum values of Raman 
intensities from the original spectrum for the polynomial fit.  In the second step, this 
minmax algorithm will take the maximum values of the fits and remove the background 
from the desired spectrum.91   
Once the raw spectrum is de-noised and background subtracted, it is normalized by 
dividing Raman intensities by the highest Raman peak in the spectrum.  Thus, the final 
Raman intensities vary from 0 to 1 as shown in Fig. 3.8 (b).  The artifacts of background 
subtraction below 600 cm-1 and above 1800 cm-1 can be clearly seen in Fig. 3.8 (b). These 
regions are excluded from the analysis as mentioned earlier. 
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3.3.3 Diffuse Reflectance Data Collection  
Diffuse reflectance and colorimetry measurements were obtained from four areas on 
the individual patient; two considered to be healthy tissue and used as a control and two 
areas of an acanthosis nigricans lesion on the neck.  The two control sites were the inner 
forearm approximately 10 cm from the wrist and the flat part of the upper shoulder several 
inches from the neck on the clavicle.  Spectra from the acanthosis nigricans lesion were 
collected from the median and lateral areas of neck.88  DRS and colorimetry data were 
collected from eight patients with acanthosis nigricans over an eight month period.  Three 
colorimetry and ten DRS absorbance spectra measurements were taken from each site.  The 
higher number of DRS measurements was necessary due to the smaller area of skin 
sampled by the smaller DRS probe area.   
 
 
Figure 3.9 Left: DRS probe applied to patient’s posterior neck; Right: Colorimeter measuring 
patient’s posterior neck88 
 
Since the probing pressure of the human skin can change the diffuse reflectance 
spectra,92 care was taken to insure uniform pressure on the skin over the course of the 
study.  Figure 3.9 shows how the posterior neck measurements are obtained using the DRS 
and the colorimeter.  All measurements were taken at the same room temperature and 
humidity.  For documentation and comparison, photographs of the lesion area were also 
taken during every visit using a digital camera with a cross-polarized filter.  A cross-
polarizer was used to remove the specular reflection of the skin surface. 
48 
 
While the colorimetry signal is analyzed purely in terms of the intensity of the 
various color components: L*, a*, and b*, the DRS data analysis software models the 
physics of the light-skin interaction to calculate biochemical concentrations from the 
reflected spectrum.  Analysis of the DRS data provides a quantification for the contributing 
skin chromophores, including melanin, oxyhemoglobin, and deoxyhemoglobin.  
Nevertheless, one can use the intensities of the raw spectral data from DRS ranging from 
350-850 mm to characterize the skin condition, and acanthosis nigricans.  However, the raw 
spectra of the colorimeter were not obtainable. 
 
3.3.4. Diffuse Reflectance Data Processing 
To lessen the scatter of the measurements between-patients due to the inherent 
differences in skin coloring and composition of the patients, both colorimetry and DRS data 
were normalized for every patient prior to analysis.  This was done by first calculating the 
average of the patient’s forearm control measurements.  The scatter of the forearm control 
measurements about this average allowed us to characterize the anticipated scatter of the 
lesion measurements which was expected to be even greater due to the heterogeneity of 
the lesion tissue.  All subsequent measurements were then divided by that patient’s average 
forearm control to insure that data obtained from the neck control or neck lesion tissue 
were really differences from that patient’s normal skin coloring or composition.88 
 
 
 
 
 
 
 
49 
 
CHAPTER 4 
STATISTICAL ANALYSIS/CHEMOMETRIC METHODS 
The Raman spectra consist of multivariate data.  The intensities are function of 
Raman shifts (variables) for a given molecule or a type of tissue.  If a large number of 
spectra are collected on a few different unknown samples (such as normal, pre-cursor 
lesions, and cancerous tissues) one would like to know how similar to one another these 
spectra are, and thus, be able to group them for identifying the samples.  Of course, the 
identification of a sample based on its spectrum is possible provided some "standard" data 
exists for the samples being analyzed.  Thus, when many observed variables (Raman 
intensities) seem to describe a particular behavior of an entity, interpreting data using 
mean, standard deviation, standard error, etc. is not sufficient and also cannot determine 
the variables responsible for that particular behavior of the entity.  New method needs to be 
developed to find the independent variables which account for most of the variance in the 
data and determine the behavior of an entity.  Principal Component Analysis (PCA) and 
Discriminant Function Analysis (DFA), chemometric methods provide means to achieve this 
purpose and often used in reduction/grouping of Raman spectroscopic data.  In this chapter 
we briefly describe the principles of these methods which are used in analyzing the data 
presented in the thesis. 
 
4.1. Principal Component Analysis 
PCA is one of the multivariate methods of analysis and it allows the number of 
variables in a multivariate data set to be reduced, while retaining most of the variance 
present in the observed variables.  According to this method, the original data set is 
transformed into a new data set93 with a reduced number of orthogonal variables which 
carry maximum variance of the original data set.  These new variables are called “principal 
components” (PC scores or eigenvectors).  The PCs could be then used as predictor or 
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criterion variables in subsequent analyses such as DFA.  PCA is useful when there is large 
data on a large number of variables and it is anticipated that some of the variables are 
correlated with one another, possibly because the measurements are on the same entity 
(such as a given type of tissue).  When the data is plotted against the principal components, 
one observes trends in the plot which are basically the independent groups in the data.  In 
case of biological tissues, the trends in the PCs plots represent pathological conditions of a 
diseased tissue where each trend is determined from a unique combination of the original 
predictors of the trend or the pathological state.  One can obtain these reduced variables in 
five steps as follows.  For simplicity, let us assume that there are three variables x, y, and z 
in our data set. 
 
1. Adjusting the data: Each variable or dimension is subtracted from its mean, i.e., all the 
x values are subtracted by the mean of the x ( x ).  Thus, the mean of the data set is 
zero.  xxd ii  , where i varies from 1 to n.  Here n the total number of data cases 
(assume n=6) and similarly we do the same for y and z variables. The mean-subtracted 
data which we call “AdjustData” matrix look like;  
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2. Calculating the covariance matrix: For three variables or dimensions, the covariance 
matrix is 3x3. 
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 for n=6.93 
3. Calculating the eigenvectors and the eigenvalues of the covariance matrix: By 
construction, eigenvectors are unit orthogonal vectors which provide information about 
the trends in the data, and thus characterize the data set.  For three 
variables/dimensions data, there will be three eigenvalues i and the corresponding three 
eigenvectors which are determined from the characteristic equation, 0||  IC   where I 
is the identity matrix.  The eigenvectors (EVs) can be calculated by solving the matrix, 
EVCEV 
     Suppose, the first two eigenvectors are enough to represent the variance in the data 
set of three variables/dimensions, then, the feature vector is a 3x2 matrix.  
5. Obtaining new data set: First, take the transpose of the two vectors, the feature vector 
and the mean-adjusted data vector.  Then, the new data set is the multiplication of these 
two transposed vectors.  
with the condition .  These EVs are unit vectors.93 12 
i
iEV
4. Choosing eigenvectors and forming a feature vector: By ordering the eigenvectors 
by the highest to lowest eigenvalue, one can determine the order of significance of these 
vectors.  The eigenvector with the maximum eigenvalue is the first principle component 
of the data set.  Feature vector is a matrix vector with the eigenvectors one needs to 
keep without losing much information of the data set.  

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TT AdjustDatatorFeatureVecFinalData   
Now, the new data are in terms of the chosen eigenvectors with the maximum 
information.  Note that one can obtain the original data by adding the original mean to the 
resulted matrix of the multiplicative of the feature vector and the final data.93 
 
4.2 Discriminant Function Analysis (DFA) 
DFA technique classifies the data into independent groups present in the data by 
minimizing the variations within the groups and maximizing the variations between the 
groups.94  The groups in our case are the pathological states of the tissue.  In the data 
analysis of all my research studies, I have used the output of the PCA as the input to DFA.  
The number of discriminant functions generated, are one less than the desired number of 
groups in the data set.  The output from the DFA can be used to find the independent 
groups in the data.  
DFA uses the reverse process of multivariate analysis of variance (MANOVA).95  In 
MANOVA the question asked is whether the groups are significantly different based on a set 
of linearly combined discriminant variables.  If they are, then the set of linearly combined 
discriminant variables can be used to predict group membership.  On the other hand, the 
DFA is usually concerned with actually putting the data into groups (classification) and 
testing how well (or how poorly) data are grouped.  In DFA, first a set of discriminant 
functions are calculated and tested for their significance, and then classification is 
performed.94  In order to carry out DFA, we assume the data set satisfy certain conditions:  
 Total number of cases (n) should be greater than the number of variables (p) 
 Number of groups (g) are greater than 2 
 A group consists of at least 2 cases (ni ≥ 2 in ith group) 
 All the discriminating variables are independent and measured at the same interval 
level 
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 Each group is normally distributed with similar covariance matrix94 
 
4.2.1 Calculating Discriminant Functions 
The discriminant function is a linear combination of the discriminating variables 
where the coefficients (ui) are determined by satisfying certain conditions which are 
explained in section 4.2.1.1. 
pkmpkmkmkm xuxuxuuf  ..............22110 ---------------------------------------(4.2.1) 
Here, is the value of the canonical discriminant function for case m in the group k.   
represents the value of the discriminating variable  for case m in the group k.  When 
calculating the ui for the first discriminant functions, the group mean has to be different as 
possible.  The ui for the second discriminant function are determined by maximizing the 
group means plus no correlations with the first discriminant function ui’s and so forth.94  
kmf pkmx
ix
 
4.2.1.1 Scatter of the Data: Within-Group and Between-Groups 
Let the total scatter or covariance matrix be T such that tij/(n-1) represent each 
element of the T matrix; 
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Here, xi.. or xj.. is the total mean of the corresponding variable i or j.  The scatter of the 
groups can be measured by the matrix W, where wij/(n-g) represents each element in the 
matrix W. 
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Here, xik. or xjk. is the mean of the variable i or j of the corresponding group k.  
Similarly, the between group scatter is B = T-W, ie. ijijij wtb  .  These two matrices 
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capture the variances in the data, W and B.  Thus, by solving the following equations 
simultaneously by setting  one can find the coefficients of the DFs.94 12  iv
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i
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where λ is the eigenvalue and vi are the set of p coefficients.  Thus, ui’s can be find through, 
gnvu ii   and ---------------------------------------------------(4.2.5) 
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0 ii xu ..
The largest eigenvalue carries the greatest discrimination.  Thus, the DF1 is the 
function with the largest eigenvalue and DF2 carries the second most variances in the data 
set, and so forth. 
 
4.2.1.2 Unstandardized Coefficients and Standardized Coefficients 
These ui values are unstandardized coefficients as they are calculated using the 
original data values.  Unstandardized coefficients make the origin of the discriminant 
function axes coincides with the grand centroid (In grand centroid, the discriminating 
variables are averaged over all the cases) by incorporating the absolute contribution of a 
variable in finding DFs.  One can convert these coefficients into standardize coefficients (c’s) 
as follows.94 
gn
wuc iiii  -----------------------------------------------------------------------(4.2.6) 
  The standardized coefficients provide the relative importance of a variable. 
Consequently, we can use these standardized coefficients to find the variables contribution 
towards the DFs. i.e. which variable contributes to which discriminant function and how 
large the contribution is, and larger the magnitude greater the contribution.  
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4.2.1.3 Structure Coefficients 
Structure coefficients show the contribution of the each variable in each discriminant 
function.  Total structure coefficients can be calculated by taking the product-moment 
between a particular variable and the DF.  In fact, one can find which variable contributes 
the most in each DF.  The structure coefficients vary from -1 to +1.  If the structure 
coefficient is close to zero, the DF and that particular variable are hardly correlated.  On the 
other hand, if the absolute value of the coefficient is close to 1, the variable and the DF are 
highly correlated and carry the same information.94   
Within a group, if one needs to find the correlation between a DF and a variable, 
then within-group structure variables can provide that information.  The within-group 
structure coefficients (Sij) can be determined using the following equation. 

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---------------------------------------------------------------------(4.2.7)  
where Ckj is the standardized canonical discriminant function coefficient for variable k on 
function j. 
 
4.2.2. Test of Significance 
In order to find the significance of the discriminant functions, relative percentage and 
canonical correlation coefficient are taken into consideration. 
 
4.2.2.1 Relative Percentage and Canonical Correlation Coefficient 
When there are two or more discriminant functions, by comparing relative 
percentages one can find the power of the DFs.  Relative percentages can be calculated by 
adding all the eigenvalues and then dividing the results into individual eigenvalue.   
The canonical correlation coefficients, r* can be calculated from the eigenvalues as 
follows. 
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for ith discriminant function.  These canonical correlation coefficients ranging between 0 and 
1 provide information about the relationship between groups and discriminant functions.94  
A value closer to 1 indicates an existence of strong correlation between the groups and the 
discriminant function.  If the value is lower the correlation is weaker.   
 
4.2.2.2 Wilk’s Lambda 
Without using the discriminant functions, one can find the ability of the variables 
which can discriminate the groups through Wilk’s lambda, Λ, which measures the group 
differences over the discriminating variables.94  
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Here, k indicates the number of discriminant functions calculated using the equation 4.2.1.  
If Λ equals to one, there are no group differences whereas Λ equals to zero indicates a high 
discrimination between groups.  In order to test the significance of Wilk’s lambda, chi-
square or F distributions are used.  The formula for chi-square is; 
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The degrees of freedom for chi-square are [(p-k)(g-k-1)].94 
 
4.2.3 Classification of the Data 
Classification of the original data into various classes can be performed either using 
discriminating variables or discriminant function scores.  Similar to discriminant functions, 
the classification functions can be calculated for each group as a linear combination of the 
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variables.  These classification functions (Gk) are determined to maximize the variance 
between the groups and minimize the variance within the groups.   
pkpkkkk XdXdXddG  ..............22110 --------------------------------------(4.2.11) 
Here, Xi can be either the discriminating variables or the DF scores.  The coefficients, d’s 
can be calculated using the equations below.  
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aij are the elements of W-1 matrix.  Once the G’s are obtained, then the classification of the 
data can be done using the Mahalanobis distance functions.94   
 
4.2.3.1 Mahalanobis Distance Functions 
This is a method of calculating the distances of each individual case from its group 
centroid.  Then, the data are categorized into the closest group.  The formula is as follows. 
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)|(2 kGXD  is the squared distance from a specific case X to the centroid of group k.  DFi 
represents the DF scores, but one can also use the original discriminating variables, Xi.  A 
particular case is classified into a group with a smallest D2 value.  If the D2 value is high, it 
may fit to a different group with similar profile as itself.94  
 
4.3 Other Statistical Methods 
The group identification can also be achieved through cluster analysis where a 
collection of statistical methods are used to identifies groups of samples that have similar 
characteristics.  Like discriminant analysis, cluster analysis is also used for data reduction. 
In cluster analysis there is no prior knowledge about which elements belong to which 
clusters and the clusters are determined through an analysis of the data.  The clustering 
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algorithms are broadly classified into two categories: hierarchical and non-hierarchical 
algorithms.  
 
4.3.1 Hierarchical Cluster Analysis 
 Hierarchical cluster analysis (HCA) is a clustering method which utilizes tree diagram 
or dendrogram which groups different cases as branches and shows the relationship among 
each data case.  Typically, all the data in a cluster assumes to have equal belonging to its 
cluster.  Thus, if a data case has a unique probability to cluster into a certain group then 
one has to use alternate methods.96 There are two approaches for HCA.  They are 
agglomerative (non-hierarchical) and divisive (hierarchical) procedures.97  The 
agglomerative procedure uses the closest and the far away cases with bottom-up clumping 
of clusters, meaning, start with n clusters and merge them to form the others, whereas 
divisive approach is a top-down method which forms one cluster and split it to make the 
other clusters.  It is not necessary to have the same scale for all the independent variables. 
Hence, hierarchical cluster analysis is much flexible compared to K-mean cluster (see 
section 4.3.2) and initiating the number of clusters is not necessary for this method. 
   However, the choice of initial cluster centers depends on the case order.  Therefore, 
one has to perform random orders with different permutations to verify the stability of a 
given solution.  Thus, this may not be suitable for a dataset with large number of cases.   
 
4.3.2 K-mean Cluster Analysis  
K-Mean Cluster Analysis is an non-hierarchical clustering algorithm which produces 
disjoint clusters. This technique is suitable for data set which is composed of a number of 
distinct classes and it classifies the data using the distances of data cases and the means of 
different clusters or k clusters.98  The number of groups has to be initiated by the user, 
which in turn is the number of k clusters.  The choice of initial cluster centers depends on 
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the case order as in HCA.  Thus, this may not be a good choice for a dataset with large 
number of cases.  Also, only variables with similar scales (variables such as years and 
money are not in the same scale) can be used to avoid any misleading results.99  If the 
variables are in different scales, either standardizing the data or using an alternate 
clustering method such as HCA is necessary.   
K-mean cluster method does not calculate the distances between all the cases as in 
hierarchical cluster analysis or DFA, thus, it is a fast and efficient method compared to HCA.  
When performing a K-mean cluster, each spectrum is assigned to a nearest cluster and then 
the means of the classification clusters are updated accordingly.  Finally, the spectra are 
grouped into the nearest cluster and the final cluster means represent the average values of 
the clustering variables for the spectra grouped into each cluster. 
 
4.3.3 Support Vector Machines 
Support vector machines (SVM) are a group of supervised learning methods that can 
be applied to classification.  These methods are mostly used for pattern recognition.100  This 
is a linear machine learning method which later modified to use kernel methods.  Kernel 
method can create possible patterns by using similar features in the data.  Thus, a kernel 
based learning algorithm consists of two parts, which includes a general purpose learning 
machine and a problem specific kernel function.  In the general purpose learning portion, 
solution is a linear combination of training points with consists of non-negative coefficients.  
The latter part is the non-linear mapping on data using kernel functions, the inner products 
in some feature space which returns the value of the dot product between the spectra of the 
two arguments.  SVM uses the hyperplane/decision surface which is one less number of 
dimensions in the data to distinguish two classes by maximizing the margins (minimal 
distance to the hyperplane) of the data set.101  
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hyperplane
 
Figure 4.1 Separation of data using SVM101 
 
As shown in the Fig. 4.1 the distance between hyperplane and the nearest data point 
should be large as possible.  Here, the decision function is the hyperplane.  Data in the 
decision function and the training algorithm appear only within dot products which is also 
called duality, a property of SVM.  This duality limitation can be resolved by creating a net 
of simple linear classifiers as in neural network or mapping data into a richer feature space, 
where, they are linearly separable.  Hence, the kernel functions can utilize infinite 
dimensions.  If the dot products are replaced with kernels, one can get a kernel matrix. 
Then, this kernel matrix can be used to extract the eigen functions which act as features in 
the data.   
Unlike PCA, SVM is not an unsupervised method.  Thus, SVM needs prior knowledge 
of target and many dimensions/variables may complicate the analysis compared to PCA.  On 
the other hand, too many features may lead to over fitting.  One study has observed when 
PCA or DFA is combined with SVM the success rate in pattern recognition is near 100%.101 
 
4.3.4 Neural Networks 
 Neural networks (NNs) are other methods which are useful for classification 
problems.  However, for better results of the classification, this method requires a lot of 
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training data. The algorithms for NNs utilize radial basis function (RBF) or multilayer 
perceptron (MLP) procedures to create a predictive model based on the variables.102  There 
are three major layers; input layer, hidden layer, and the output layer.  MLP is the most 
popular procedure which consists of multiple hidden layers.103   
 
 
 Outputs  
Hidden 
 
 
 
 
 
Figure 4.2 Structure of neural network 
 
The structure of NN is known as the feedforward architecture (see Fig. 4.2).  
Because, the network flows in the forward direction: input layer to the output layer.  No 
feedback loops are used.  The weights associated with the nodes are repeatedly adjusted by 
the training algorithm to minimize the errors and to increase the accuracy of the 
predictions.  The hidden layer in each procedure (RBF or MLP) predicts the output.  Usually, 
the hidden unit function is a Gaussian function which consists of three different standard 
deviations.104  In RBF procedure, the network training depends on the number of hidden 
layer units, centers and sharpness of the Gaussians.     
 One of the limitations of NN is that the weights associated with the nodes are 
difficult to interpret and also it is unable to identify the process/processes which lead to the 
relationship between dependent variables and independent variables.  In such cases, it’s 
better to use a different statistical method such as PCA or PLS (see section 4.3.5), etc.  
 
 
Inputs  
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4.3.5 Partial Least Squares Regression 
 Partial least squares (PLS) regression is another regression method which can be 
utilized when the predictor variables are correlated with each other.105  This may be the 
best alternate to PCA method, when the number of variables is greater than the number of 
spectra in a dataset.  In fact, the features of PCs and multiple regressions are combined in 
PLS.  Based on one or more independent variables a model is constructed in PLS, and then 
one or more dependent variables are tested using this model.  As in PCA, PLS solves an 
eigenvalue problem to obtain the eigenvectors in a given dataset.   
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CHAPTER 5 
RAMAN SPECTROSCOPIC STUDY OF HEAD AND NECK SQUAMOUS CELL CARCINOMA 
Head and neck squamous cell carcinoma is the most common malignancy of the 
head and neck region.  This chapter illustrates the results of Raman spectroscopic 
investigation of head and neck squamous cell carcinoma of tongue tissues. 
 
5.1 Introduction to Head and Neck Squamous Cell Carcinoma  
Head and neck squamous cell carcinoma (HNSCC) represent 9% of the cancers.4 
Although there are rapid advances in the fields of therapeutics and diagnostics, the long-
term survival of HNSCC patients has not significantly improved in the past 30 years.106  The 
five-year survival in advanced stage cancer is less than 40% and the survival rate for early 
stage disease is about 80%.8  Currently the tumor-node-metastasis (TNM) staging is one of 
the most important factors clinically used for estimation of survival.  It is important to have 
reliable estimates for patient survival and it may also impact the treating physician’s choice 
of therapy.  TNM staging is taken into consideration when recommending treatment options.  
Early stage patients are offered single modality treatment such as radiation or surgery, 
while multimodality treatment is offered for advanced stage cancer.  As HNSCC is a 
heterogeneous disease, TNM staging only provides a rough estimate.8  Not all patients with 
the same tumor stage respond in a uniform manner to the available treatment options.   
 
Motivation 
Raman spectroscopy has been extensively applied to detect cancers in a wide range 
of organs including breast, cervical,107, 108 skin,109 and brain110 tumors.  So far, only a few 
studies have been performed on HNSCC49, 50 and most of these studies are on frozen tissue 
specimens or biopsies.  The studies on nasopharyngeal biopsy tissues showed the spectral 
features of three Raman bands varied significantly when tissue changed from normal to 
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malignant state,49 and another study on frozen tissues from the larynx showed that the 
characteristic Raman spectral features for normal, carcinoma, and papilloma tissues are 
different.50   
In this exploratory study, our primary objective was to investigate the formalin fixed 
deparaffinized tissues of invasive SCC, normal, and carcinoma in situ of tongue.  The 
purpose of this study was to investigate: (i) whether Raman spectroscopy when combined 
with chemometric methods could become a potential diagnostic tool to detect HNSCC in its 
early stages, and (ii) whether there are reproducible and identifiable HNSCC-specific 
biomarkers in the Raman spectra.  
 
5.2 Materials and Methods 
5.2.1 Sample Preparation 
In this exploratory study, we have investigated a total of 17 formalin-fixed 
deparaffinized tissues from 17 different patients, of which 7 were normal, 4 with carcinoma 
in situ, and 6 with invasive squamous cell carcinoma.  The tissue blocks were processed at 
the University Pathology Research Services, Karmanos Cancer Center.  The samples were 
prepared as described in Chapter 3.  The images were taken from the tissue sections to 
ensure that the Raman spectra were collected from the same regions on the unstained 
tissue sections as the ones marked by the pathologists on the stained sections.  Standard 
tissue processing methods were used to process the tissues and to remove the wax from 
them.  
 
5.2.2 Pathological Examination  
The H&E stained sections were examined separately by three experienced 
pathologists from Detroit Medical Center, Detroit, MI who marked normal, carcinoma in situ, 
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and invasive SCC regions on every H&E stained slide.  In all the tissue samples used in our 
study, there was no discrepancy in the evaluations by the three pathologists.   
 
5.2.3 Raman Spectroscopic Measurement  
For this study, a Jobin-Yvon Horiba Triax 550 Raman spectrometer system with an 
argon-ion laser (514.5 nm) was used record the spectra (see Chapter 3). The spectral 
resolution of the Raman spectrometer was about 4 cm-1 and the laser power at the spot was 
6 mW.  The spectrometer was calibrated using the known peak from silicon.  The Raman 
spectra were collected in backscattering configuration with a 100x long working distance 
(3.4 mm) objective with a numerical aperture of 0.8 (spot size ~ 1 µm diameter).  To 
improve signal to noise ratio, spectra were recorded using 40 second integration time and 
averaged over 5 accumulations.  Each spectrum was collected from a new location on the 
tissue.  
 
5.2.5 Raman Data Processing   
For statistical analysis, we considered Raman data from 550–1800 cm-1 which 
contains fundamental vibrations of the biomolecules providing information about their 
molecular structure and conformation.  The Raman spectra often contain fluorescence 
background emanating from the aromatic chromophores and other noise.  The data were 
preprocessed for reducing the noise using adaptive minmax/wavelets method91 and then 
normalized with respect to the peak with highest Raman intensity in the spectrum.  In order 
to obtain a reliable statistical analysis, approximately 130 spectra from each category 
(totaling 401 Raman spectra) from 17 different tissue specimens were recorded. 
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Figure 5.1 Mean Raman spectra of (a) normal, (b) carcinoma in situ, and (c) invasive SCC. 
The three images on the right represent corresponding pathology images.  Circle marks 
represent the approximate locations where the spectra were taken (images are taken from 
20)111 
 
Figure 5.1 shows the mean Raman spectra of the normal, carcinoma in situ, and 
invasive SCC tissues along with their corresponding pathology images (right panels).  The 
marked circles indicate the representative regions from where the Raman spectra were 
collected.  The Raman shifts of some of the bands whose intensities change when tissue 
changes from normal to invasive SCC are also marked in the spectra.  
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Figure 5.2 PCA plots for full spectrum analysis (a) PC 2 vs. PC 1, (b) PC 3 vs. PC 1111 
 
A total of 544 Raman intensities separated by 2 cm-1 intervals from the 600-1716 
cm-1 spectral region (lower and upper edges of the measurement range were discarded to 
minimize any artifacts due to background subtraction) were used as statistical variables. 
PCA was performed on the whole data to reduce the number of original variables to fewer 
independent variables.  The initial 544 intensity variables were reduced to 16 variables 
[principal components (PCs)] which captured 98.2% of the variance in the Raman data.111 
The first three PCs contained the maximum variance of the Raman data and when 
plotted against each other, one can see two trends (Fig. 5.2) due to the normal and the 
invasive SCC data.  These PCs were used as input variables for the DFA to classify the data 
into the three pre-assigned groups.  This is achieved by maximizing the variance between 
the groups while minimizing the variance within the groups.  Figure 5.3 shows the groupings 
in a plot of discriminant functions (DFs).  Most of the data are very well separated into 
distinct groups representing normal, carcinoma in situ, and invasive carcinoma.  
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5.3 Results 
The Raman spectra of tissue samples are quite complex as the tissues contain a 
diverse set of small and large biomolecules.  The observed spectral intensity variations and 
frequency shifts shown in Fig. 5.1 are due to molecular compositional and conformational 
differences in the tissues.  The vibrational frequencies associated with different functional 
groups and backbone chains, for example, in proteins, saccharides and nucleic acids,42 often 
overlap, thus making it difficult to assign a specific observed band in the Raman spectrum 
to a specific functional group of a particular molecule in the tissue.  Thus, the frequency 
assignments have varied significantly among different published studies in the literature.  
Nevertheless, some functional groups associated with specific molecules often give rise to 
relatively narrow and well resolved bands in the Raman spectra.  These bands can provide 
direct information about the biochemical composition of the tissue and can be used to study 
the changes that occur due to the onset of cancer. 
 
5.3.1 Chemometric Analysis of the Raman Spectra 
The physical significance of the variations in the band intensities can be understood 
through chemometric analysis methods which correlate the spectral differences with the 
pathological variations in tissues and thus help in interpreting the spectral differences in 
terms of changes in biochemical composition.  The classification predictions based on 
Raman spectroscopy measurements performed by a leave-one-out validation test were 
cross-validated with the "gold standard" results of pathology. The comparison of the two 
outcomes is given in the cross-validation table (Fig. 5.3).  From the data presented in Fig. 
5.3, it is encouraging to note that Raman spectroscopy can detect HNSCC about 89% of the 
time in the tissues we have studied; with 91% accuracy in carcinoma in situ and normal 
tissues.   
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Classification: cross-validated data (%) 
Group Normal In situ 
Invasive 
SCC 
Normal 91.4 7.9 0.7 
In situ 4.5 90.9 4.5 
Invasive SCC 2.6 8.6 88.8 
Figure 5.3 DF plot for the analysis using full spectrum, and the corresponding classification 
results. Ellipse (blue), star (green), and cross (red) symbols represent normal, carcinoma in 
situ, and invasive SCC, respectively111 
 
Biomarkers play very critical role in drug development and treatment as they are the 
indicators of the normal and cancerous physiologies of an organ.  Raman spectroscopy has 
the potential to determine the biomarkers of a disease.  In this exploratory study, we have 
attempted to determine the Raman bands which play a significant role in differentiating the 
pathological states of tissue by performing statistical analysis using 12 Raman bands that 
show largest variation in their intensity (marked on Fig. 5.4).  For another DFA, we 
calculated the sum of the intensities under these bands and used these sums as the input 
variables for the calculation.  
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Figure 5.4 DF plot for the analysis using 12 selected Raman bands (shown on the Raman 
spectra), and the corresponding classification results. Ellipse (blue), star (green), and cross 
(red) symbols represent normal, carcinoma in situ, and invasive SCC, respectively111 
 
Figure 5.4 shows the DFA plot representing normal, carcinoma in situ, and invasive 
SCC states of the tissues as well as the cross-validated classification results using leave-
one-out method.  It is interesting to compare these results with the full spectrum analysis 
as done in Fig. 5.3.  Comparison of these results with full data (544 intensity variables) 
shows that these 12 Raman bands are quite successful in classifying the data.  The 
classification table shows that 86% of the original carcinoma in situ tissue samples and 85% 
of the invasive carcinoma tissue samples are correctly classified, whereas the normal tissue 
sample accuracy was only reduced by 2%.  The prediction accuracy only decreased by 4% 
compared with the whole spectrum analysis (Fig. 5.3), indicating that this set of 12 Raman 
bands carry sufficient biochemical information of a tissue to accurately predict its 
pathological state.111  
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5.3.2 Signatures of Tryptophan and Keratin in Invasive SCC of Tongue  
We have investigated the biochemical origin of these 12 prominent Raman bands 
whose intensities change noticeably when tissue changes from normal to invasive SCC.  
Interestingly, we can assign these bands to specific amino acid residues and a particular 
class of proteins.  
 
 
Figure 5.5 Upper panel: The mean Raman spectra for normal (solid blue line), carcinoma in 
situ (dotted green line), and invasive SCC (dashed red line), lower panel: Raman spectra of 
keratin and L-tryptophan111 
 
In Fig. 5.5, we show the Raman spectra of normal, carcinoma in situ, and tumor 
tissues along with the spectra of keratin (of human white hair) and L-tryptophan (Sigma-
Aldrich).   
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Raman Shift 
 (cm-1) 
Peak Assignment 
640 C-C stretching and twisting of proteins-Tyrosine 
664 Ring breathing mode in the DNA bases 
718 C-N nucleotide peak or lipid/DNA 
753 Symmetric breathing of tryptophan 
780 DNA/uracil ring breathing mode 
824 Tyrosine, phosphodiester 
850 Amino acids, keratin  
872 Tryptophan or single bond stretching vibration for amino acids or C-C stretching 
933 C-C stretch, collagen backbone, α-helix, , keratin  
1000 Phenylalanine 
1028 Phenylalanine 
1080 Typical phospholipids, phosphodiester groups in nucleic acids/collagen 
1097 Nucleic acid PO-2 or C-N stretch 
1124 Lipid or C-N and C-C stretch, proteins, lipids 
1152 C-N stretch, proteins 
1167 C=C stretch lipids 
1230 Tryptophan 
1235 Amide III, keratin  
1240 Amide III, RNA , keratin  
1306 Lipid/protein, keratin  
1335 CH3/CH2 wagging (collagen, nucleic acids), tryptophan, keratin  
1366 Tryptophan or phospholipid (CH3) 
1390 CH-rocking 
1420 COO- symmetric stretch, CH2 wag, bend, Tryptophan 
1446 CH2 bending mode of proteins & lipids, keratin  
1562 Tryptophan 
1584 Tryptophan, phenylalanine 
1614 Tryptophan 
1650 Amide I, C=C stretch, keratin  
Table 5.1 Raman peaks assignment for the observed bands.42, 112, 113, 114, 115, 116, 117  The 
Raman shifts written in bold face show a significant variation in intensity depending on the 
pathological state of the tissue 
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The Raman bands at 753, 1365, 1562, 1584, and 1614 cm-1 which show increase in 
their intensities in invasive SCC tissue can be assigned to L-tryptophan.  While the bands at 
850, 933, 1235/1240, 1306, 1335, 1446, and 1650 cm-1 which show decrease in their 
intensities can be attributed to keratin.118  A strong correlation between peaks associated 
with tryptophan and keratin is seen from their Pearson correlation coefficient values (shown 
in Table A1 in the Appendix A).  Thus, our chemometric analysis strongly suggests that 
enhancement of tryptophan and down-regulation of keratin may be linked to the 
progression of SCC of tongue.  
It is interesting to note that a recent study by Tankiewicz et al119 has shown an 
enhancement in the concentration of tryptophan and its derivatives (anthralinic and 
kynurenic acids) in oral tongue squamous cell carcinoma leading to a proposition that 
tryptophan may be a factor responsible for the development of cancer.  An earlier study by 
Crowe et al showed a down-regulation of keratin K19 in squamous cell carcinoma cell lines 
in oral cavity120 and in another study by Balm et al showed the absence of cytokeratin-18 in 
66% of the carcinoma of oral cavity.121  Our assignment of changes in Raman band 
intensities to L-tryptophan and keratin are consistent with the above studies.  However, it 
should be noted that the Raman bands of the pure L-tryptophan are much sharper and the 
1420 cm-1 peak appears to be absent or shifted in the spectra of the tissues.   
The peak broadening in complex systems such as proteins and inhomogeneous 
system like a tissue compared to pure monomer is expected to occur due to interaction 
effects.  In amino acids and small oligo-peptides and other molecules, the 1420 cm-1 Raman 
band is assigned to mixed vibrational mode consisting of symmetric COO- stretching, CH2 
wagging and bending vibrations.  Thus, it is possible that the 1420 cm-1 is absent in the 
spectra of tissues because it arises from the symmetric stretching of COO- group of free 
amino acid112-105. In tryptophan, the Raman band ~1420 cm-1 is assigned to one of the well-
known vibrational modes of the indole ring.115-118   However, as expected, the energy of this 
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mode changes when present in other medium due to its interaction with the medium’s 
components, e.g., in aqueous solution it shifts107 to ~1440 cm-1.  Thus, it is possible that, 
when L-tryptophan is present in tissue’s environment, this mode is either strongly damped 
or blue-shifted and buried under the intense band structure at 1446 cm-1. 
 
5.3.3 Monitoring the Progression of SCC with Raman Spectroscopy 
It is interesting to note that as normal tissue transforms into carcinoma in situ, 
changes in the intensities of bands at 753, 850, 933, 1235, 1240, 1306, 1335, 1365, 1446, 
1562, 1584,1614, and 1650 cm-1 are quite significant.  These spectral changes are caused 
by the changes in the biochemical composition of tissues upon normal tissues turning into 
carcinoma in situ.  Table 5.1 lists all the observed Raman frequencies along with possible 
assignments.  The frequencies of the peaks that change intensity depending on the state of 
the tissue are shown in bold in Table 5.1.  Further, changes in intensities occur when a 
carcinoma in situ tissue turns into SCC, and thus Raman spectroscopy can distinguish 
carcinoma in situ from normal tissues.  
 
5.4 Discussion 
Of the available prognostic factors in HNSCC such as TNM stage, surgical margin 
status, extra-capsular spread, number of positive lymph nodes, perineural and 
angiolymphatic invasion.122, 123  TNM staging is currently the most often used clinically.  It 
helps in selecting the aggressiveness of postoperative adjuvant therapy (radiation alone 
versus chemoradiation).  To maximize treatment effectiveness and minimize toxicity, it is 
important to have reliable survival estimates.  Unfortunately, TNM staging provides an 
estimation of overall survival and is not always correct in predicting treatment response in 
individual patients.  
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In this study, we have used Raman spectroscopy which uses characteristic Raman 
spectral features rather than morphological features to determine the pathological state of 
tongue squamous cell tissues.  It is an objective technique which eliminates inter-observer 
variability and requires short time (a few minutes) to measure the spectrum of a tissue.  In 
this study, we have identified the spectral features of normal, carcinoma in situ, and 
invasive SCC tissues of tongue that can discriminate between these three tissue types.  We 
have analyzed the Raman spectral data using PCA93 and DFA94 chemometric methods.  PCA 
found two distinct trends in the data while DFA was able to group the data into three 
distinct groups.  The classification results were further tested by leave-one-out cross-
validation method and compared with the "gold standard" of pathology which clearly 
predicted the normal, carcinoma in situ, and invasive SCC with high accuracy.  
We found that the intensities of the Raman bands assignable to tryptophan (753, 
1365, 1562, 1584 and, 1614 cm-1) increase while those attributable to protein keratin (850, 
933, 1235/1240, 1306, 1335, 1446, and 1650 cm-1) decrease when tissue changes from 
normal to carcinoma in situ and then to invasive SCC.  This suggests that tryptophan and 
keratin play an important role in SCC of tongue.111  
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Figure 5.6 ROC curves calculated from the analysis (from left to right) of; full spectra 
analysis and 12 Raman bands111  
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Based on the discriminant function 1 calculated from the whole data and 12 Raman 
bands, Receiver Operating Characteristic (ROC) curves (Fig. 5.6) were determined.124  They 
are sensitivity vs 1- specificity plots.  Sensitivity, calculated from the ratio of carcinoma data 
to the total data, represents the true positives of a test (for example, in our study it is 
carcinoma).  And 1- specificity describes the false positives of a test (normal but identified 
as carcinoma) as a ratio of normal to the total data.  In the perfect scenario, ROC curve is a 
step function.  If the area is close to 1, then the test result is considered perfect whereas 
area close to 0.5 is considered bad.  In our case, the area under the curve for whole 
spectrum and analysis using 12 Raman peaks are 0.97 and 0.959.  Thus, the capability of 
differentiation between invasive squamous cell carcinoma and normal using Raman 
spectroscopy is quite remarkable even with twelve selective Raman peaks that exhibit 
intensity variations. 
 
5.5 Conclusions  
Raman spectroscopy is an optical technique capable of providing molecular level 
information, enabling investigation of functional groups and molecular conformations.  
Molecule-specific spectral bands can provide direct information about the biochemical 
composition in a tissue thus allowing one to detect small changes in biochemical 
compositions which occurs at the inception of cancer.  We were able to detect with 91% 
success rate the normal and carcinoma in situ tissues of tongue and with 89% accuracy the 
invasive squamous cell carcinoma tissues.  Thus, this exploratory study shows that Raman 
spectroscopy can be used in studying the head and neck squamous cell carcinoma.  Our 
study shows increased levels of tryptophan and decreased levels of keratin as the tissue 
changes from normal to squamous cell carcinoma which is consistent with other biochemical 
investigations.119-121 
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le biopsy.   
CHAPTER 6 
RAMAN SPECTROSCOPIC STUDY OF PROSTATIC INTRAEPITHELIAL NEOPLASIA 
Prostatic intraepithelial neoplasia is the precursor lesion of prostate cancer.  If this 
pathological state can be optically identified from different grades of cancer, then, this could 
lead to the screening of potential prostate cancer patients in vivo or in vitro using Raman 
spectroscopy.  In this chapter, we have attempted to explore this possibility using Raman 
spectroscopy. 
 
6.1 Introduction to Prostate Cancer  
Prostate cancer is the second most common cancer among men worldwide based on 
the statistical data collected through 2008.1  Ever since screening with the Prostate Specific 
Antigen (PSA) test began, which measures the level of PSA in patients’ blood, its mortality 
rate has trended downwards due to its early detection and treatment.125, 126  Other 
detection method involves a digital rectal examination to check for growths in or 
enlargement of the prostate gland in men.  If there is a tumor growth in the prostate, it can 
often be felt as a hard lump.  To further confirm the tumor, a pathological examination is 
performed on biopsies of the prostate and the initial grade of the cancer is given by the 
pathologist.15  According to the current policy, the age limit to obtain PSA has been lowered 
to 40 years.  In addition, a decision to perform biopsies is not followed by PSA and DRE 
alone, other factors such as patient age, PSA velocity, PSA density, family history, ethnicity, 
etc. are also considered.127  One of the common tissue extraction methods is need
 
Motivation 
Detection and confirmation of prostate cancer is very crucial for its successful 
treatment in order to improve survival rate.  Sometimes the standard screening programs 
can provide misleading results leading to wrong or over-treatments and occasionally to fatal 
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consequences.  The interpretations of histological examination of biopsies, considered as the 
“gold standard” for diagnosis, are often subjective and can vary significantly from one 
pathologist to another.128  Hence, it is imperative to detect the state of the disease with a 
method which is objective and capable of providing results within a very short period of 
time, in 1-2 minutes.  Raman spectroscopy techniques are very well suited for these types 
of goals and, in addition, they are also capable of probing disease at cellular level.  This 
optical method can provide information about the changes in the concentrations of the 
constituent biomolecules of tissues and detect the progression or state of the disease.  
Therefore, this technique can be used to diagnose pathological condition of organs and 
progression of disease.   
Apart from benign epithelia (BE), PIN, or cancerous micro acinar clusters, stromal 
cells also surround these biomolecular patterns.  The interaction between human prostatic 
stroma and the epithelial cells in normal prostate is somewhat different from the stromal 
cells in prostate tumors.129  The normal human prostatic stroma which consists of 
fibromuscular matrix enclosing the prostatic ducts limits the proliferation of the epithelia 
unlike the stromal cells in the prostatic tumors, which contains fibroblasts or myofibroblasts.  
The stroma bordering prostatic tumors is called “reactive stroma” or “carcinoma associated 
fibroblasts”.129  It is imperative to explore the spectral features of the stromal cells in benign 
epithelia (BE), PIN, and tumor stages and understand its linkage with cancer and its 
progression.  It appears that the reactive stroma in prostate initiates the carcinogenesis and 
helps its progression.130, 131, 132  Our primary goal is to investigate luminal cells of PIN and 
compare their spectral features with BE and cancerous cells of the prostate tissues.  It is 
important to compare luminal cells alone of each pathological category since basal cells are 
absent in the epithelium of microacinar structures of the prostate cancer.  Our secondary 
goal is to examine the Raman spectral features of the stroma surrounding BE, PIN, and 
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cancer in deparaffinized tissues.  To the best of our knowledge, our exploratory Raman 
study is the first report of such an investigation. 
 
6.2 Materials and Methods 
6.2.1 Raman Spectroscopy 
As in the pediatric tumor study, we used a Renishaw RM1000 Raman microscope-
spectrometer with a 785 nm diode laser excitation source.  Each Raman spectrum was 
averaged over three scans with 20 second integration time to gain a good signal-to-noise 
ratio.  The scattered light was collected through back scattering geometry and dispersed 
through a 1200 lines/mm grating structure before being sent to the CCD detector. 
 
6.2.2 Preparation of Tissues for Raman Spectroscopy 
Tissue specimens which were embedded in paraffin wax were obtained from 
Karmanos Cancer Center and Harper University Hospital in Detroit, MI, and were processed 
at the University Pathology Services at Karmanos Cancer Center.  In this study, we 
particularly selected those tissue specimens that were purely either BE, PIN, or cancerous.  
For each specimen, two parallel sections were cut.  One 5 μm in thickness (H&E stained) 
was used for pathological examination and the second 10 μm adjacent thick section was 
used for Raman spectroscopic measurements.  These H&E slides were reviewed by three 
experienced pathologists and none of the cases were found to be in dispute.  Standard 
procedure was used to remove paraffin wax from the 10 μm thick tissue specimens before 
they were used for Raman study.  The wax in the tissue layers was removed by using 
xylene and ethanol baths.  However, if this was not done properly, the wax residues would 
likely interfere with the Raman spectrum in the Raman bands at 1063, 1130, 1296, 1436, 
and 1465 cm-1.  In our samples, we did not observe any of these sharp wax bands.  It is 
assumed that the morphological features do not change across the few micrometer thick 
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layers, hence the H&E stained layer can be used as a guide layer to collect Raman spectra 
from the specific sites of the adjacent unstained deparaffinized tissue section.  
 
6.2.3 Raman Spectroscopic Measurements 
A total of 34 tissue specimens obtained from 33 patients were used in this study.  
Out of these, 12 specimens were benign, 11 were PIN, and 11 with cancer.  Images were 
taken from the marked regions corresponding with each H&E slide to insure that the data 
were taken from the correct regions of interest.  When collecting Raman spectra, the laser 
beam was focused only on the luminal cells.  The circular regions in Fig. 6.1 show the 
regions from where the Raman spectra were collected.  In addition, each data location was 
imaged to make sure that each Raman spectrum is taken from a new luminal cell of the 
target tissue.   
The Raman spectra were collected in the 500-1900 cm-1 range as the region of 600-
1800 cm-1 is commonly known as the “biological window” in the field of biomedical research.  
Most of the biomolecules show intense Raman excitations across the biological window.  The 
extra 100 cm-1 were recorded in both ends of the Raman spectra to avoid any artifacts 
which may occur while removing the fluorescence background from each spectrum.  A total 
of 1220 Raman spectra were collected from the tissue samples in which 207, 202, and 208 
were from BE, PIN, and cancer, respectively.  We have collected roughly the same number 
of spectra from each category so that the variations in the spectral features of BE, PIN, and 
cancer can be reliably compared.  In addition, 201 Raman spectra were obtained from the 
stromal areas surrounding the BE, PIN, and cancer (Gleason grade 6).  Here, the Raman 
measurements of stromal cells in cancer tissues were obtained from the bordering of the 
micro acinar clusters as shown in Fig. 6.1.  
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Figure 6.1 Pathology pictures of (a) BE, (b) PIN, and (c) Cancer (images are taken with 40x 
magnification).  Elliptical symbols represent locations of the Raman measurements133 
 
6.2.4 Raman Data Processing and Chemometric Analysis 
While collecting Raman spectra, we made sure that there was no non-standard noise 
in any spectrum and, if found, we discarded those spectra from our database.  The 
remaining spectra were cleaned from any spurious bands due to cosmic event and noise by 
using wavelets method.91  The fluorescence background from each spectrum was removed 
with a minmax adaptive algorithm that requires no a priori knowledge of the spectra.  
Finally, each spectrum was normalized with respect to the highest intensity value of the 
spectrum.   
Multivariate/chemometric statistical method, like PCA93 which determines correlation 
in the variance, can be used to detect trends in the data set and data can be further 
analyzed using DFA94 to find classes of the data.  First, we analyzed the data using PCA 
which reduced the dimensionality of the original data set from 601 variables to 19 new 
variables, called the eigenvectors.  These new variables captured 97% of the variance of the 
data.  Examination of the first two eigenvectors showed distinct trends in the data 
representing BE, PIN, and cancer.  These new fewer variables carrying most of the variance 
of the data are useful for determination of the groups in the data.  To find classes in the 
data, we have performed DFA94 using the 19 eigenvectors as the input variables.  The 
classification of each pathological state was done using the leave-one-out method, where 
each data case is considered a new case and compared with the rest of the data pool.  
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6.3 Results and Discussion  
The average Raman spectral features of BE, PIN, and cancer are shown in Fig. 6.2. 
We found changes in the peak intensities of most of the Raman bands (Raman band 
assignments are listed in Table 6.1) of the PIN spectrum.  These changes are fundamentally 
related to the changes in the concentrations of the biochemicals of BE and normal luminal 
cells.  Significant changes were found in the region from 600 cm-1 to 1145 cm-1 which are 
shown in the lower panel of the Fig. 6.2.   
 
 
Figure 6.2 Average Raman spectra of BE (Blue dash line), PIN (green), and cancer (red 
dotted line).  The lower panel shows the Raman spectral range of 600-1145 cm-1 133 
 
Some of the changes are noteworthy: the band at 726 cm-1 (assigned to ring 
breathing mode of DNA/RNA bases) becomes quite intense in PIN, and in addition the 
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Raman bands at 853, 931 cm-1 ((C-C) stretching mode of proline, valine, and protein), 960 
cm-1, and 1090 cm-1 (symmetric phosphate stretching vibrations) also showed increases in 
their intensities when the pathological state of the cell changes from BE to PIN, while the 
bands at 1605 cm-1 and 1667 cm-1 (amide I) showed suppression in their intensities.  When 
comparing the average spectral changes of PIN with cancer, we found that the peak 
intensities at 780 cm-1, 1240 cm-1 (proline, tyrosine), 1330 cm-1, and 1605 cm-1 are 
enhanced when the pathological state of luminal cells changes from PIN to cancer, while the 
bands at 726, 853, 931, 960, and 1090 cm-1 showed a decrease in their intensities which 
also showed a similar trend like the bands of BE.   
 
Raman 
Shift (cm-1) Peak Assignment 
726 A ring breathing mode of DNA/RNA bases 
758 Symmetric breathing of tryptophan 
780 DNA/uracil ring breathing mode 
829 Tyrosine, phosphodiester, O-P-O stretching DNA/RNA 
853 
Ring breathing mode of tyrosine, C-C stretch of proline 
ring,  glycogen 
878 Tryptophan, hydroxyproline, C-O-C ring 
931 C-C stretch, α-helix, protein band  
960 Cholesterol, phosphate of HA 
1004 Phenylalanine 
1032 Phenylalanine, proline 
1081 
Typical phospholipids, phosphodiester groups in nucleic 
acids/collagen 
1090 Symmetric phosphate stretching vibrations 
1240 RNA, Amide III, collagen 
1313 Lipid/protein  
1330 Collagen, nucleic acids & phospholipids  
1450 
CH2 bending mode of proteins & lipids, methylene 
deformation  
1557 Tryptophan, tyrosine 
1605 Cytosine, phenylalanine, tyrosine, C=C 
1667 Protein, C=C stretch, amide I  
Table 6.1 Raman peak assignment41, 42 
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The Raman bands at 780 and 878 cm-1 showed progressive increase in their 
intensities when cells change from BE to PIN and then to cancer indicating that the increase 
in the concentrations of the biochemicals related to these bands is continuous.  These 
Raman bands should be further investigated and if found to show the same trend, then they 
can be used as diagnostic variables for the detection and progression of prostate cancer. 
 
6.3.1 Chemometric Analysis of the PIN, BE and, Cancer  
 The first three eigenvectors or the principal scores (PCs) are plotted against each 
other in Fig. 6.3.  The left panel is the plot of PC2 vs. PC1 and the right panel represents 
PC3 vs. PC1.  These three principal scores contain 76% of the variance in the data showing 
different trends for each pathological state.  Although some of the data seem to be 
overlapping with each other, the different trends are still very clear in the data.  Largest 
variance in the data was captured by the PC1 which is shown by the spread of the BE, PIN 
and cancer data along the PC1 axis.  PC3 shows a distinct trend present in the PIN spectral 
data.  
 
 
Figure 6.3 PCA results of BE, PIN, and cancer. PC2 vs PC1 is on the left panel and the PC3 
vs. PC1 is on to the right133 
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Figure 6.4 DF plot of BE, PIN, and cancer133 
 
The average spectra of BE, PIN, and cancer showed distinct variations in the 
intensities of certain peaks while the spectral features of the individual spectra of each 
category are expected to be scattered about its average value and must also be different 
from other categories.  As tissue changes from BE to PIN and then to cancer, the spectral 
variances in the data must exhibit some distinct classes if each of these categories is 
pathologically different.  The classification results are shown in Fig. 6.4 where we clearly 
observed three distinct classes with their centroids (marked with black squares) far away 
from each other.  It is interesting to note that the PIN class was a very distinct class from 
other classes and doesn’t have much overlap with others.  There are only three pathological 
states, which means, there are only two discriminant functions.  The discriminant function 1 
shows the maximum variance in the Raman data and the discriminant function 2 contains 
the rest of the variance.94  The x-axis shows a continuous change from BE to PIN and then 
to cancer.  The group prediction of the Raman spectroscopy data using DFA was compared 
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with that of pathological diagnosis, the gold standard for diagnosing cancer.  To test the 
validity of our predicted classifications, we have performed a leave-one-out cross-validation 
where the group classification for each spectrum with one of the known pathological states 
is determined while using the remaining data as a training set.  The results of cross-
validation were compared with the classification results in Table 6.2.  We found that the PIN 
could be predicted with 82% accuracy while the prediction accuracies for BE and cancer 
were 76% and 91 %, respectively.  
 
  Predicted Group Membership 
  Group BE PIN Cancer Total 
BE 158 20 29 207 
PIN 33 165 4 202 
Count 
Cancer 16 2 190 208 
BE 76.3 9.7 14.0 100.0 
PIN 16.3 81.7 2.0 100.0 
Cross-
validated 
% 
Cancer 7.7 1.0 91.3 100.0 
Table 6.2 Classification results of BE, PIN, and cancer133 
 
6.3.2 Stroma-Epithelium Raman Spectra Comparison 
It is interesting to study the stroma around each pathological state as it could 
provide useful information about the onset of cancer.  The nature of stroma observed was 
found to depend on its environment.129  Figure 6.5 shows the average Raman spectra of 
stroma surrounding BE, PIN, and cancer together with the average Raman spectra of the 
relevant epithelium in black.   
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Figure 6.5 Average Raman spectra of stroma in BE, stroma in PIN, and stroma in cancer 
together with the epithelial cells of BE, PIN, and cancer, respectively which represent in 
black dotted format133 
 
Most of the Raman bands show significant differences between PIN and stroma 
associated with it, especially the Raman bands at 726, 780, 853, 931, 960, 1081, 1313, 
1330, 1605, and 1667 cm-1.  The Raman bands associated with DNA/RNA (726, 780, 829, 
and 1330 cm-1) are suppressed in all the stromal Raman spectra compared to the luminal 
cells of BE, PIN, and cancer.  In fact, the Raman bands incorporating amino 
acids/protein/collagen (853, 931, 960, and 1240 cm-1) were significantly enhanced. The 
Raman band at 1081 cm-1 which is related to phospholipids was also enhanced in stroma.  
These observations are in full agreement with the actual biochemical composition of stroma. 
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The chemometric analysis was performed on the stromal data.  Similar to the 
epithelia investigation, the PCA created 15 principal scores containing 98% of the variance 
in the Raman data.  Apparently, the three categories: stroma in BE, stroma in PIN, and 
stroma in cancer are quite distinct as shown in the DF plot together with the overlapping 
average Raman spectra of stroma in BE, stroma in PIN, and stroma in cancer (see Fig. 6.6). 
 
 
Figure 6.6 DF plot of stroma surrounding BE, PIN, and Cancer.  The average Raman spectra 
of stromal data for each category are shown to the right of the figure133  
 
Table 6.3 shows the predicted group membership using a leave-one out classification 
method for stromal investigation.  We found that the stroma surrounding PIN could be 
correctly identified with 83.6% accuracy.  The stroma in BE and cancer were classified with 
81.6% and 87.1% accuracy, respectively. 
 
 
 
 
89 
 
  Predicted Group Membership 
  
Group 
Stroma-
BE 
Stroma-
PIN 
Stroma-
Cancer Total 
Stroma-BE 164 3 34 201 
Stroma-PIN 14 168 19 201 
Count 
Stroma-Cancer 18 8 175 201 
Stroma-BE 81.6 1.5 16.9 100.0 
Stroma-PIN 7.0 83.6 9.5 100.0 
Cross-
validated 
% 
Stroma-Cancer 9.0 4.0 87.1 100.0 
Table 6.3 Classification results of stroma in BE, PIN, and cancer133 
 
It seems that when comparing stroma enclosing PIN with stroma in cancer, the 
Raman bands at 853, 931, 1240, and 1330 cm-1 were increased while the Raman bands at 
1081 cm-1 and 1450 cm-1 were decreased.  In fact, the stroma associated with PIN showed 
less interference with the changes occurring in the PIN structure whereas the stroma 
associated with cancer interfered more with the progression of the cancer epithelia as the 
Raman bands at 1313, 1330, and 1450 cm-1 are relatively the same as in cancer and stroma 
around it.  Thus, the stroma associated with BE, PIN, and cancer can be detected with high 
accuracy using Raman spectroscopy.   
When spectral data of all the pathologies are combined and analyzed statistically to 
find their distinct classes, interestingly we found a clear separation of stroma from BE, PIN, 
and cancer.  In addition, stroma-BE, stroma-PIN and stroma-cancer were also well 
separated as shown in Fig. 6.7.  Note that DFA constructs one less number of discriminant 
functions than the number of user-defined categories.  Thus, this analysis produces 5 
discriminant functions due to 6 categories.  Figure 6.7 only shows the first two discriminant 
functions which carry 89% of the information in the Raman spectra.  Hence, the overlapping 
of data in this 2-D plot may not be the same for the other dimensions.   
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Figure 6.7 DF plot of all the categories: BE, PIN, cancer, and stroma surrounding BE, PIN, 
and cancer133 
 
The results clearly show that as a luminal cell changes from its normal state to PIN 
before becoming cancerous, the Raman spectral features have already changed and these 
changes continue as the disease progresses.  Moreover, if the laser beam is shined only on 
the stromal regions far away from its corresponding pathologies (PIN, BE, and cancer), we 
expect the Raman spectral features to be very different and capable of identifying itself with 
much higher accuracy.  
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Figure 6.8 ROC curves for PIN vs cancer (left) and stromal PIN vs stromal cancer (right)133 
 
We also constructed Receiver Operating Characteristic (ROC) curves114 for both the 
analyses, PIN compared to cancer and stromal comparison between stroma around PIN and 
stroma associated with cancer as shown in Fig. 6.8.  This ROC curve is a graph where 
sensitivity and 1-specificity are plotted against each other.  Sensitivity is the ratio of true 
positives (cancer measurements which are correctly identified as cancer) over the total PIN 
data and specificity is the ratio of true negatives (PIN measurements which are correctly 
identified as PIN) over the total PIN data.  The sensitivity and specificity for luminal cell 
investigation of PIN and cancer are 98% and 99%.  For the stromal investigation, the 
sensitivity and specificity are about 90% and 94%, respectively.  The area under the curves 
(AUC) infers the validity of the test.  As shown in Fig. 6.8, both the AUC’s are more than 
0.96 indicating a very good test for PIN and stromal investigation.133   
 
6.4 Conclusions 
In this study, we investigated using Raman spectroscopy on luminal cells from 
tissues which are purely either BE, PIN, or cancerous.  We particularly focused on PIN and 
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compared its spectral features with BE and cancer.  As tissue transforms into PIN, most of 
the Raman bands of BE showed changes in their intensities and, in addition, an intense 
Raman band at 780 cm-1 (assigned to DNA/RNA) also appeared in PIN’s spectrum.  As 
luminal cells become cancerous, some of the Raman bands including 780 cm-1 showed 
progressive increase in their intensities.  Additionally we also studied stromal cells around 
each pathological state; BE, PIN, or cancer.  Chemometric analysis of the data shows that 
the spectral variations in the data are quite pronounced and can be easily classified with 
very high accuracies into distinct pathological groups.  The sensitivity and specificity of 
luminal cells of PIN and cancer are about 98% for each and for the stroma associated with 
these pathologies, both the sensitivity and specificity are more than 90%.  The current 
study suggests a further investigation of different grades of PIN pathology: low grade and 
high grade, including basal cells, and expand Raman spectral database for better prediction 
accuracy.  Since some of the PIN structures may not lead to carcinoma, by spectroscopic 
investigation one can find the Raman signatures of a PIN structure which can lead to cancer.  
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CHAPTER 7 
RAMAN SPECTROSCOPIC STUDY OF PEDIATRIC TUMORS 
In this chapter, the investigation of the cellular regions in normal adrenal gland and 
pediatric tumors, specifically neuroblastoma and ganglioneuroma, using Raman 
spectroscopy is discussed in detail.  Our investigation is the first report of comparison of 
frozen and deparaffinized pediatric tissues of the same patients using Raman spectral 
signatures. 
 
7.1 Introduction to Neuroblastoma and Ganglioneuroma 
Neuroblastoma and ganglioneuroma are peripheral neuroblastic tumors derived from 
immature sympathetic nervous system and the adrenal gland.  Neuroblastoma, the third 
most common type of children’s cancer, occurs in embryonic neuroblasts of the sympathetic 
peripheral nervous system which can spontaneously mature into ganglioneuroma.17  It is a 
solid malignant tumor which can be observed in the abdomen, around the spinal cord near 
the chest region, or pelvis.  MYCN (v-myc myelocytomatosis viral related oncogene) gene 
amplification, DNA ploidity, chromosome 1p depletion or loss of heterozygosity, and gain of 
17p chromosome are the most vital prognostic markers.134  Neuroblastoma can be of 
favorable or unfavorable histopathology/prognosis based on the Shimada classification.19, 20  
When MKI (mitosis-karyorrhexis index, number of mitoses and karyorrhexis per 5,000 cells) 
is low or intermediate in neuroblastoma at age less than 1.5 years, these cases belong to 
the favorable histology group.  In addition, when the differentiating neuroblastoma is 
diagnosed with low MKI between ages 1.5-5 years, the histology group is also favorable.135 
If a child is diagnosed with neuroblastoma, it is frequently unamenable to surgical 
removal at diagnosis and requires chemotherapy followed by surgical debulking.  Prognosis 
is dependent on the patient age, morphological findings such as degree of ganglionic 
differentiation, stromal maturation, mitotic/karyorrhectic count and biological molecular 
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markers.134  Ganglioneuroma on the other hand is a benign neoplasm that is considered the 
end result of spontaneous maturation of neuroblastoma in a subset of patients.  This is a 
unique phenomenon that is still incompletely understood.  Ganglioneuromas are usually 
treated by surgical removal, no chemotherapy is needed and the prognosis is excellent. 
Chemotherapy treatment in neuroblastoma also induces ganglionic maturation and stromal 
maturation and often neuroblastomas at the time of debulking surgery appear histologically 
similar to ganglioneuromas.17 
 
Motivation 
Although several Raman spectroscopic investigations have been carried out on frozen 
tissues, the abundant availability of archived formalin fixed paraffin preserved (FFPP) 
tissues may provide a venue for conducting a thorough investigation for diagnostic purpose.  
However, the preservation of tissue specimens by embedding them in paraffin wax is known 
to alter their biochemical composition.  In a study using human placenta specimens it has 
been shown that formalin fixation results in additional peaks as well as shifts in the amide 
bands resulting from changes in protein conformation and possible cross-links.136  Thus, for 
a reliable diagnosis of pathological state in deparaffinized or FFPP tissues using Raman 
spectroscopy, it is important to identify the biochemical changes which occur in archived 
FFPP tissues.  Once the nature of the loss of biochemical information is known and 
understood, one can pursue further studies using FFPP tissues using Raman spectroscopy. 
Further, the pathological evaluations have inherently an element of subjectivity as the 
outcome of the evaluation is based on the experience and intuition of the pathologist.  The 
information extracted from the pathological evaluations has a high impact in determining 
the treatment strategy.  Hence, it is crucial to develop an objective optical technique such 
as Raman spectroscopy to diagnose the pathological state of tissue with high reliability.  The 
diagnostic ability of Raman spectroscopy for paraffin embedded archived pediatric 
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tumors/neoplasm has not yet been fully explored.  In this study, our aim is investigate 
frozen tissue sections of normal adrenal gland, neuroblastoma, and ganglioneuroma 
obtained from three different patients, and compared their Raman spectral features with the 
corresponding deparaffinized sections of FFPP tissues.  The goal of this study is to 
understand the nature of biochemical changes that occur in FFPP tissues and to assess their 
feasibility for diagnosis of diseases using Raman spectroscopy.  We have attempted to 
determine the Raman spectroscopic signatures of each type of tumor, particularly, from the 
cellular regions of well identified pathology rather than collecting data from random sites in 
the bulk tissue specimens as was done in the earlier studies.51-53  
 
7.2 Materials and Methods 
For this research work, the Renishaw RM1000 Raman microscope-spectrometer (785 
nm excitation laser source) was used to collect the Raman spectra.   
 
7.2.1 Normal adrenal gland, Neuroblastoma, and Ganglioneuroma Tissues 
For a comparison study of frozen versus deparaffinized specimens using Raman 
spectroscopy, the frozen specimens were obtained from three patients from the Children’s 
Hospital of Michigan, Detroit, MI.  Patient #1 is a 3 year old infant with adrenocortical tumor 
present in right adrenal gland.  A normal adrenal gland specimen was obtained from this 
patient.  The pathology examination verified the absence of any malignant cells in the 
tissue.  Patient #2 is an 18 month old female infant having neuroblastoma.  The specimen 
was obtained from the left adrenal gland.  The tumor (12 cm in dimension and weight 0.510 
kg) was poor in stroma and was poorly differentiated.  This neuroblastoma specimen has 
been identified as having a favorable histology, and pathological evaluation shows that this 
specimen contains nests of tumor cells with centering neuropils.  Patient #3 is a 7 year old 
child with ganglioneuroma.  The specimen is a spinal mass having differentiating mature 
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ganglions in a dominant Schwannian stroma environment.   The tumor was 3 cm  2 cm  
1.5 cm in size, and clusters of ganglions were observed throughout the specimen.  
As explained in Chapter 3, these frozen specimens were thawed for about 20 
minutes and then the four frozen sections were cut with a microtome using optimal cutting 
temperature (OCT) solution. The first cut (5 μm thick section) was stained with 
Haematoxylin and Eosin (H&E) for pathological examination and the rest (10 μm thick 
parallel sections) which are adjacent to each other were cut for Raman measurements. 
Once the tissue sections were obtained, the remaining tissue specimen, keeping the same 
orientation, was put in formalin for about 24 hours and subsequently preserved in paraffin 
wax.  From this tissue block, four additional parallel sections were cut, one for H&E staining 
and the rest for Raman spectroscopic investigation.  The paraffin was removed from the 
tissue sections using the standard deparaffinizing procedure.  Additionally, we have also 
studied archived FFPP tissues from nine other patients.   
 
Cases 
No. 
Patient 
No. Pathology Tissue Source 
Raman 
Spectra 
1 P1 Normal Adrenal 78 
2 P2 Normal Adrenal 11 
3 P3 Normal Adrenal 36 
4 P3 Ganglioneuroma Adrenal 8 
5 P4 Ganglioneuroma Extradural spinal cord mass 20 
6 P5 Ganglioneuroma Abdominal mass 40 
7 P6 Ganglioneuroma Retroperitoneal mass 71 
8 P7 Neuroblastoma Retroperitoneal mass 37 
9 P8 Neuroblastoma Posterior mediastinal mass 68 
10 P9 Neuroblastoma Paraspinal mass 12 
Table 7.1 The pathologies and the number of Raman spectra obtained from FFPP tissues of 
nine patients137  
 
The details of the pathologies of these patients are given in Table 7.1.  Tissue 
sections were cut from these samples for pathological examination and Raman 
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spectroscopic investigation as described above.  No frozen specimens were available for 
these cases.  
All the H&E slides were examined by two experienced pathologists who marked the 
regions of interest on the slides and the images were taken from each pathological condition 
of the tissues.  We used the pathologically examined/marked H&E slides of the tissue as a 
guide to find the locations of appropriate pathology in the frozen or deparaffinized tissue 
sections to collect the Raman spectra.  We assume that the pathological state of the tissue 
in the 10 μm thick sections is the same as in the adjacent 5 μm thick tissue section used by 
the pathologists.  We have used three tissues from each state (frozen or deparaffinized) to 
collect Raman data.  
 
7.2.2 Data Collection 
For a comparison study of frozen versus deparaffinized specimens, a total of 558 
Raman spectra were collected: 205 from normal adrenal gland (103 frozen and 102 
deparaffinized), 201 were from neuroblastoma (101 frozen and 100 deparaffinized) and 196 
were from ganglioneuroma (102 frozen and 94 deparaffinized). 
In the second part of the study, FFPP tissue specimens from nine patients were 
investigated. The details of the pathologies of these patients and the number of spectra 
collected are given in Table 7.1.  A total of 381 Raman spectra were collected from the 
tissue specimens. Each spectrum is an average of three accumulations with 20-second 
integration time.  The power at the sample was 20 mW.  The Raman spectra were recorded 
in the range of 500 - 1900 cm-1.  Each spectrum was recorded on a fresh spot of the tissue. 
 
7.2.3 Data Processing 
Each Raman spectrum was visually examined and any cosmic-ray noise was 
removed.  The fluorescence background present in the spectrum was removed using a 
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customized MatLab program which incorporates an adaptive minmax wavelet method.90 
Subsequently, all the Raman spectra were smoothed and their intensities were normalized 
with respect to the peak of the highest intensity in the spectrum.  To eliminate the influence 
of the artifacts which can occur during data processing, we excluded a 100 cm-1 region of 
the spectrum at both ends, i.e. the region of the spectrum used was from 600 to 1800 cm-1, 
which is commonly known as the “biological window” in Raman spectroscopic studies.  
To quantify the spectral differences among the various groups present in the data, 
we have analyzed the data using principal component analysis (PCA) and discriminant 
function analysis (DFA), both commonly used chemometric analysis techniques in 
biomedical research.93, 94   PCA is called an “unsupervised” differentiation algorithm and it 
lowers the dimensionality of the original data and constructs new fewer variables which 
capture most of the variance in the original data.93  It is unsupervised because the identities 
of the original sets are not provided in the analysis.  These new orthogonal variables 
basically represent the main independent trends in the original data set.  In our PCA, 591 
Raman intensity channels, or variables, separated by ~2 cm–1, from 600–1800 cm–1 were 
used as independent variables, and the PCA reduced them to 18 principal components (PCs) 
capturing approximately 96.7% variance in the data sets.  The PCs were then used as input 
variables for the DFA, which is supervised, and which expresses the data in terms of a 
number of discriminant functions (DFs) which is one less the number of groups being 
classified.94 
 In order to assess the utility of FFPP tissues for diagnostic purpose, the Raman data 
were collected from the FFPP tissues obtained from nine patients (Table 7.1) and used as 
training/reference set to test the data obtained from three patients.  For training set, the 
classification predictions based on Raman spectroscopy measurements with leave-one-out 
method are cross-validated with the "gold standard" results of pathology. 
 
99 
 
7.3 Results and Discussion 
7.3.1 Comparison of Frozen and the Corresponding Deparaffinized Tissues  
Figure 7.1 shows the mean Raman spectra of frozen and deparaffinized tissue 
sections, of normal adrenal gland along with the pathology image.  Both tissues produce 
good quality spectra with quite sharp and well defined bands.  Clearly, there are noticeable 
significant differences in the spectra.  To highlight the spectral differences, we also show the 
difference spectrum in Fig. 7.1.   
 
 
Figure 7.1 The mean Raman spectra of normal adrenal gland: from top to bottom, frozen 
(black), deparaffinized (red), difference (blue), beta-carotene (orange), lipid (dark yellow), 
and cholesterol (brown).  Pathology image of the normal adrenal gland is taken with 40x 
magnification137 
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A reduction in the intensity of the bands at 698, 1155, 1439, 1517, 1656, and 1738 
cm-1 is evident in the deparaffinized tissue compared to the frozen tissue, while the bands 
around 1003 and 1613 cm-1 show enhancement in the intensity.  The Raman bands ~1155 
and 1517 cm-1 arise from C-C and C=C stretching in carotenoids, which is present in high 
concentrations in different human organs including the adrenal gland.138  The Raman bands 
at 1656 and 1738 cm-1 can be assigned to C=O and C-O stretching in lipids.  In the 
literature, the band ~1656 cm-1 is often assigned to amide I band of proteins.42  However, it 
can also arise from lipids.  Thus, the Raman band at 1650 cm-1 is often broad in tissues as it 
has C=O stretching contributions from proteins, lipids and other molecular groups whose 
frequencies are slightly different.  The 698 and 1439 cm-1 (CH2 bend) bands are two of the 
strong bands observed in cholesterol and it is generally assigned to "lipids" in the literature, 
as lipid also has strong band ~1440 cm-1.  
Figure 7.1 also shows the Raman spectra of -carotene, fat, and cholesterol.  A 
comparison of the Raman spectra of frozen and deparaffinized tissue sections of normal 
adrenal gland clearly indicates that deparaffinizing of the tissue sections with xylene and 
ethanol removes lipid, cholesterol, and -carotene.  However, the majority of the spectral 
features of frozen tissue are preserved in the deparaffinized state.  The other small 
differences are in the variation of the band intensities and shifts in the frequencies which 
can be understood in terms of the conformational changes and the intermolecular 
interactions that occur during the formalin fixing and subsequent deparaffinizing processes.  
A reaction of proteins with formaldehyde leading to formation of methylene cross-link has 
been described,139 and such chemical reactions lead to change in the protein configuration 
as well as conformation. 
Figure 7.2 shows the mean Raman spectra of frozen and deparaffinized tissue 
sections of neuroblastoma along with the pathology image.  Compared to the normal 
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adrenal gland (frozen tissue section) the neuroblastoma seems to contain no -carotene and 
less lipid/cholesterol. 
  
 
Figure 7.2 The mean Raman spectra of neuroblastoma: frozen (black), deparaffinized (red), 
and difference (blue)137 
   
  The intensity of the Raman bands ~1580-1600 cm-1 (nucleic acids), 1333 cm-1, 
~1250 cm-1 (amide III/nucleic acids), 1100 cm-1 (C-N stretch, nucleic acids), 967, 780, and 
743 cm-1 (nucleic acids),  and ~664 cm-1 (C-S vibration of collagen type I or nucleic acids) is 
higher in neuroblastoma compared to the normal adrenal gland.140  This indicates that the 
neuroblastoma cells are rich in nucleic acids which is consistent with the fact that nuclear 
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and cytoplasmic enlargement can occur during the progression of the tumor141, 142 in 
neuroblastic cells.   
In this study, the measurements were made from the cellular areas avoiding stromal 
regions.  The measurements were made specifically from the cellular areas avoiding stromal 
regions which are rich in collagen. Typical size of neuroblasts being around 10-20 μm (2 to 
3 red blood cell diameters),17 the laser spot is confined to the perimeter of the cell in most 
of the cases.  A comparison of the Raman spectra of frozen and the corresponding 
deparaffinized FFPP tissue sections of neuroblastoma indicates that the majority of the 
spectral features are preserved in the deparaffinized state very similar to that of normal 
adrenal gland.  
The mean Raman spectrum obtained from deparaffinized neuroblastoma (Fig. 7.2) 
tissue sections is very similar to that of the corresponding frozen tissue but with a 
somewhat reduced intensity of the overall spectrum.  However, from a visual inspection of 
the two spectra it is clear that the reduction in the intensity of the bands ~740, ~1250, and 
~1580 cm-1 is higher than at other frequencies.  These can be attributed to conformational 
and configurational changes that occur due to the formalin fixation process as described 
above.  
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Figure 7.3 The mean Raman spectra of ganglioneuroma: frozen (black), deparaffinized 
(red), and difference (blue)137 
 
  Figure 7.3 shows the average Raman spectra of frozen and deparaffinized tissue 
sections of ganglioneuroma along with the pathology image.  The Raman data were 
collected from isolated ganglions (much larger than neuroblasts) and thus the laser spot is 
confined to the perimeter of the cell.  Hence, the Raman bands arise from nucleus and 
cytoplasm of ganglions. Several Raman spectra from deparaffinized ganglioneuroma tissue 
sections showed residual paraffin wax peaks although tissues were processed very similar to 
normal adrenal and neuroblastoma.  This is perhaps due to the intrinsic differences in the 
molecular interaction with paraffin wax in these tissues.  It should be noted that the Raman 
spectra with residual wax peaks were not included in the analysis.  A comparison of the 
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Raman spectra of frozen and the corresponding deparaffinized FFPP tissue sections indicates 
that the majority of the spectral features are preserved in the deparaffinized state, very 
similar to neuroblastoma and normal adrenal gland.    
  We also compared the mean Raman spectra of frozen ganglioneuroma (Fig. 7.3) with 
that of frozen neuroblastoma (see Fig. 7.2).  There are significant differences observed, 
especially in the spectral region of 1530-1630 cm-1 and 1200-1300 cm-1.  In both of these 
spectral regions the neuroblastoma has more intensity compared to that of ganglioneuroma.  
The bands in the 1530-1630 cm-1 region can be assigned to amino acid residues such as 
tryptophan and phenylalanine and the bands in the 1200-1300 cm-1 region are assignable to 
amide III vibrations arising from the protein backbone.  Thus, these intensity variations can 
be interpreted as an indication of the variation in the protein content in these tissues.  
 
7.3.2 Chemometric Analysis of Frozen Tissues 
To quantify the differences in the Raman spectra of normal adrenal, neuroblastoma, 
and ganglioneuroma tissues, we have analyzed the data using advanced chemometric 
methods such as PCA93 and DFA.94  Figure 7.4 shows the DF plot of the analysis using the 
Raman data for the frozen tissue sections.  Clearly, the analysis separates the data into 
three distinct pathological groups representing neuroblastoma, ganglioneuroma, and normal 
with no overlap.  As there are enough significant spectral differences in the spectra of the 
tissues as discussed above, it is not surprising to see this clear-cut separation.  A DF plot of 
the analysis using the Raman data from the corresponding deparaffinized tissue sections 
also shows a similar grouping and separation.  This is perhaps due to the fact that the each 
type of tissues in this part of the study came from a single patient and thus lacking any 
patient to patient variability within a given pathology.  
105 
 
 
Figure 7.4 DF plots of the frozen tissue data (left) and the deparaffinized tissue data (right): 
normal adrenal gland (green circles), neuroblastoma (red triangles), and ganglioneuroma 
(blue squares)137 
 
7.3.3 Chemometric Analysis of Deparaffinized Tissues 
In order to address the variability of Raman spectral differences among patients of a 
specific pathology we have studied normal adrenal, neuroblastoma, and ganglioneuroma 
archived tissues from nine different patients (see Table 7.1).  The tissues were available 
only in the form of FFPP blocks without the corresponding frozen tissues.  Figure 7.5 (a) 
shows the average Raman spectra of tissues from each distinct pathology as listed in Table 
7.1.  It is clear from Fig. 7.5 (a) that the overall shape of the spectra is similar with 
observable differences in the intensity and broadening of the bands which are quantified by 
the DF analysis. 
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(b)(a)
Figure 7.5 (a) The mean Raman spectra of the archived FFPP tissues: normal adrenal gland 
(green), neuroblastoma (red), and ganglioneuroma (blue) and (b) DF plot of the archived 
FFPP tissue data137 
 
Figure 7.5 (b) shows DF plot of the PCA-DFA analysis using the FFPP tissue data.  
The chemometric analysis does separate the spectra into three distinct groups belonging to 
each pathological state of the tissues, although the extent of spread around the group 
centroids is considerably larger compared to the analysis shown in Fig. 7.4 (b) for 3 
patients.  This could be attributed to the inter-patient variability in nine patients.  The 
observed overlap between the ganglioneuroma and neuroblastoma can be understood in 
terms of the similarity of their spectra (Fig. 7.5 (a)) and the presence of some ganglions in 
neuroblastoma tissues.17   
According to leave-one out classification method, the accuracies  of the training set 
for normal, neuroblastoma, and ganglioneuroma are 100%, 89.7%, and 95%, respectively.  
We believe addition of more data to the training set will improve the accuracy of 
identification. However, the observed overlap between the ganglioneuroma and 
neuroblastoma may continue to persist because of the presence of some ganglions in 
neuroblastoma tissues and their histologically similar appearance.  
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  Raman spectral data from the FFPP tissues from the nine patients (Fig. 7.5) were 
used as the training set in the chemometric analysis to validate the data from the 
deparaffinized tissues (the test set) obtained from the three patients in the first part of the 
study.  In this external validation, the test data was fed one patient at a time into the 
statistical analysis of the training set without assigning a particular user defined group.  The 
results are shown in Fig. 7.6. 
   
 
Figure 7.6 DF plots of the archived FFPP training set with three test patients: normal 
adrenal gland (green circles), neuroblastoma (red triangles), ganglioneuroma (blue 
squares). From left to right: Patient 1 (black crosses), patient 2 (purple crosses), and 
patient 3 (orange crosses) 
 
  The analysis of normal adrenal test data grouped correctly ~97% of the time with 
the data from the training set.  A similar analysis of neuroblastoma test data correctly 
identified and grouped with the training set 100% of the time.  However, the identification 
was very poor for the ganglioneuroma with ~10.6%, 8.5%, and 80.9% of the time 
identifying it as normal, ganglioneuroma, and neuroblastoma, respectively (see Fig. 7.6). 
However, it is encouraging to note that only a small percentage of the ganglioneuroma data 
are associated with the normal.  The idea behind this external validation is to find the 
prediction ability of a new patient data.  Although, in this study the test data are from only 
three patients, in an ideal scenario, one can divide the total data set into two and test each 
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patient of data set 1 against data set 2 and wise versa.  This method provides realistic 
values of sensitivity and the specificity of a particular research data.   
  As seen in Fig. 7.5, the data from neuroblastoma has much larger spread compared 
to the normal, and ganglioneuroma.  This is, perhaps, the reason for poor identification. 
Addition of more data to the training set may improve the accuracy of identification. 
However, the presence of some ganglions in neuroblastoma tissues and their histologically 
similar appearance may lead to poor categorization in the case of ganglioneuroma.  It has 
been observed that chemotherapy treatment in neuroblastoma also induces ganglionic and 
stromal maturation and often neuroblastomas appear histologically similar to 
ganglioneuromas at the time of debulking surgery.17   
 
7.4 Conclusion 
  We have investigated neuroblastoma and ganglioneuroma using Raman spectroscopy 
and compared their spectral characteristics with those of normal adrenal gland.  In the first 
part of the study, the data were collected from frozen and FFPP tissues, obtained from the 
same tissue block, from three patients.  The frozen tissue samples produce a high quality 
Raman spectra with distinguishable differences compared to the spectra from the 
corresponding FFPP tissues.  The frozen sections of normal adrenal gland tissues show 
higher levels of carotenoids, lipids, and cholesterol compared to the neuroblastoma and 
ganglioneuroma tissues.  A comparison of Raman spectra of frozen and deparaffinized 
tissues shows a significant alteration of several biochemicals, including complete removal of 
carotenoids, lipids, and cholesterol in adrenal tissues.  The chemometric analysis of the data 
from both, the frozen and the deparaffinized, tissues show a clear-cut grouping.  Our study 
shows that the deparaffinized tissues could be utilized for diagnostic research using Raman 
spectroscopy.  However, its prediction accuracy is less than those of the frozen tissues due 
to removal of some of the diagnostic biomarkers by formalin fixation and subsequent 
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deparaffinizing processes.  At present, it takes ~4 minutes to record a full Raman spectrum 
ranging from 500 to 1900 cm-1.  However, this time can be reduced by choosing a narrow 
wavenumber region relevant to the pathology of interest.  As a result, once the database is 
established, the total detection time required to identify the pathological state of the tissue 
can be reduced to less than 5 minutes. 
  In the second part of the study, a Raman spectral data set obtained from 
deparaffinized tissues from nine different patients was used as a training set against which 
the data from the deparaffinized tissues from the first part of the study, the test set, was 
validated using chemometric methods.  The validation process successfully identified and 
correctly grouped the data with the training set in normal adrenal (>97% of the time) and 
in neuroblastoma (100% of the time) tissues whereas the validation was not so strong for 
ganglioneuroma.  This exploratory study indicates that Raman spectroscopy combined with 
chemometric methods can be successfully used to distinguish neuroblastoma and 
ganglioneuroma in frozen and deparaffinized tissue sections.  The frozen tissues offer 
superior diagnostic outcome compared to the deparaffinized tissues because of their high 
quality spectral features and no alteration and loss of biochemicals which occurs in the 
process of formalin-fixation, paraffin preservation, and subsequent deparaffinization of 
tissues for Raman studies.  
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CHAPTER 8 
DIFFUSE REFLECTANCE SPECTROSCOPIC/COLORIMETRIC STUDY OF  
ACANTHOSIS NIGRICANS 
Diffuse reflectance spectroscopy and colorimetry are non-invasive optical techniques 
which are beginning to gain acceptance in dermatology.  The physics behind both these 
techniques is the same, although analysis of the data produces different parameters based 
on different models for each, allowing fundamentally different measurements to be made.   
One can determine skin color or monitor skin color changes via both diffuse reflectance 
spectroscopy and colorimetry.  In this chapter, the results of our attempts to implement an 
optical diagnosis of acanthosis nigricans skin condition using both of these optical 
techniques are discussed.  
 
8.1 Why Acanthosis Nigricans? 
There are many people who suffer from hyperinsulinemia and hypertension and they 
are prone to type II diabetes.  Acanthosis nigricans (AN), skin thickening and darkening in 
various parts of the body, is common among these patients.  If untreated, 90% of the 
people who have acanthosis nigricans will eventually get type II diabetes over the next 10 
years of their lifetime.  There are no optical instruments which can diagnose and quantify 
this skin disease.  Thus, it is imperative to develop new technologies or even to use existing 
optical instruments to develop the capability of detecting AN optically.  These 
techniques/instruments should be non-invasive as they will be used for the real time 
screening of patients or children, producing point-of-care diagnoses without any time-
consuming laboratory evaluations.  This research work is the beginning of such an attempt 
to investigate whether diffuse reflectance spectroscopy (DRS) or colorimetry or both 
together can be utilized for optical screening of acanthosis nigricans.  
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Traditionally, dermatologists have measured skin color through visual observations, 
but there is an inherent subjectivity to this type of measurement, as the human eye cannot 
quantify small changes in shades of color.  This can be overcome through an optical 
diagnostic.  A diffuse reflectance spectrophotometer or colorimeter provides a modality for 
characterizing the biophysical basis of color on light absorption and the surface properties of 
the skin.  In DRS, light is delivered onto and into the skin and the reflected light is collected 
and analyzed with a broadband spectrometer.  The reflected light spectrum is used to 
calculate an apparent absorption spectrum for the skin, which can then be used to calculate 
the concentration of known skin chromophores, specifically melanin, oxyhemoglobin, and 
deoxyhemoglobin.56  These calculations can be very model-dependent and are also highly 
dependent on the spectral distribution of the excitation source, as in colorimetry.  In 
colorimetry, a white light excitation source illuminates the skin and the reflected light is 
parameterized by the L*a*b* color system as determined by the Commission International 
d’Eclairage (CIE) in 1976.143  Here, L* is the lightness to darkness component and a* and 
b* are the color components of red (positive) to green (negative) and yellow (positive) to 
blue (negative), respectively.  Thus, colorimetry can be used for complex color analysis with 
high precision and can accurately determine the spectral reflectance at each wavelength.87 
Neither colorimetry nor DRS has been fully explored as a way to study the 
hyperpigmentation of acanthosis nigricans.  Few studies have directly compared these two 
techniques, and none on a single patient pool.  Our objective is to evaluate the reliability of 
colorimetry in quantifying color change and DRS in characterizing the chromophore changes 
associated with AN.  The significance of this lies in the possibility that the degree of a 
quantifiable color change may be related to the severity of disease states such as 
hyperinsulinemia when assessed in future studies. 
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8.2 Materials and Methods 
The DRS light source (LS-1 Series Tungsten Halogen Light Source HL-2000, 
Mikropack and Ocean Optics, Inc., USA) emits light in the visible to near-infrared range 
(360 nm - 2000 nm).  This source is connected to one end of a bifurcated fiber optic probe 
(measurement/illumination diameter of 2.5 mm), which also collects reflected light into a 
spectrophotometer (BWTEK, Inc., USA).  The spectrophotometer measures diffuse 
reflectance spectra in the range of 350-850 nm.  These reflectance/absorbance spectra are 
used to calculate melanin, deoxyhemoglobin, and oxyhemoglobin chromophore 
concentrations using the known in vivo absorbance characteristics of these complex 
biomolecules.78    
The colorimeter instrument (Minolta CM-2600d, Osaka, Japan) consists of an 8 mm 
diameter measurement/illumination aperture.  A pulsed xenon lamp emits an intense white 
light covering the entire visible spectrum which illuminates the specimen under the aperture 
uniformly.  The colorimeter measures L*, a*, and b* values of the reflected light as defined 
by the standard CIE system.87  Figure 8.1 shows the L*a*b* color space. 
 
 
Figure 8.1 L*a*b* color space87 
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In order to calculate L*, a*, and b* values, first, tristimulus values need to be 
determined.  The tristimulus values, XYZ can be determined through the convolution of 
spectral power distribution of the illuminant (stored in the instrument memory), spectral 
reflectance of the specimen and the color matching functions ( )(x , )(y , and )(z ) as 
shown in Fig. 8.2.87 
 
 
Figure 8.2 Steps to obtain L*, a*, and b* parameters87 
 
  Once XYX values are obtained the L*, a*, and b* can be calculated using the 
following equations, 
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Here, Xn, Yn, and Zn are the tristimulus values of a perfect reflecting diffuser.87 
While the colorimetry signal is analyzed purely in terms of the intensity of the 
various color components, the DRS data-analysis software modeled the physics of the light-
skin interaction to calculate biochemical concentrations from the reflected spectrum.  
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Analysis of the DRS data provides a quantification for the contributing skin chromophores, 
including melanin, oxyhemoglobin, and deoxyhemoglobin.  The subsection 2.3 in Chapter 2 
describes how to extract these chromophore concentrations from the spectral information of 
the DRS. 
Prior to every patient measurement, both instruments were corrected for detector 
dark current and were calibrated using manufacturer-provided white and black tile 
standards.   
 
8.2.1 Patient Enrollment 
Eight female African American patients, ages 12 years and older with AN as 
diagnosed by a dermatologist were enrolled.  It is a necessary requirement that all the 
patients were in an insulin resistant condition, meaning elevated fasting insulin levels with 
normal fasting glucose levels.  During the course of this research, all patients were 
consulted by an endocrinologist for treatment of their hyperinsulinemia with diet control, 
weight reduction and/or oral metformin.  Patients’ consents were obtained through an 
informed consent form and all study-related procedures were explained before enrolling.  
Exclusion criteria for patient enrolment was patients with type 1 diabetes, women who were 
lactating, pregnant, or planning to become pregnant, and those who were hypersensitive to 
oral metformin medication.  
A skin prosthesis provided by Henry Ford Hospital was used to assess the 
repeatability of the measurements.  In addition, we also obtained measurements from nine 
healthy volunteers one time to evaluate and compare the DRS and colorimetric 
measurements of the healthy control group and the AN patients. 
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8.2.2 Data Collection  
The pigmented areas were measured from the areas within the AN neck lesion on the 
posterior neck and the lateral neck.  The inner surface of the forearm and the skin over the 
clavicle (normal neck) were treated as normal controls.  The probes of both devices were 
placed perpendicularly on the skin with light pressure to avoid the skin blanching effect.  
Due to differences in the diameter of the probe sizes, the colorimeter obtained 3 
measurements at 1 spot, and the DRS obtained 10 measurements at 10 different spots.  
The colorimeter probe is approximately 10 times larger in area than the DRS probe.  
Photographs of the measurement areas of AN and normal controls were marked so that 
subsequent measurements were taken at approximately the same location.  These 
photographs were taken every visit to observe and document clinical changes.  All 
measurements were taken in an exam room at a dermatology outpatient clinic at Henry 
Ford Hospital.  Follow-up periods were conducted for 8 consecutive months. 
 
8.2.3 Data Analysis Methods 
In the first part of the study, we analyzed the eight month data using standard 
analytical methods such as mean, standard deviation, Pearson correlation, etc. and in the 
second part of the study we used chemometric methods, principal component analysis 
(PCA)93 and discriminant function analysis (DFA)94 to compare the measurements of both 
the DRS and colorimetry instruments.  
 
8.2.3.1 Standard Analyses 
We calculated the mean and standard deviation values of the 6 model-dependent 
parameters (L*, a*, b*, melanin, oxyhemoglobin, and deoxyhemoglobin) of each skin site 
for each patient over the eight month period.  Also, we determined the differences of the AN 
lesion-control sites (normal neck or forearm) for each individual parameter.  In determining 
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a scatter of measurements for all the patients, we wanted to utilize a single parameter to 
interpret the data.  This is because some of the patients exhibited more variance of the 
monthly measurements from the average than the others.  Hence, characterizing the 
measurement scatter of all the patients around the mean value with a single parameter 
assists in determining the sensitivity of the measurement.  We call this single parameter a 
“global standard deviation”.  Global standard deviations for the three skin measurements 
(AN lesion - normal neck, normal neck - forearm, and AN lesion – forearm) were calculated 
by measuring the standard deviation of the individual measurements from the average 
values for all patients, and then averaging those standard deviations to obtain one global 
standard deviation.  In addition, we used the Pearson correlation method to evaluate the 
correlation between the six parameters (see Table A2).  We also calculated the percent 
difference in these parameters between AN lesion and normal skin as described below:  
lesion value - normal valuepercent difference 100%
normal value
  ------------------------------(8.2) 
Changes in these calculated percent differences between visits allow an evaluation of 
absolute changes in skin color.  
 
8.2.3.2 Chemometric Approach 
It is important to apply a chemometric approach to analyze the spectral data 
obtained from these AN patients by colorimetry and DRS to evaluate whether a reliable 
classification of skin as “lesion” skin or “healthy” skin can be made more reliably.  A 
chemometric model which utilizes more of the data at one time compared to a straight-
forward calculation of a skin chromophore concentration or the use of individual color 
parameters (e.g. melanin concentration or L* value related to skin darkness).  Another 
important aspect of the chemometric analysis of the DRS data is its use of only the raw 
diffuse reflectance (or absorbance) spectra instead of a reliance on calculated model-
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dependent melanin, oxyhemoglobin, and deoxyhemoglobin chromophore concentrations to 
differentiate normal healthy skin from AN lesion.  The scattering of light from a medium as 
heterogeneous as skin, is a complex phenomenon.  Thus, any model of this scattering is at 
best an approximation.  Moreover, there were also limitations with using this DRS system 
for measurement of AN lesions since the original algorithm was designed to evaluate 
smooth normal skin.  The use of the entire raw spectrum eliminates this need for an 
approximate model and the calculation of any chromophore concentration. 
As a result, colorimetry data consisting of the L*, a*, and b* values and the raw 
absorption spectra of skin were analyzed separately using two chemometric methods known 
as principal component analysis and discriminant function analysis.93, 94 
Principal component analysis and discriminant function analysis are statistical 
methods which have already been described in detail in Chapter 4.  In the PCA of the DRS 
data, the entire broadband DRS spectrum (226 channels spanning 450 nm with a 2 nm 
channel width) was used as an input data set.  The PCA reduced the 226 variables to 4 
variables which captured 99.7% of the variance in the data.  These new variables were then 
used as the input to the DFA.  The colorimetry data, consisting of only 3 parameters or 
variables (L*, a*, and b*) were not analyzed with a PCA.  The raw spectra were not 
obtainable from the CM-2600d instrument.  
The DFA method classifies the data into the independent groups present in the data 
by minimizing the variations within the groups and maximizing the variations between the 
groups.94  The DFA constructs N-1 discriminant functions (DFs) for discrimination amongst N 
user-defined groups.  Each spectrum can then be classified by N-1 DF scores.  The DF 
scores were then used to allow a classification of an unknown sample as “lesion” or 
“healthy”.  Typically each data set possessed only two DF scores, as we were attempting to 
differentiate between only three user-defined groups: control (forearm), control (neck), and 
AN lesion.   Although median and lateral AN lesion measurements were obtained, a careful 
118 
 
analysis showed no difference in these measurements and no utility in separating these 
measurements.  Therefore, all these lesion measurements were combined in the analysis. 
To lessen the between-patient scatter of the measurements due to the inherent 
differences in skin coloring and composition of the patients, prior to analysis both 
colorimetry data and DRS data were normalized for every patient.  This was done by first 
calculating the average of the patient’s forearm control measurements.  The scatter of the 
forearm control measurements about this average allowed us to characterize the anticipated 
scatter of the lesion measurements which was expected to be even greater due to the 
heterogeneity of the lesion tissue.  All subsequent measurements were then divided by that 
patient’s average forearm control to insure that data obtained from the neck control or neck 
lesion tissue were really differences from that patient’s normal skin coloring or composition.    
 
8.3 Results: Standard Analyses 
8.3.1 Reproducibility of Measurements 
The reproducibility of the colorimeter and the DRS instrument was measured using a 
skin prosthesis obtained from the Orthopedic Department of Henry Ford Hospital twice daily 
for 5 days.  The percent deviations obtained (pooled standard deviation divided by mean) of 
the prosthesis and the forearm of patients are shown in Table 8.1. 
 
Patient# L* a* b* Melanin Oxyhemoglobin Deoxyhemoglobin 
Prosthesis 0.20% 0.12% 0.18% 10.01% 19.31% 20.87% 
1 0.40% 1.54% 0.58% 2.47% 23.07% 11.44% 
2 0.94% 1.62% 0.73% 2.42% 20.40% 8.81% 
3 0.80% 1.66% 1.10% 2.40% 32.47% 8.44% 
4 0.78% 1.56% 0.46% 2.58% 26.85% 5.39% 
5 0.90% 2.73% 1.67% 2.90% 33.49% 10.46% 
6 0.61% 1.00% 0.68% 1.69% 37.87% 9.97% 
7 0.52% 1.36% 0.66% 2.78% 36.50% 11.33% 
8 1.15% 0.98% 2.10% 2.15% 36.22% 9.74% 
Table 8.1 Percent deviations for prosthesis and patients 
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The colorimeter parameters, L*, a*, and b* values showed a reproducible results, 
deviating by less than 1% in the prosthesis.  Most of the patients also indicated low 
deviations close to 1%.  In contrast, the DRS instrument exhibited significant variance in 
the values calculated for the chromophores.  The melanin percent deviation of the 
prosthesis is about 10%, whereas oxyhemoglobin and deoxyhemoglobin are approximately 
20%.  Surprisingly, the DRS measurements on patient skin showed a very low deviation 
(<3%) for melanin.  Deoxyhemoglobin deviation was in the range of approximately 5% to 
10%, while oxyhemoglobin deviation ranged from approximately 20% to as high as 38%. 
Although it may seem intuitive that an unchanging substrate such as the prosthesis 
would give reproducible values for melanin concentration, it appears that the absence of the 
actual chromophores leads to variable results. Also the skin prosthesis is not a 
homogeneous calibrator.  Melanin values on patient skin showed a very good reproducibility, 
of about 3%.  The hemoglobin values showed significant variation in the prosthesis as well 
as all patients.  This may be due to the physiologic effect of blood vessels affecting the 
hemoglobin concentration. Therefore, the hemoglobin concentration was not a good 
parameter to monitor the changes in skin color, and as such has little value as diagnostic 
parameter for use in measuring AN skin. 
 
8.3.2 Changes in Pigmentation  
In order to determine the changes in the pigmented areas month-to-month basis, 
the posterior neck lesion measurements were compared to the control data.  Figure 8.3 
shows both colorimetry and DRS parameter difference of AN lesion and forearm skin (black 
squares) and also the difference between normal neck and forearm (red stars) for a single 
patient (Patient 1).   
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Figure 8.3 Patient 1; comparison between normal neck-normal forearm and AN lesion skin-
It is noted that almost all of the measurements fall within one standard deviation of 
the average and show no discernible trend with time, a result consistent with no change in 
value over the course of 8 months.  The difference of normal neck and forearm values, for 
all the parameters is relatively close to zero.  Thus, normal neck and forearm values are 
very similar.  As a result, the comparison of the difference between normal neck skin and 
AN lesion skin is plotted in Fig. 8.4.  This skin difference is much more realistic for 
diagnostic purposes as the characteristics of forearm skin may be different from a normal 
neck area. 
      
normal forearm144 
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Figure 8.4 Patient 1; comparison between AN lesion skin-normal neck 
 
8.3.3 Scatter of the Measurements 
In Figs. 8.3 and 8.4, the averaged values show as dashed horizontal lines.  This 
serves as scatter of the measurements in the instruments.  Global standard deviations for 
calculated melanin, oxyhemoglobin, and deoxyhemoglobin of AN lesion-normal neck 
measurements were 0.28, 0.09, and 0.19, respectively.  The global standard deviations for 
L*, a*, and b* were 2.26, 0.81, and 1.17, respectively.  In Fig. 8.4, the shaded regions 
show the global standard deviations about their mean and represent the spread of this 
patient’s AN lesion–neck normal measurements over the 8-month period.  Similarly, shaded 
regions in Fig. 8.3 show the global standard deviations of normal neck-forearm and AN 
lesion-forearm for all the six parameters. 
As can be seen in Fig. 8.4, the ∆L* values for the lesion tissue relative to normal 
neck tissue were -12.1.  This is approximately 5.4σ from the normal neck average.  All the 
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eight patients showed differences between normal neck and lesion greater than 3σ.  In fact, 
b* values also showed more than a 3σ difference between normal neck and AN lesion for all 
the 8 patients.  However, a* varied from 0.14σ to 8σ and did not show a consistent 
difference. 
Among DRS parameters, only melanin, showed a potential to be an effective 
discriminator.  The average AN lesion-normal neck skin value, 0.78, a difference of 
approximately 2.8σ, which is above a 95% confidence level.  With the exception of one 
patient (Patient 8), all patients showed more than a 2σ statistical difference for melanin 
concentrations measured in AN lesion skin compared to normal neck skin.  Patient 8 also 
showed a higher concentration of melanin for lesion skin, but it was not statistically 
significant enough to reliably differentiate AN.  Oxyhemoglobin rarely showed any 
statistically significant difference between AN lesion tissue and healthy neck tissue (see 
Figs. 8.3 and 8.4).  Deoxyhemoglobin showed a difference in some patients (including 
patient 1), but not all patients.  
 
8.3.4 Evaluation of Lesion Visit-wise 
 The absolute difference of AN lesion and normal skin were determined through L*, 
a*, b*, melanin, oxyhemoglobin, and deoxyhemoglobin values obtained from these two 
instruments (e.g. *L  L*(lesion) – L*(normal)).  The percent difference were calculated in 
these parameters between visits, but none of the patients showed any statistically 
significant change between visits in the percent differences of the six parameters during the 
eight month testing period.  This was also confirmed by periodic insulin level measurements 
which remained relatively constant for all the patients.  In addition, dermatological 
diagnosis of AN remained unchanged. 
123 
 
 
Figure 8.5 Dermatological images of the 8 visits of a patient 
 
For a single patient, photographs taken for eight visits were shown in Fig. 8.5.  Thus, 
spectroscopic measurements, insulin measurements, and dermatological observations all 
confirmed no change in AN condition during this eight month period. 
 
8.3.5 Healthy Volunteers’ Measurements 
Similar to AN patients’ measurements, DRS and colorimetry measurements were 
obtained from the same skin areas including posterior neck from nine healthy volunteers. 
These measurements were made only once for all the healthy volunteers, but used the 
same protocols as on the patients, specifically with reference to the number of 
measurements and sampling locations.  
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Figure 8.6 Comparison of colorimetry and DRS measurements made on control subjects and 
diagnosed AN patients.  (left) Difference of the colorimetry data (L*, a*, b*) obtained from 
the posterior neck and normal neck measurements for both control subjects and patients.  
(right) Difference of the DRS-calculated concentrations (melanin, oxyhemoglobin, and 
deoxyhemoglobin) obtained from the posterior neck and normal neck measurements for 
both control subjects and patients.  The data points with error bars represent the control 
subjects and the blue shaded areas represent the patients’ standard deviation around the 
mean   
 
Figure 8.6 compares the difference between the measurements made at the 
potential lesion site and the neck normal site for patients and controls.  Figure 8.6 shows 
each of the three parameters obtained from DRS and colorimetry showing the difference of 
posterior neck and normal neck for a total of six graphs.  Each graph shows the average 
value of the patient data (obtained by averaging the value from all 8 patients) with 1σ (blue 
band around the average dashed line).  The uncertainties of individual volunteers for each 
parameter are also shown in each graph.  L*, a*, and b* show a difference of -3.92, -1.02, 
and -3.25, respectively while DRS parameters, melanin, oxyhemoglobin, and 
deoxyhemoglobin show 0.22, -0.02, and -0.12 respective differences. The difference 
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between the control average and patient average for each of the six parameters is also 
calculated, and expressed in units of standard deviation.  These results are shown in Table 
8.2, where there is about a 4σ difference in L* and b* values between the average of the 
healthy volunteers and the patients.  Note that a zero difference is interpreted as “healthy”. 
As the control subjects’ difference (healthy posterior neck-NN) is rather close to the zero, 
this gives us confidence that the patients are showing statistically significant differences in 
AN lesion compared to the control data.  
 
L* a* b* Melanin Oxy Deoxy 
3.8 1.8 3.9 1.8 0.5 1.4 
Table 8.2 Difference in patient average and control subject average for each of the six 
measured parameters expressed in units of sigma (the standard deviation of the patient 
measurements) 
 
Note that, if two values are within 1σ of each other there is a 32% possibility that 
this happened by chance.  If two values differ by 2σ there is only about a 5% possibility that 
this is by chance, and if two values differ by 3σ there is only a 0.3% possibility that it occurs 
by chance.  Therefore, two values that differ by 3σ or more are almost certainly statistically 
different.  L* and b* seem to satisfy this criterion.  It can also be seen that none of the 
control measurements fall within the uncertainly of the patient average, as expected.  For 
the other four parameters, the differences are all less than 2σ, and thus more uncertain.  
This can be seen in the graphs, where control subject measurements frequently fall into the 
blue uncertainty band of the patient data.   
 
8.4 Discussion: Standard Analyses 
In this research work, the reproducibility of the colorimeter and DRS was examined 
on skin prosthesis and on normal skin of patients with AN.  Colorimetry showed a high 
reproducibility in both prosthesis and in vivo skin measurements, with variation below or 
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near 1% in most cases.  The slightly higher variation for in vivo measurements can be 
explained by small month-to-month variations present in normal skin.  We can conclude 
from these measurements that colorimetry values for L* and b* may be reliable modalities 
to objectively quantify skin color in pigmented areas of skin, while a* is a weak indicator of 
skin color, and thus not reliable. 
When determining the difference between AN lesion skin and normal skin, it was 
important to use normal neck skin as the control, and not forearm skin.  As can be seen in 
Fig. 8.3, neck skin varied on a month-to-month basis when compared to forearm skin in AN 
lesion as well as normal neck.  This variation may be caused by sun exposure or other 
factors.  This month-to-month change is less apparent in Fig. 8.4, which compares AN lesion 
skin to normal neck skin. 
The scatter of these instruments was determined to distinguish the intensity of the 
pigmented skin caused by AN from the intensity of the pigment from normal skin.  L* and 
b* color parameters obtained from the AN lesion were shifted by more than a 3σ difference 
from correspondingly healthy neck tissue for all the patients, which corresponds to less than 
0.27% chance that the measurement differed by chance alone.  These parameters are 
therefore sensitive enough to differentiate AN from normal pigmented skin color.  However, 
no parameters obtained from DRS showed sufficient sensitivity to diagnose AN for all the 
patients.  Melanin concentration in the AN lesion showed a significant statistical difference of 
more than 2σ from the correspondingly healthy neck in all the patients except Patient 8.  
None of the patients showed a greater than 3σ difference in oxyhemoglobin or 
deoxyhemoglobin concentration.  
By performing a Pearson correlation analysis on the data measured by both 
instruments, we found a strong negative correlation between L* and melanin values (see 
Table A2).  This means when L* increases, melanin should decrease.  We also found that L* 
and b* decrease while melanin increases in AN compared to normal skin.  In addition, the 
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results of the percent difference from normal for the first four months of the trial are shown 
in Table A3.  We found that L*, b*, and melanin values measured in AN lesions were 
different from normal skin with statistical significance, as shown by their very low p value 
(P-value <0.001).  This p-value analysis implied that L*, b*, and melanin could be good 
parameters to objectively quantify skin color in AN lesions, as L* and b* values tended to 
be lower while melanin values were higher in lesion tissues.  Data in subsequent months 
was similar.  Taken together, this suggests that the hyperpigmentation of AN may have a 
higher melanin content than the normal pigmented skin.  This study supports the conclusion 
that the brown color of AN is caused by hyperkeratosis of the epidermis as well as increased 
melanin content.145, 146, 147 
L* and b* seem to be consistent measures of skin color in AN lesions, as the 
measurements obtained from patients are very different, statistically, than the 
measurements obtained from the healthy volunteers.  Although a* and melanin values are 
indeed indicative of a change in AN patients (relative to healthy controls), they do not 
appear to be reliable.  Further experiments need to be carried out to draw any conclusions.  
The oxyhemoglobin and deoxyhemoglobin values do not show a significant difference 
between patient and healthy volunteers’ data, therefore we would conclude, that these 
values are unreliable for use as an objective color measurement of AN. 
A significant limitation of the DRS instrument is that the size of the measurement 
probe is being small.  Therefore, DRS is ideal for skin lesions which are homogeneous or 
smaller in size where the illuminated spot size needs to be smaller than the integrating 
sphere aperture of the colorimeter.76  Another limitation to this study was the fact that AN, 
as well as other skin conditions, possesses a velvety, rough texture, which causes 
significant light scattering at the skin surface.  A larger DRS probe would be able to capture 
the light that is reflected from these relatively large surface features.  
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8.5 Results and Discussion: Chemometric Approach 
The mean DRS absorbance spectra of the three measurement sites for one patient 
are shown in Fig. 8.7. Absorbance is a unitless quantity obtained from the diffuse 
reflectance spectrum.  Each of the three spectra shown in Fig. 8.7 is the average of the all 
the measurements made at that particular site.  Regions of large absorbance indicate strong 
absorption or scattering of the light at that wavelength, sometimes indicative of the 
presence of a specific chromophore.   
 
 
Figure 8.7 Mean absorbance spectra of forearm control, neck control, and lesion.  Lesion 
tissue obviously demonstrates significantly greater absorption/scattering91 
 
In Fig. 8.7, a clear increase in the absorbance of the lesion can be seen compared to 
the normal controls (forearm and neck).  This is indicative of an increase in the 
concentration of the chromophores melanin, oxyhemoglobin, and deoxyhemoglobin, as was 
shown in our previous analysis of these patients.  Aside from this overall increase in 
absorbance, statistically meaningful and reproducible spectral differences are hard to 
quantify in the three spectra shown in Fig. 8.7. 
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Chemometric techniques provided a more reliable way to obtain quantitative 
classification of the differences in the spectra.   Figure 8.8 shows the first two discriminant 
function scores of the DFA performed on (a) the normalized DRS data (subject to PCA first, 
as explained above) and (b) the colorimetry data obtained from all eight patients spanning 
all patient visits.   
 
Figure 8.8 Discriminant function plots for (a) DRS and (b) colorimetry data obtained from all 
patients over the course of this study91 
 
In the DFA results, DF1 expresses the maximum variance of the data and DF2 
contains the rest of the variance in the data.  It is evident that while there is some overlap 
of individual measurements, the center of mass of the lesion data distribution (shown as the 
labeled dark square in Fig. 8.8) is well separated from the centers of mass of the 
distribution for the two controls.  The reversal of the DF1 scores for the two modalities (i.e. 
positive DF1 lesion scores for DRS and negative DF1 scores for colorimetry) has no physical 
significance and is purely a computational artifact.  The fact that all the patients’ data can 
be clustered significantly implies that the variations of the lesion tissue from the control 
sites are reproducible and similar in all patients. 
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8.5.1 Classification 
A leave-one-out (LOO) classification was also performed for both data sets.  In a 
LOO method, each data point is treated as an unknown case and is classified against a data 
set consisting of all the other data points.  The accuracy of that classification is then 
compared to the known identity of the data point to create a truth table.  The truth tables 
for both spectral methods are shown in Table 8.3.  The interpretation of these truth tables is 
as follows:  true positives (TP) indicate a lesion measurement was correctly classified as 
lesion.  True negatives (TN) indicate a normal control measurement was correctly classified 
as normal.  False positives (FP) indicate a normal control measurement was incorrectly 
classified as lesion.  False negatives (FN) indicate a lesion measurement was incorrectly 
classified as normal.  
 
DRS (%) Colorimetry (%) 
 True False  True False 
Positive 91.4 4.9 Positive 98.4 3.9 
Negative 95.1 8.6 
 
Negative 96.1 1.6 
Table 8.3 Truth tables for leave-one-out classification results of (a) DRS and (b) 
colorimetry91 
 
Colorimetry data showed the highest true positive and true negative results, 98.4% 
and 96.1% respectively, which confirmed our earlier result that colorimetry seems to be 
more efficacious for diagnosing AN than DRS as we currently perform it.  Impressively, 
when analyzed with the PCA/DFA the DRS data showed more than 91% sensitivity 
(TP/TP+FN) and specificity (TN/TN+FP), which was not the case for the standard statistical 
analyses as reported in subsection 8.3.  
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8.5.2 External Validation  
In the previous leave-one-out analysis, an unclassified measurement was classified 
with a set of discriminant functions constructed using all the other data points, including 
other data points from that same patient.  However, if either of these techniques is to be 
used for patient screening, it is not realistic to expect the discriminant functions to have 
been constructed with any data from that patient.  Therefore, we performed a DFA 
excluding one patient at a time from the analysis.  Unclassified lesion and neck control data 
from that patient were then input to the DFA (which contained none of that patient’s other 
data) and were classified according to the library of results from other patients.  The truth 
tables for this analysis are shown in Table 8.4.   
 
DRS (%) Colorimetry (%) 
 True False  True False 
Positive 87.7 5.2 Positive 97.2 5.4 
Negative 94.8 12.3 
 
Negative 94.6 2.8 
Table 8.4 Truth tables for patient exclusion classification results of (a) DRS and (b) 
colorimetry91 
 
As expected the rates of true positives and true negatives declined, although only by 
a small amount (by 3.7% and 0.3% for DRS and 1.2% and 1.5% for colorimetry) and rates 
of false positives and false negatives increased (by 0.4% and 3.7% for DRS and 1.5% and 
1.2% for colorimetry).  These results show a more realistic truth table for the techniques if 
they were to be used to screen previously unexamined patients for AN. 
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Figure 8.9 DF plots showing (a) DRS and (b) colorimetry data with patient 8’s lesion data 
input as unclassified data into the analysis.  This patient’s lesion data, which clustered well 
with itself, was significantly different from the mean of the other patients’ lesion data.  
Nonetheless, it was easily and reliably classified as “lesion” in both analyses91 
 
One of the strong benefits of using a chemometric approach is shown in Fig. 8.9 
which shows the DF plot of the patient exclusion analysis for patient 8.  Patient 8 was the 
only case in our previous analysis that did not show a 3σ standard deviation between the 
calculated melanin concentration in the forearm control and the AN lesion indicating that 
this patient’s lesion tissue was very hard to diagnose spectrally.  Nonetheless, in Fig. 8.9, 
when patient 8’s lesion data was entered as unclassified data into the DFA (shown as x 
symbols in Fig. 8.9), almost all of the measurements were easily classified as “lesion” 
compared to the forearm control or the neck control. 
Although forearm and neck controls were both used as normal controls in this AN 
study, the more realistic site for a normal control is the neck normal (which should have 
similar properties compared to the lesion measurement site due to tanning, aging, etc.).  
This can be observed by the neck control data being closer to the lesion data than the 
forearm control data in Figs. 8.8 and 8.9.  
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8.5.3 ROC Curves 
It was vital to know the sensitivity and specificity of the lesion site measurements as 
compared to the neck control.  To investigate this, receiver operating characteristic (ROC) 
curves were constructed using the DF1 values of the DRS and colorimetry data to act as a 
“cut point” to discriminate lesion and neck control data (discarding the forearm control 
data). 
 
Figure 8.10 ROC curves of a test to differentiate neck control measurements from lesion 
measurements as shown in Fig. 8.8 on the basis of the DF1 score alone for (a) DRS and (b) 
colorimetry data.  The area under the curves for (a) was 0.985 and for (b) was 0.99591 
 
In a ROC curve114, the sensitivity of the technique (as defined above) is plotted 
against 1-specificity (as defined above).  ROC curves are shown in Fig. 8.10 for DRS (a) and 
colorimetry (b).  The ROC area under the curve (AUC) establishes the usefulness of the test, 
with an AUC of 1.0 denoting a perfect test, and an AUC of 0.5 denoting a worthless test.  
The ROC curves of Fig. 8.10 possess an AUC of more than 0.98, indicating a highly reliable 
test for this AN investigation.   
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8.6 Conclusions 
In the standard analytical methods, the average values that differed by more than 
3σ were considered to be valuable predictors of the presence of lesion tissue.  Of the three 
CIE L*, a*, and b* parameters, the luminosity parameter “L*” was found to most reliably 
distinguish lesion from normally pigmented skin.  b* also showed more than 3σ statistical 
difference between AN lesion and the skin control sites and a* was considered as a weak 
indicator.  The calculated melanin concentration of the DRS instrument was able to 
characterize a lesion as compared to normally pigmented skin on the neck, though melanin 
is a weak indicator of skin change and not a reliable measure to be used independently. 
However, oxyhemoglobin and deoxyhemoglobin concentrations were not found to be reliable 
indicators of AN. 
Spectroscopic and colorimetric measurements combined with chemometric analysis 
methods provided sensitive and specific diagnoses of acanthosis nigricans lesions compared 
to nearby control skin.  Analysis of raw DRS absorbance spectra showed clear clustering of 
normal controls and lesion groups (Fig. 8.8 (a)) for all patients denoting a commonality that 
may allow diagnosis of previously unmeasured lesions.  Colorimetry data also showed the 
ability to reliably identify AN lesions (Fig. 8.8 (b)).  Excluding patients one at a time from a 
DFA model and then testing that patient’s spectral data with the model constructed only 
from other patient measurements provided a realistic simulation of an acanthosis nigricans 
screening test.  DRS data provided more than 87% sensitivity and 94% specificity and 
colorimetry data showed more than 95% sensitivity and specificity (Table 8.4) in this type 
of test.  ROC curves also confirmed that the use of a discriminant function analysis on DRS 
and colorimetry data can provide a sensitive and specific AN test even when only the DF1 
score is used to assess skin condition.   
Unfortunately, none of the patients showed any improvement in acanthosis nigricans 
from treatment during the duration of this study which was also confirmed by visual and 
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photographic observations.  Thus, the changes in skin DRS and colorimetry data that occur 
during the healing process of AN could not be established.  However, the existing data 
showed both DRS and colorimetry can be used as a successful diagnostic tool for acanthosis 
nigricans when combined with chemometric methods such as PCA and DFA.  
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CHAPTER 9 
CONCLUSIONS AND FUTURE WORK 
This chapter summarizes the conclusions drawn from Raman spectroscopic 
investigations of head and neck squamous cell carcinoma, prostate cancer, and pediatric 
tumors, and also summarizes the results of identifying acanthosis nigricans skin disease 
using diffuse reflectance spectroscopy and colorimetry followed by future work.  
 
9.1 Conclusions 
Head and Neck Squamous Cell Carcinoma: Tongue Tissues 
We have studied the Raman spectral characteristics of normal, carcinoma in situ, and 
invasive squamous cell carcinoma (SCC) tissues of tongue.  There are substantial spectral 
differences in the observed spectra of these tissues and we were able to identify the 
spectral features that can discriminate these three tissue types.  We were able to assign the 
observed spectral changes in the intensities of certain Raman bands to specific molecules or 
category of molecules, and thus, draw inferences on the nature of biochemical 
compositional changes in these tissues (see Chapter 5).  We found tryptophan to increase 
while keratin to decrease when the tissue changes from normal to invasive SCC.  The 
analysis of Raman spectral data using chemometric methods, principal component analysis 
(PCA) and discriminant function analysis (DFA), clearly separated the data into three distinct 
groups consistent with results of pathology.  We were able to distinguish with 91% success 
rate the normal and carcinoma in situ tissues, and with 89% accuracy the invasive SCC 
tissues of tongue. This exploratory study suggests that Raman spectroscopy can be used to 
distinguish normal, carcinoma in situ and invasive SCC.111   
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 Prostatic Intraepithelial Neoplasia 
In this study, we investigated the benign, prostatic intraepithelial neoplasia, and 
difference cancer grades in FFPP tissues using Raman spectroscopy.  The tissue specimens 
used in the study were obtained as radical prostatectomy and each of the diseased tissues 
contained regions with three pathologies mentioned above.88  We found that, even with 
other pathologies present in the tissue, Raman spectroscopy can differentiate each 
pathological state through careful investigation of epithelia.  Thus, the Raman spectra 
contain signatures from both luminal and basal cells.  Further, Raman spectroscopy was 
able to classify the tissues with Gleason scores of 6, 7, and 8 with more than 85% accuracy.  
As a part of this study, we also investigated the luminal cells of benign epithelia, prostate 
intraepithelial neoplasia, and cancer using additional 34 patients’ specimens.133  The reason 
being, that basal cells are not present in cancerous micro acinar structures.  These tissues 
contain only one pathology, either BE, PIN or cancer (Gleason grade 3).  Our aim was to 
diagnose PIN pathology and compare and contrast its Raman spectral features with that of 
BE or cancer.  The study did show difference in the spectral features, as discussed in 
Chapter 6.  We also examined the Raman fingerprints of stromal cells around each 
pathological state: BE, PIN, and cancer.  The spectral data was analyzed with PCA and DFA, 
and were able to classify the data into distinct pathological groups with very high accuracy. 
The sensitivity and specificity of luminal cells of PIN and cancer were about 98% for each 
and for the stroma associated with these pathologies the sensitivity and specificity were 
more than 90%.133   
   
Pediatric Tumors: Neuroblastoma and Ganglioneuroma 
 In this work, we investigated the cellular regions in neuroblastoma and 
ganglioneuroma using Raman spectroscopy and compared their spectral characteristics with 
those of the corresponding normal adrenal gland.  Thin sections from both frozen and 
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formalin-fixed paraffin processed (FFPP) tissues, obtained from the same tissue block, were 
studied in conjunction with the pathological examination of the tissues.  Investigation of the 
spectral data showed that the normal adrenal gland tissues have higher levels of 
carotenoids, lipids, and cholesterol compared to the neuroblastoma and ganglioneuroma 
frozen tissues137.  However, in comparison to the frozen tissues the FFPP tissues show a 
significant alteration in several biochemicals, including complete removal of carotenoids, 
lipids, and cholesterol in adrenal gland tissues as shown in Chapter 7.  
The quantitative analysis, of the Raman data obtained from the frozen tissues, using 
PCA and DFA showed a clear-cut classification among pathological groups with high 
sensitivity and specificity.137  This study showed that Raman spectroscopy combined with 
chemometric methods can be successfully used to distinguish neuroblastoma and 
ganglioneuroma at cellular level in frozen tissue sections.  Further, the nature of chemical 
changes that occur in processing and preservation of these tissues were evident in Raman 
spectra, and thus suggesting that one can also use the FFPP tissues for optical diagnosis 
using Raman spectroscopy. 
 
Acanthosis Nigricans: Diffuse Reflectance Spectroscopy/Colorimetry 
In this study, we investigated acanthosis nigricans (AN) skin diseases, 
hyperpigmented velvety plaques in skin using diffuse reflectance spectroscopy (DRS) and 
the colorimetry in vivo.  The non-invasive optical technique DRS provides information on 
skin melanin, oxyhemoglobin, and deoxyhemoglobin content through the measured 
absorption spectrum whereas colorimetry measures the skin color based on the standard 
Tristimulus values (so called L*, a*, and b* parameters).  Measurements were conducted 
on eight AN patients, spanning eight months of treatment by diet control and/or oral 
metformin.  The study indicated an increase in melanin concentration AN lesion areas 
compared to the normal control sites.  L* and b* show a significant differences between AN 
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lesion and normal controls, and a* and melanin are weak indicators.144  In fact, 
oxyhemoglobin and deoxyhemoglobin didn’t show any significant differences what so ever, 
so they are not reliable for the screening of AN.  
PCA and DFA of the spectral data provided more robust results compared to the 
standard analytical methods in attempting to classify an undiagnosed skin sample as 
“lesion” or “healthy.”  PCA-DFA successfully differentiated between AN lesion and normal 
skin controls with 87.7% sensitivity and 94.8% specificity in DRS measurements, and 
97.2% sensitivity and 96.4% specificity in colorimetry measurements.137  These 
chemometric methods provided a better diagnostic ability than skin chromophore 
concentration calculations based on DRS data.  
Both spectroscopic measurements, dermatological evaluations, and insulin level 
measurements showed no change in AN patients between the chronological visits to their 
doctors.  Thus, we could not draw any conclusions regarding suppression of AN as none of 
the patients healed during the course of this research work.   
 
9.2 Future Work 
The investigation of the head and neck squamous cell carcinoma, prostate cancer, 
and pediatric tumors using deparaffinized tissue sections from archived paraffin embedded 
blocks has lots of advantages.  The easy access to these archived tissue blocks reduces the 
waiting time to obtain a fresh tissue sample from a patient.  Since, there are a large number 
of tissue specimens available in the archives, a large Raman spectroscopic data can be 
collected for different types of cancers.  In order to validate any hypothesis, it is important 
to have the analysis done with a large data set.  However, a prior knowledge of loss of 
Raman information upon preserving the tissues using formalin fixating and embedding in 
paraffin is very important.  Our study has documented this in the case of pediatric tumors, 
where, we studied the spectral difference between frozen and their corresponding FFPP 
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tissues.  The nature of changes that occur in preserving the tissues for archival purposes 
could be different for different types of tissues and the type of cancer.  Thus, one needs to 
investigate the nature of changes that entail tissue archival in different types of cancers 
using frozen and their corresponding preserved tissues before using the Raman 
spectroscopy for diagnosis using the archived FFPP tissues.  The investigation of frozen 
tissues seems more realistic and useful as the frozen tissues produce Raman spectra similar 
to the fresh tissues.  By increasing spectral database for the frozen tissues of different 
cancer types, one can use this technique as an additional tool to obtain complementary 
information about the state of a disease or cancer to augment the pathological evaluations.  
Pathological evaluations can be subjective depending on the experience of the pathologists.  
Raman spectroscopic detection may provide new means for disease/cancer detection, in 
vitro or in vivo.  
Regarding prostate cancer investigation, it is an established observation that a 
prostate gland exhibiting PIN cell architecture may or may not progress to carcinoma.  So, 
the fundamental and most important issue here is to determine which cell architecture will 
lead to cancer.  Thus, future studies could focus on finding the unique Raman spectral 
features of the PIN cell architecture that leads to carcinoma.  
 Regarding, optical diagnosis of acanthosis nigricans, there are certain draw backs.  
The main disadvantage is the difficulty in enrolling new patients into this research project.  
Even if new patients enroll, some of them abandon the research study in the middle of the 
study period.  Another disadvantage is that although the patients are advised not to 
consume any food during fasting insulin level measurements, this cannot be strictly 
controlled.  If this happens, the measured values have to be discarded from the study.  
Although, the patients are supposed to control their diet and are advised on exercising to 
control and get better from this AN skin disorder, as researchers, we do not have the 
control over the patients’ activities but one can minimize these issues with close doctor-
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patient relationship and motivating the enrolled patients to remain in the study.  One could 
also conduct this study on other ethnic groups, although, AN is common among African-
Americans using other ethnic groups may provide dependence on skin type.  
This study also suggests that we can use a different predictor of the patients’ insulin 
level.  That would be the hemoglobin A1c test, which does not require fasting.  This test 
provides a reliable measure to know whether the patient’s blood glucose level for the 
previous 3 months is persistently elevated or not.  Thus, more meaningful results can be 
obtained by conducting this research work for about 5 years. 
In a near-perfect scenario, one can determine the skin changes during the healing 
process using diffuse reflectance spectroscopy/colorimetry and correlate the measurements 
with serum insulin level and insulin sensitivity in AN.  Then, this particular skin disorder 
becomes a diagnostic parameter for insulin-resistant obese AN patients to evaluate the 
insulin sensitivity.  The ultimate objective is to replace the time consuming and resource 
extensive procedures of blood collection and laboratory evaluations of obese patients having 
AN by non-invasive DR measurements. 
Furthermore, we can strengthen the statistical/chemometric analysis by increasing 
the size of the data set.  For a large enough data set, PCA-DFA analysis can be used to 
propose a reliable model.  Then using this model, one can validate the new data set with the 
proposed model.  The alternate advanced chemometric methods such as partial-least 
square regression method or support vector machines method could be used to analyze the 
Raman or diffuse reflectance spectral data to assess the discrimination ability of these 
techniques compared to the PCA and DFA.  
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APPENDIX A 
SUPPLEMENTARY TABLES  
 
Raman Shift 
(cm-1) 753 850 933 
1235
/40 1306 1335 1365 1446 1562 1584 1614 1650 
Pearson 1 -.064 -.010 -.356 -.484 -.219 .712 -.461 .809 .616 .744 -.464 
753 
Sig.  .200 .836 .000 .000 .000 .000 .000 .000 .000 .000 .000 
Pearson -.064 1 .717 .191 .357 .224 -.517 .283 -.501 -.666 -.495 .533 
850 
Sig. .200  .000 .000 .000 .000 .000 .000 .000 .000 .000 .000 
Pearson -.010 .717 1 .062 .236 .183 -.310 .181 -.280 -.444 -.206 .293 
933 
Sig. .836 .000  .217 .000 .000 .000 .000 .000 .000 .000 .000 
Pearson -.356 .191 .062 1 .915 .874 -.086 .609 -.475 -.346 -.268 .573 
1235/
40 
Sig. .000 .000 .217  .000 .000 .085 .000 .000 .000 .000 .000 
Pearson -.484 .357 .236 .915 1 .911 -.262 .759 -.641 -.537 -.438 .649 
1306 
Sig. .000 .000 .000 .000  .000 .000 .000 .000 .000 .000 .000 
Pearson -.219 .224 .183 .874 .911 1 .103 .681 -.335 -.251 -.122 .510 
1335 
Sig. .000 .000 .000 .000 .000  .039 .000 .000 .000 .015 .000 
Pearson .712 -.517 -.310 -.086 -.262 .103 1 -.197 .851 .843 .879 -.474 
1365 
Sig. .000 .000 .000 .085 .000 .039  .000 .000 .000 .000 .000 
Pearson -.461 .283 .181 .609 .759 .681 -.197 1 -.558 -.410 -.501 .620 
1446 
Sig. .000 .000 .000 .000 .000 .000 .000  .000 .000 .000 .000 
Pearson .809 -.501 -.280 -.475 -.641 -.335 .851 -.558 1 .892 .929 -.646 
1562 
Sig. .000 .000 .000 .000 .000 .000 .000 .000  .000 .000 .000 
Pearson .616 -.666 -.444 -.346 -.537 -.251 .843 -.410 .892 1 .838 -.552 
1584 
Sig. .000 .000 .000 .000 .000 .000 .000 .000 .000  .000 .000 
Pearson .744 -.495 -.206 -.268 -.438 -.122 .879 -.501 .929 .838 1 -.670 
1614 
Sig. .000 .000 .000 .000 .000 .015 .000 .000 .000 .000  .000 
Pearson -.464 .533 .293 .573 .649 .510 -.474 .620 -.646 -.552 -.670 1 
1650 
Sig. .000 .000 .000 .000 .000 .000 .000 .000 .000 .000 .000  
Table A1 Pearson correlation with 2-tailed significance for selected 12 Raman bands in head 
and neck squamous cell carcinoma (see Chapter 5) 
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Pearson Correlation Coefficient (r) 
(P-value) Parameters 1st-2nd 
month 
1st-3rd 
month 
1st-4th 
month 
1st–5th 
month 
1st–6th 
month 
∆L* / ∆melanin -0.50 (0.31) 
-0.48 
(0.33) 
-0.67 
(0.22) 
-0.88 
(0.12) 
-0.97 
(0.17) 
∆a* / ∆ HbO2 -0.32 (0.54) 
-0.29 
(0.58) 
0.29 
(0.63) 
0.76 
(0.24) 
1.00 
(0.04) 
∆b* / ∆Hb 0.09 (0.87) 
0.48 
(0.34) 
-0.97 
(0.01) 
0.76 
(0.80) 
-0.37 
(0.76) 
Table A2 Correlations between the L*, a*, and b* color parameters (colorimetry) vs 
melanin, oxyhemoglobin (HbO2), and deoxyhemoglobin (Hb) (DRS) measured on acanthosis 
nigricans neck lesions (see Chapter 8) 
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Variable N Mean Std Dev P-value 
L* 1st month 
L* 2nd month 
L* 3rd month 
L* 4th month 
 
a* 1st month  
a* 2nd month 
a* 3rd month 
a* 4th month 
 
b* 1st month 
b* 2nd month 
b* 3rd month 
b* 4th month 
 
Melanin  1st month 
Melanin  2nd month  
Melanin 3rd month 
Melanin 4th month 
 
Oxyhemoglobin  1st month  
Oxyhemoglobin 2nd month  
Oxyhemoglobin  3rd month  
Oxyhemoglobin  4th month 
 
Deoxyhemoglobin 1st month 
Deoxyhemoglobin 2nd month 
Deoxyhemoglobin  3rd month  
Deoxyhemoglobin  4th month 
 
8 
8 
8 
8 
 
8 
8 
8 
8 
 
8 
8 
8 
8 
 
6 
8 
8 
8 
 
6 
8 
8 
8 
 
6 
8 
8 
8 
 
-27.56 
-26.83 
-27.65 
-29.48 
 
-29.26 
-19.49 
-17.84 
-16.31 
 
-47.85 
-42.26 
-42.17 
-43.92 
 
33.68 
27.50 
30.11 
31.05 
 
64.29 
10.92 
-3.43 
10.10 
 
-32.08 
-44.81 
-32.02 
-44.91 
 
7.86 
7.63 
7.56 
7.77 
 
15.16 
25.88 
27.74 
30.60 
 
12.98 
17.24 
18.46 
18.53 
 
10.45 
10.37 
14.56 
12.98 
 
114.45 
32.92 
73.03 
61.29 
 
27.05 
26.06 
25.87 
35.59 
<0.001 
<0.001 
<0.001 
<0.001 
 
<0.001 
0.071 
0.112 
0.176 
 
<0.001 
<0.001 
<0.001 
<0.001 
 
<0.001 
<0.001 
<0.001 
<0.001 
 
0.227 
0.380 
0.898 
0.655 
 
0.034 
0.002 
0.010 
0.009 
 
Table A3 Percent difference in measured parameters between lesion skin and normal skin144 
in the AN study (see Chapter 8) 
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APPPENDIX B 
STEP BY STEP INSTRUCTIONS FOR DATA PROCESSING 
All the Raman spectral data obtained from Renishaw Raman spectrometer and Jobin-
Yvon Horiba Triax550 Raman spectrometer system are in .txt format.  
 
Denoising and Normalizing  
1. Make a folder, say “Data”, copy all the .txt files to the “Data” folder together with the 
MatLab “adaptminmax” program. 
2. Create a text file, "filelist.txt" containing all the names of the Raman spectral data 
files.  
a. Copy the “Data” folder to the desktop 
b. Open the “command prompt” window 
c. Enter "cd desktop" 
d. Enter "cd Data " (now you are in the "Data" folder) 
e. Enter "dir /b >filelist.txt", make sure you open the "filelist.txt" and delete the 
name filelist.txt, keep only the names of the relevant files) 
3. Run the “adaptminmax” program, enter "y" to see the graphs while processing. 
 
Creating Mean Raman Spectra 
1. Make a folder on the desktop, say “Mean”, and copy all the relevant .txt files to the 
“Mean” folder together with the matlab “gulaygraph2” program. 
2. Create a text file, “N-filelist.txt” 
a. Repeat step 2, from (b) to (d) of “De-noising and Normalizing” 
b. Now enter “dir /b >N-filelist.txt”.  Similarly, open the "N-filelist.txt" and 
delete the name “N-filelist.txt” 
3. Run the “gulaygraph2” program. 
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Creating a one txt file with all the Raman Data 
1. Make a folder on the desktop, say “All-Data”, and copy all the .txt files to the “All-
Data” folder together with the MatLab “combinespectra81706” program. 
2. Create a text file, “filelist.txt” 
a. Repeat step 2 of “De-noising and Normalizing” 
b. Now enter “dir /b >filelist.txt”. Similarly, open the "filelist.txt" and delete the 
name “filelist.txt” 
3. Run the “combinespectra81706” program. 
4. This will create a .txt file “allspectra.txt” with variables in columns. 
 
PCA using SPSS 
1. Open “SPSS” software 
2. Click “file”, enter “read a text” 
3. Change the variable names of V1 - V601 to VV600, VV602,…..VV1800 
4. Go to “View variable” mode and insert three variables in the first raw. 
5. Change the first variable to “string”,  change the name to “Spectra” 
6. Change name of the 2nd variable to “Diagnosis”  and the 3rd to “Groups” 
7. Click “Value” and create group names and numbers, say 1-Normal, 2-
Neuroblastoma, and 3-Ganglioneuroma 
8. Go to the Data mode and copy paste the name list to the “Spectra” column 
9. Now, enter value 1-3 to the relevant data cases. 
10.  Click “Analyze/Dimension Reduction/Factor”, select all the variables and bring those 
variables to the window named variables.  Now, select “extraction” as shown by the 
following window. 
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11.  Select “Covariance matrix” and press “Continue”.  Then click “Scores” and select 
“Save as variables” and press “Continue”.  Now press “OK”.  Then, one can see the 
principal scores at the end of the variables. 
 
DFA using SPSS 
1. Click “Analyze/Classify/Discriminant”, then the following window will appear. 
 
2. Bring the principal components from the left window to the “Independents”.  Also 
bring variable “Group” to the “Grouping Variables”, then define the range from 1-3. 
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Now, select “Statistics”, and select “Fisher’s” under “Functions Coefficients” and 
press “Continue”. 
3. Click “Classify”, and select options of “Case wise Results, Summary Table and Leave-
one-out Classification” under “Display”, and “Combined-groups” under “Plots” and 
press “Continue”. 
4. Click “Save” and select the option of “Discriminant Scores” and press “Continue”. 
Finally press “OK”.  Then, the software will generate the appropriate tables and plots. 
 
 
External Validation 
1. Once you choose which patient data to feed as test data, delete the values of the 
columns “Diagnosis” and “group” in those data cases before you do the DFA analysis. 
2. Perform the DFA as explained above. 
3. The results of the selected ungrouped data cases appear in the  classification table as 
“ungrouped cases”  
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Cancer and diabetes are common chronic diseases in today’s world causing 
numerous deaths in adults as well as children.  Most common types of cancers in adults 
include prostate, lung, breast, colorectal and head and neck squamous cell carcinoma, while 
among children; leukemia, and brain and central nervous system cancers are quite 
common.  In each of these cases, early detection of the cancer or disease dramatically 
increases the chances of successful treatment.  In recent years, there has been much 
interest in using Raman spectroscopy and diffuse reflectance spectroscopy as analytical 
optical spectroscopic methods for early diagnosis of diseases.  Raman spectroscopy can be 
used to measure changes in the bio-molecular composition of a tissue specimen, and diffuse 
reflectance spectroscopy can measure chromophores of the skin.  In this research, archived 
(formalin-fixed paraffin processed) tissues of head and neck squamous cell carcinoma, 
prostate, and pediatric tumors have been investigated using Raman spectroscopy.  We have 
utilized statistical methods such as principal component analysis (PCA) and discriminant 
function analysis (DFA) to analyze the spectral output and distinguish between normal and 
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cancerous tissues.  The results show cancerous tissues can be successfully distinguished 
from normal tissues in three cancer types in ex vivo.  However, due to loss of biochemical in 
the tissue processing (paraffinizing and deparaffinizing procedure), the prediction ability of 
the archived tissues are less compared to frozen tissues as observed in the pediatric tumor 
investigation.  
We also investigated the diagnostic capability of diffuse reflectance spectroscopy and 
colorimetry on a skin disease, acanthosis nigricans in vivo.  The aim is to quantify and 
characterize the skin color change associated with acanthosis nigricans skin disease in 
insulin-resistant obese individuals.  We observe both the instruments can be utilized to 
detect acanthosis nigricans with more than 87% sensitivity and 94% specificity when 
combined with advanced chemometric methods.  
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